Lung cancer cells and their sensitivity/resistance to cisplatin chemotherapy: Role of microRNAs and upstream mediators
Cisplatin (CP) is a well-known chemotherapeutic agent with excellent clinical effects. The anti-tumor activity of CP has been demonstrated in different cancers such as breast, cervical, reproductive, lung, brain, and prostate cancers. However, resistance of cancer cells to CP chemotherapy has led to...
Uloženo v:
| Vydáno v: | Cellular signalling Ročník 78; s. 109871 |
|---|---|
| Hlavní autoři: | , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
England
Elsevier Inc
01.02.2021
|
| Témata: | |
| ISSN: | 0898-6568, 1873-3913, 1873-3913 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Cisplatin (CP) is a well-known chemotherapeutic agent with excellent clinical effects. The anti-tumor activity of CP has been demonstrated in different cancers such as breast, cervical, reproductive, lung, brain, and prostate cancers. However, resistance of cancer cells to CP chemotherapy has led to its failure in eradication of cancer cells, and subsequent death of patients with cancer. Fortunately, much effort has been put to identify molecular pathways and mechanisms involved in CP resistance/sensitivity. It seems that microRNAs (miRs) are promising candidates in mediating CP resistance/sensitivity, since they participate in different biological aspects of cells such as proliferation, migration, angiogenesis, and differentiation. In this review, we focus on miRs and their regulation in CP chemotherapy of lung cancer, as the most malignant tumor worldwide. Oncogenic miRs trigger CP resistance in lung cancer cells via targeting various pathways such as Wnt/β-catenin, Rab6, CASP2, PTEN, and Apaf-1. In contrast, onco-suppressor miRs inhibit oncogene pathways such as STAT3 to suppress CP resistance. These topics are discussed to determine the role of miRs in CP resistance/sensitivity. We also describe the upstream modulators of miRs such as lncRNAs, circRNAs, NF-κB, SOX2 and TRIM65 and their association with CP resistance/sensitivity in lung cancer cells. Finally, the effect of anti-tumor plant-derived natural compounds on miR expression during CP sensitivity of lung cancer cells is discussed.
[Display omitted]
•Cisplatin is widely applied in cancer chemotherapy with promising clinical outcomes,•Resistance of cancer cells to chemotherapy has restricted its therapeutic potential,•MicroRNAs (miRs) are potent regulators of cellular events,•MiRs induce/inhibit cisplatin resistance in lung cancer cells,•Upstream mediators such as long non-coding RNAs, circular RNAs and NF-κB regulate miRs in resistance/sensitivity of lung cancer cells to cisplatin chemotherapy. |
|---|---|
| AbstractList | Cisplatin (CP) is a well-known chemotherapeutic agent with excellent clinical effects. The anti-tumor activity of CP has been demonstrated in different cancers such as breast, cervical, reproductive, lung, brain, and prostate cancers. However, resistance of cancer cells to CP chemotherapy has led to its failure in eradication of cancer cells, and subsequent death of patients with cancer. Fortunately, much effort has been put to identify molecular pathways and mechanisms involved in CP resistance/sensitivity. It seems that microRNAs (miRs) are promising candidates in mediating CP resistance/sensitivity, since they participate in different biological aspects of cells such as proliferation, migration, angiogenesis, and differentiation. In this review, we focus on miRs and their regulation in CP chemotherapy of lung cancer, as the most malignant tumor worldwide. Oncogenic miRs trigger CP resistance in lung cancer cells via targeting various pathways such as Wnt/β-catenin, Rab6, CASP2, PTEN, and Apaf-1. In contrast, onco-suppressor miRs inhibit oncogene pathways such as STAT3 to suppress CP resistance. These topics are discussed to determine the role of miRs in CP resistance/sensitivity. We also describe the upstream modulators of miRs such as lncRNAs, circRNAs, NF-κB, SOX2 and TRIM65 and their association with CP resistance/sensitivity in lung cancer cells. Finally, the effect of anti-tumor plant-derived natural compounds on miR expression during CP sensitivity of lung cancer cells is discussed.Cisplatin (CP) is a well-known chemotherapeutic agent with excellent clinical effects. The anti-tumor activity of CP has been demonstrated in different cancers such as breast, cervical, reproductive, lung, brain, and prostate cancers. However, resistance of cancer cells to CP chemotherapy has led to its failure in eradication of cancer cells, and subsequent death of patients with cancer. Fortunately, much effort has been put to identify molecular pathways and mechanisms involved in CP resistance/sensitivity. It seems that microRNAs (miRs) are promising candidates in mediating CP resistance/sensitivity, since they participate in different biological aspects of cells such as proliferation, migration, angiogenesis, and differentiation. In this review, we focus on miRs and their regulation in CP chemotherapy of lung cancer, as the most malignant tumor worldwide. Oncogenic miRs trigger CP resistance in lung cancer cells via targeting various pathways such as Wnt/β-catenin, Rab6, CASP2, PTEN, and Apaf-1. In contrast, onco-suppressor miRs inhibit oncogene pathways such as STAT3 to suppress CP resistance. These topics are discussed to determine the role of miRs in CP resistance/sensitivity. We also describe the upstream modulators of miRs such as lncRNAs, circRNAs, NF-κB, SOX2 and TRIM65 and their association with CP resistance/sensitivity in lung cancer cells. Finally, the effect of anti-tumor plant-derived natural compounds on miR expression during CP sensitivity of lung cancer cells is discussed. Cisplatin (CP) is a well-known chemotherapeutic agent with excellent clinical effects. The anti-tumor activity of CP has been demonstrated in different cancers such as breast, cervical, reproductive, lung, brain, and prostate cancers. However, resistance of cancer cells to CP chemotherapy has led to its failure in eradication of cancer cells, and subsequent death of patients with cancer. Fortunately, much effort has been put to identify molecular pathways and mechanisms involved in CP resistance/sensitivity. It seems that microRNAs (miRs) are promising candidates in mediating CP resistance/sensitivity, since they participate in different biological aspects of cells such as proliferation, migration, angiogenesis, and differentiation. In this review, we focus on miRs and their regulation in CP chemotherapy of lung cancer, as the most malignant tumor worldwide. Oncogenic miRs trigger CP resistance in lung cancer cells via targeting various pathways such as Wnt/β-catenin, Rab6, CASP2, PTEN, and Apaf-1. In contrast, onco-suppressor miRs inhibit oncogene pathways such as STAT3 to suppress CP resistance. These topics are discussed to determine the role of miRs in CP resistance/sensitivity. We also describe the upstream modulators of miRs such as lncRNAs, circRNAs, NF-κB, SOX2 and TRIM65 and their association with CP resistance/sensitivity in lung cancer cells. Finally, the effect of anti-tumor plant-derived natural compounds on miR expression during CP sensitivity of lung cancer cells is discussed. Cisplatin (CP) is a well-known chemotherapeutic agent with excellent clinical effects. The anti-tumor activity of CP has been demonstrated in different cancers such as breast, cervical, reproductive, lung, brain, and prostate cancers. However, resistance of cancer cells to CP chemotherapy has led to its failure in eradication of cancer cells, and subsequent death of patients with cancer. Fortunately, much effort has been put to identify molecular pathways and mechanisms involved in CP resistance/sensitivity. It seems that microRNAs (miRs) are promising candidates in mediating CP resistance/sensitivity, since they participate in different biological aspects of cells such as proliferation, migration, angiogenesis, and differentiation. In this review, we focus on miRs and their regulation in CP chemotherapy of lung cancer, as the most malignant tumor worldwide. Oncogenic miRs trigger CP resistance in lung cancer cells via targeting various pathways such as Wnt/β-catenin, Rab6, CASP2, PTEN, and Apaf-1. In contrast, onco-suppressor miRs inhibit oncogene pathways such as STAT3 to suppress CP resistance. These topics are discussed to determine the role of miRs in CP resistance/sensitivity. We also describe the upstream modulators of miRs such as lncRNAs, circRNAs, NF-κB, SOX2 and TRIM65 and their association with CP resistance/sensitivity in lung cancer cells. Finally, the effect of anti-tumor plant-derived natural compounds on miR expression during CP sensitivity of lung cancer cells is discussed. [Display omitted] •Cisplatin is widely applied in cancer chemotherapy with promising clinical outcomes,•Resistance of cancer cells to chemotherapy has restricted its therapeutic potential,•MicroRNAs (miRs) are potent regulators of cellular events,•MiRs induce/inhibit cisplatin resistance in lung cancer cells,•Upstream mediators such as long non-coding RNAs, circular RNAs and NF-κB regulate miRs in resistance/sensitivity of lung cancer cells to cisplatin chemotherapy. |
| ArticleNumber | 109871 |
| Author | Najafi, Masoud Hashemi, Farid Khan, Haroon Owrang, Marzieh Hushmandi, Kiavash Moghadam, Ebrahim Rahmani Hashemi, Fardin Makvandi, Pooyan Goharrizi, Mohammad Ali Sheikh Beig Ashrafizadeh, Milad Zarrabi, Ali |
| Author_xml | – sequence: 1 givenname: Milad surname: Ashrafizadeh fullname: Ashrafizadeh, Milad organization: Faculty of Engineering and Natural Sciences, Sabanci University, Orta Mahalle, Üniversite Caddesi No. 27, Orhanlı, Tuzla 34956, Istanbul, Turkey – sequence: 2 givenname: Ali surname: Zarrabi fullname: Zarrabi, Ali organization: Sabanci University Nanotechnology Research and Application Center (SUNUM), Tuzla 34956, Istanbul, Turkey – sequence: 3 givenname: Kiavash surname: Hushmandi fullname: Hushmandi, Kiavash organization: Department of Food Hygiene and Quality Control, Division of Epidemiology & Zoonoses, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran – sequence: 4 givenname: Farid surname: Hashemi fullname: Hashemi, Farid organization: Department of Comparative Biosciences, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran – sequence: 5 givenname: Ebrahim Rahmani surname: Moghadam fullname: Moghadam, Ebrahim Rahmani organization: Department of Anatomical Sciences, School of Medicine, Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran – sequence: 6 givenname: Marzieh surname: Owrang fullname: Owrang, Marzieh organization: Department of Anatomical Sciences, School of Medicine, Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran – sequence: 7 givenname: Fardin surname: Hashemi fullname: Hashemi, Fardin organization: Student Research Committee, Department of Physiotherapy, Faculty of Rehabilitation, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran – sequence: 8 givenname: Pooyan surname: Makvandi fullname: Makvandi, Pooyan organization: Istituto Italiano di Tecnologia, Centre for Micro-BioRobotics, viale Rinaldo Piaggio 34, 56025 Pontedera, Pisa, Italy – sequence: 9 givenname: Mohammad Ali Sheikh Beig surname: Goharrizi fullname: Goharrizi, Mohammad Ali Sheikh Beig organization: Atherosclerosis Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran – sequence: 10 givenname: Masoud surname: Najafi fullname: Najafi, Masoud email: najafi_ma@yahoo.com organization: Medical Technology Research Center, Institute of Health Technology, Kermanshah University of Medical Sciences, Kermanshah, Iran – sequence: 11 givenname: Haroon surname: Khan fullname: Khan, Haroon email: haroonkhan@awkum.edu.pk organization: Department of Pharmacy, Abdul Wali Khan University Mardan, 23200, Pakistan |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33279671$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkUtv1DAUhS1URKeFnwDykk2mfsSPwAJVFS9pBFIFa8vj3LQeJXawnZHm35OQgQWbrq509Z2je8-5QhchBkDoNSVbSqi8OWwd9H32D1tG2LJrtKLP0IZqxSveUH6BNkQ3upJC6kt0lfOBECqIZC_QJedMNVLRDTrupvCAnQ0OEv7jiG1ocXkEn3CGkH3xR19ONwmyz2XhcInY-Tz2tviA3SMMccaTHU_v8H3sAccOD96leP_tdnWbxlwS2AEP0HpbYsov0fPO9hlenec1-vnp44-7L9Xu--evd7e7ynEpStXtrSZNK2vRcaGFU84RJR1t24a5RijrLNG1FpJbbq2kknQSuGo1E6xr9J5fo7er75jirwlyMYPPy5s2QJyyYbVUuia1ZDP65oxO-_lOMyY_2HQyf7OaAbEC82s5J-j-IZSYpRNzMOdOzNKJWTuZde__0zlf5uxiKMn6_kn1h1UNc0xHD8lk52GuofUJXDFt9E84_AY_ZqyF |
| CitedBy_id | crossref_primary_10_1016_j_envres_2023_116458 crossref_primary_10_1016_j_ejphar_2024_177221 crossref_primary_10_1080_1120009X_2022_2043515 crossref_primary_10_1097_COC_0000000000001106 crossref_primary_10_1016_j_indcrop_2025_121474 crossref_primary_10_1007_s00210_023_02386_9 crossref_primary_10_1016_j_biopha_2022_113609 crossref_primary_10_1002_mco2_583 crossref_primary_10_1111_cbdd_14493 crossref_primary_10_1002_iub_2624 crossref_primary_10_1111_bcpt_13648 crossref_primary_10_3390_cells10123479 crossref_primary_10_1016_j_semcancer_2022_05_012 crossref_primary_10_1016_j_ejphar_2021_174178 crossref_primary_10_1016_j_biopha_2023_115979 crossref_primary_10_1007_s10565_022_09778_2 crossref_primary_10_1016_j_drup_2022_100888 crossref_primary_10_1002_ardp_202300269 crossref_primary_10_1016_j_phrs_2022_106568 crossref_primary_10_1186_s12935_025_03657_6 crossref_primary_10_3390_pharmaceutics15051325 crossref_primary_10_1007_s10555_023_10129_8 crossref_primary_10_1002_jcp_31296 crossref_primary_10_1016_j_ijbiomac_2024_132347 crossref_primary_10_1016_j_lfs_2021_119649 crossref_primary_10_1016_j_mtchem_2021_100740 crossref_primary_10_1017_erm_2021_15 crossref_primary_10_3390_jcm11020341 crossref_primary_10_3390_biom11020304 crossref_primary_10_1002_jcp_30751 crossref_primary_10_1016_j_jconrel_2024_04_020 crossref_primary_10_1016_j_jpba_2023_115346 crossref_primary_10_3389_fphar_2024_1469830 crossref_primary_10_1002_jcp_30759 crossref_primary_10_1111_jcmm_17005 crossref_primary_10_2147_JEP_S267383 crossref_primary_10_1016_j_yexcr_2021_112914 crossref_primary_10_1002_ijc_35499 crossref_primary_10_3389_fonc_2022_729088 crossref_primary_10_1016_j_ejbt_2022_04_006 crossref_primary_10_1002_ptr_7305 crossref_primary_10_1016_j_prp_2023_154906 crossref_primary_10_1016_j_envres_2023_115914 crossref_primary_10_1007_s00417_024_06723_3 crossref_primary_10_1039_D2NR05403E crossref_primary_10_3390_ph14040313 crossref_primary_10_1016_j_prp_2023_154988 crossref_primary_10_1016_j_prp_2024_155316 crossref_primary_10_1016_j_heliyon_2024_e27302 crossref_primary_10_1016_j_abb_2021_108952 crossref_primary_10_1016_j_intimp_2021_107895 crossref_primary_10_1093_jpp_rgae141 crossref_primary_10_1016_j_cellsig_2023_110797 crossref_primary_10_1186_s12967_024_05126_6 crossref_primary_10_1186_s13045_022_01235_1 crossref_primary_10_1016_j_lfs_2022_121340 crossref_primary_10_4103_JAPTR_JAPTR_334_23 crossref_primary_10_1002_adma_202308977 crossref_primary_10_1007_s12672_023_00686_3 crossref_primary_10_1007_s12032_021_01626_3 crossref_primary_10_1016_j_mvr_2022_104362 crossref_primary_10_1080_1120009X_2023_2213490 crossref_primary_10_3390_cancers16091729 crossref_primary_10_1097_CAD_0000000000001622 crossref_primary_10_1007_s10495_023_01849_x crossref_primary_10_2147_JHC_S336858 crossref_primary_10_1016_j_envres_2023_115942 crossref_primary_10_1016_j_jep_2022_115654 crossref_primary_10_1016_j_diabres_2023_110804 crossref_primary_10_3390_md22040147 crossref_primary_10_1590_s2175_97902023e23259 crossref_primary_10_3389_fimmu_2025_1593793 crossref_primary_10_1038_s41420_024_01798_7 crossref_primary_10_1016_j_critrevonc_2022_103680 crossref_primary_10_1016_j_scitotenv_2024_175262 crossref_primary_10_1186_s10020_023_00602_z crossref_primary_10_1016_j_prp_2024_155132 crossref_primary_10_1016_j_biopha_2023_115927 crossref_primary_10_3389_fphar_2021_736442 crossref_primary_10_1155_2022_3796218 crossref_primary_10_2147_OTT_S324015 crossref_primary_10_1007_s12672_024_01525_9 crossref_primary_10_1016_j_jpha_2024_101179 crossref_primary_10_3390_molecules26082382 crossref_primary_10_1016_j_envres_2023_116007 crossref_primary_10_1002_slct_202401449 crossref_primary_10_1007_s00432_024_05611_x crossref_primary_10_1016_j_brainresbull_2021_11_016 crossref_primary_10_1016_j_intimp_2023_109905 crossref_primary_10_1016_j_omto_2022_02_011 crossref_primary_10_1016_j_biopha_2023_114313 crossref_primary_10_1016_j_tice_2021_101680 crossref_primary_10_1002_bab_2386 crossref_primary_10_1002_ptr_7189 crossref_primary_10_1038_s41467_022_34718_3 crossref_primary_10_1186_s12935_025_03666_5 crossref_primary_10_1080_1120009X_2022_2056995 crossref_primary_10_1016_j_cellsig_2022_110566 |
| Cites_doi | 10.18632/oncotarget.22171 10.7150/thno.43142 10.1038/s41598-019-39453-2 10.2147/IJN.S131516 10.1016/j.eurpolymj.2019.02.007 10.1016/j.jprot.2010.06.006 10.1016/j.bbrc.2014.10.054 10.2174/1389200221666200106105201 10.1016/j.cell.2019.05.026 10.1002/jcp.28832 10.1159/000481754 10.1186/s12943-018-0869-y 10.3390/ijms21062092 10.3892/ol.2015.4000 10.1038/cddis.2014.386 10.1093/jb/mvz066 10.1007/s00018-019-03053-0 10.1186/s12935-019-0985-9 10.1007/s11010-016-2827-6 10.18632/oncotarget.6852 10.1080/15384047.2018.1529091 10.1007/s10637-019-00886-1 10.18632/oncotarget.24474 10.2147/OTT.S193097 10.1097/GME.0000000000001526 10.1080/10799893.2020.1720240 10.1016/j.canlet.2019.12.039 10.1038/leu.2011.356 10.1038/nrm3758 10.1101/gad.224503 10.3892/ijo.2015.3144 10.1016/j.omtn.2019.10.047 10.1038/srep19455 10.1002/jcb.29586 10.3389/fphar.2019.00836 10.1007/s13277-015-4017-7 10.1016/j.lungcan.2012.05.107 10.1097/CAD.0000000000000524 10.1038/onc.2016.414 10.3892/ijmm.2016.2513 10.1016/j.biopha.2020.110100 10.1038/s41598-018-26381-w 10.1186/s12885-019-6194-z 10.1186/s12890-020-1112-3 10.1158/1055-9965.EPI-18-0569 10.1002/jcb.29554 10.1186/1476-4598-13-193 10.1002/jcp.29266 10.1007/s00280-020-04061-9 10.1093/nar/gks670 10.1080/21655979.2019.1657327 10.1021/acs.jpcb.0c00946 10.1080/21691401.2019.1703724 10.1093/nar/gku1279 10.1096/fj.201900731RR 10.1016/j.lfs.2020.117325 10.1038/s41586-018-0453-z 10.1007/s11033-018-4416-0 10.1016/j.cancergen.2014.04.003 10.18632/oncotarget.8708 10.1016/j.canlet.2018.04.028 10.1016/j.bbrc.2016.08.006 10.3389/fonc.2020.00308 10.1016/j.bcp.2020.113939 10.3389/fonc.2020.00215 10.1016/S0092-8674(04)00045-5 10.1016/j.jare.2020.07.004 10.1016/j.bbrc.2017.05.075 10.1007/s00280-019-03808-3 10.18632/oncotarget.8011 10.1186/s12885-018-4460-0 10.1158/1535-7163.MCT-05-0102 10.1016/j.imlet.2018.10.012 10.1073/pnas.0707628104 10.1016/j.biopha.2020.109896 10.1186/s12935-020-1162-x 10.2147/CMAR.S243796 10.1186/s12935-019-1051-3 10.1016/j.omtn.2020.03.002 10.3892/etm.2017.4433 10.1111/1759-7714.13409 10.7150/jca.40974 10.1186/s13287-018-1072-1 10.1038/s41419-019-1660-8 10.1016/j.bbamem.2009.07.009 10.1021/acsami.9b03960 10.1038/s41598-020-61295-6 10.3390/jcm9020542 10.1186/s12885-017-3132-9 10.1097/WNR.0000000000001440 10.1002/jcp.29656 10.1186/s13059-017-1368-y 10.1186/s12935-019-0910-2 10.1016/j.biopha.2020.110099 10.1038/boneres.2014.3 10.1038/ncb1596 10.1038/s41419-017-0103-7 10.1038/s41419-019-2190-0 10.12659/MSM.916075 10.3390/biomedicines6030082 10.1080/09553002.2018.1400191 10.1002/mc.22765 10.1002/mc.22901 10.18632/oncotarget.1798 10.1016/j.bbrc.2016.11.037 10.1007/s12032-010-9797-4 10.1016/j.canlet.2020.02.035 10.3233/CBM-190672 10.2147/OTT.S214104 10.1016/j.bbrc.2018.05.174 10.1248/bpb.b14-00265 10.18632/oncotarget.20475 10.18632/oncotarget.23483 10.1016/j.omtn.2018.01.004 10.1038/cgt.2014.73 10.1002/jcp.28607 10.1158/1078-0432.CCR-16-2813 10.1016/j.bcp.2020.113795 10.1016/j.biochi.2019.04.019 10.3892/ol.2017.5574 10.1002/ijc.25260 10.1016/j.biopha.2020.110037 10.1016/j.ebiom.2018.08.001 10.1016/S0168-9525(99)01955-1 10.1002/jcp.28763 10.1158/2159-8290.CD-15-0893 10.3390/biom10101406 10.1016/j.lungcan.2007.07.024 10.1016/j.celrep.2019.12.071 10.1038/cdd.2014.221 10.7150/thno.40566 10.1111/jcmm.13625 10.18632/oncotarget.8229 10.3389/fphar.2018.00082 10.1007/s00210-019-01662-x 10.2147/OTT.S215012 10.3390/ijms21041242 10.1002/jcp.29676 10.1155/2018/1769040 10.1016/j.canlet.2008.03.055 10.1177/0300060519850739 10.2741/4842 10.1038/s41598-020-69615-6 10.1038/s41388-019-0984-2 10.1007/s13277-016-5244-2 10.1016/j.bbrc.2009.04.004 10.1111/1759-7714.13256 10.1126/science.1114519 10.1101/gad.13.22.2905 10.4149/gpb_2019041 10.18632/oncotarget.14512 10.1093/jb/mvaa027 10.1186/s12935-020-1164-8 10.2147/OTT.S186922 10.1007/s00280-017-3435-1 10.1038/s41598-020-58906-7 10.3892/or.2017.5624 10.1177/1533033818758905 10.1038/nri.2016.40 10.1111/cas.13764 10.1111/j.1349-7006.2010.01707.x 10.1002/jcp.27366 10.1038/s41389-020-0207-2 10.1016/j.cellsig.2020.109622 10.1016/j.phrs.2020.104774 10.2147/OTT.S230963 10.1007/s13277-015-3950-9 10.1080/15384047.2020.1727700 10.1016/j.ejphar.2020.173483 10.18632/aging.101907 10.3389/fonc.2020.00233 10.1016/j.biopha.2020.109828 10.1002/jcp.29296 10.1074/jbc.273.49.32380 10.18632/oncotarget.7884 10.1016/j.omtn.2020.01.003 10.1007/s12253-013-9630-4 10.1080/21691401.2019.1645150 10.1002/mgg3.1195 10.1080/01902148.2018.1536174 10.1371/journal.pone.0094639 10.1515/med-2019-0007 10.1002/2211-5463.12855 10.1007/978-1-4614-5398-7_10 10.1016/j.gene.2020.144629 10.1016/j.biopha.2017.06.089 10.1016/S0092-8674(00)80405-5 10.2147/IJN.S221383 10.1074/jbc.M114.632125 10.1016/j.jep.2011.10.036 10.18632/aging.102271 10.1002/1873-3468.12566 10.1016/j.yexcr.2020.112061 10.1038/onc.2017.286 10.7150/thno.33680 10.1038/s41388-018-0619-z 10.1111/1759-7714.13248 10.3892/ol.2017.5967 10.1080/15384047.2015.1095405 10.1038/cgt.2012.60 10.1186/s12885-017-3930-0 10.2147/OTT.S212649 10.1016/j.biopha.2018.07.024 10.1038/s41598-017-02816-8 10.1111/jcmm.14763 10.1038/10028 10.7150/jca.34285 10.1038/bjc.2014.157 10.1038/s41416-020-0773-2 10.1080/01635581.2014.894101 10.1038/srep40384 10.4149/neo_2018_181218N980 10.2147/OTT.S146423 10.1007/s10495-020-01591-8 10.2174/138161210791209009 10.1038/nrg2843 10.1111/jcmm.13556 10.1002/mc.23135 10.1016/j.lfs.2020.118094 10.1186/1476-4598-13-240 10.2147/OTT.S225010 10.1016/j.sbi.2005.05.006 10.1158/0008-5472.CAN-09-3112 10.1530/ERC-19-0087 10.1053/j.gastro.2012.07.009 10.1002/jcp.21993 10.1186/s13046-017-0582-5 10.1007/s13277-014-2284-3 10.1016/j.canlet.2020.03.013 10.1371/journal.pone.0039379 10.18632/oncotarget.2787 10.1371/journal.pone.0121547 10.1016/j.jhep.2019.08.026 10.1016/j.abb.2018.11.020 10.2147/HP.S93413 10.1016/j.dnarep.2013.01.008 10.3892/or.2017.5505 10.3233/CBM-182374 10.1002/jcb.24665 10.1089/dna.2019.5282 10.3389/fendo.2018.00402 10.1080/15384047.2017.1385679 10.2147/IJN.S134833 10.1007/s13277-015-3831-2 10.1002/ptr.6584 10.1042/CS20200039 10.1111/jphp.12995 10.1038/nrc2167 10.1016/j.canlet.2016.12.006 10.1002/cbf.3331 10.1172/JCI39104 10.1038/s41418-020-0495-2 10.3390/ijms21051710 10.1016/j.biopha.2019.108662 10.1007/s13277-014-2793-0 10.1016/j.lfs.2019.117142 10.1016/j.canlet.2019.09.016 10.1111/1440-1681.13307 10.2147/CMAR.S228718 10.1016/j.biopha.2018.12.007 10.1186/s12935-016-0305-6 10.1016/j.lfs.2020.118239 10.1016/j.semcancer.2019.11.005 10.1016/j.bbrc.2013.09.111 10.1016/j.lfs.2019.117238 10.1080/15384101.2016.1224043 10.1016/j.canlet.2019.10.044 10.18632/oncotarget.21693 10.1038/s41419-018-1093-9 10.1186/s13578-018-0221-7 10.1038/s41388-019-0891-6 10.1111/jcmm.14050 10.1016/j.canlet.2019.12.011 10.1371/journal.pone.0095240 10.3390/ijms21031014 10.3389/fphar.2020.00567 10.1111/1759-7714.13097 10.1016/j.bioorg.2020.103768 10.1002/jcp.29451 10.1016/j.bbrc.2018.10.086 10.1016/j.phrs.2016.12.037 10.1007/s10620-019-05771-8 10.1002/cbin.10995 10.1016/j.lfs.2019.116984 10.3892/or.2017.5866 10.1016/j.biopha.2018.08.107 10.3390/molecules25061386 10.5507/bp.2016.034 10.1016/j.actbio.2016.09.045 10.2147/OTT.S237456 10.1371/journal.pone.0177171 10.1016/j.jconrel.2017.03.007 10.1016/j.cllc.2015.01.008 10.1159/000495835 10.1186/s12967-015-0488-y 10.1038/s41401-019-0340-7 10.1097/00001813-200304000-00005 10.1158/1541-7786.MCR-10-0052 10.1159/000477884 10.1038/ncb1800 10.1097/CAD.0000000000000781 10.1186/s12935-019-0934-7 10.2147/OTT.S217536 10.1016/j.cell.2004.12.038 10.1093/abbs/gmw099 10.18632/aging.102683 10.3390/ijms21030937 10.1371/journal.pone.0050999 10.1016/j.biopha.2017.12.092 10.1016/j.gene.2020.144623 10.1016/j.fct.2019.110807 10.1016/j.biochi.2015.07.024 10.1016/j.jhazmat.2019.03.098 10.1016/j.phrs.2019.104396 10.3892/ijmm.2013.1439 10.1016/j.gene.2018.08.026 10.1016/j.lungcan.2018.02.002 10.1002/mgg3.757 10.1016/j.biopha.2016.09.027 10.3748/wjg.v26.i5.499 10.1186/s12890-019-1035-z |
| ContentType | Journal Article |
| Copyright | 2020 Elsevier Inc. Copyright © 2020 Elsevier Inc. All rights reserved. |
| Copyright_xml | – notice: 2020 Elsevier Inc. – notice: Copyright © 2020 Elsevier Inc. All rights reserved. |
| DBID | AAYXX CITATION NPM 7X8 |
| DOI | 10.1016/j.cellsig.2020.109871 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 1873-3913 |
| ExternalDocumentID | 33279671 10_1016_j_cellsig_2020_109871 S089865682030348X |
| Genre | Journal Article |
| GroupedDBID | --- --K --M .GJ .~1 0R~ 1B1 1RT 1~. 1~5 29B 4.4 457 4G. 53G 5GY 5VS 6J9 7-5 71M 8P~ 9JM AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AAXUO ABFNM ABFRF ABGSF ABJNI ABMAC ABUDA ABXDB ABYKQ ACDAQ ACGFO ACGFS ACIUM ACRLP ADBBV ADEZE ADMUD ADUVX AEBSH AEFWE AEHWI AEKER AENEX AFKWA AFTJW AFXIZ AGHFR AGRDE AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJBFU AJOXV ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC CS3 DOVZS DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HLW HVGLF HZ~ IHE J1W KOM LX3 M41 MO0 N9A O-L O9- OAUVE OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SBG SCC SDF SDG SDP SES SEW SPCBC SSU SSZ T5K WUQ ZGI ~G- 9DU AATTM AAXKI AAYWO AAYXX ABWVN ACLOT ACRPL ACVFH ADCNI ADNMO AEIPS AEUPX AFJKZ AFPUW AGQPQ AIGII AIIUN AKBMS AKRWK AKYEP ANKPU APXCP CITATION EFKBS ~HD NPM 7X8 |
| ID | FETCH-LOGICAL-c365t-fba809d645f3585c7cc076c1dd92c957aca0848563a3aa6160f6e37d8252f98b3 |
| ISICitedReferencesCount | 116 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000604742800003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0898-6568 1873-3913 |
| IngestDate | Thu Oct 02 11:22:47 EDT 2025 Wed Feb 19 02:29:29 EST 2025 Sat Nov 29 07:16:20 EST 2025 Tue Nov 18 22:17:38 EST 2025 Fri Feb 23 02:44:51 EST 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | HOTAIR TC-NER circRNAs TRIM Lung cancer JNK PTEN TAZ IL-22 ncRNAs NF-κB CAV-1 PI3K DLEU1 mTOR PBK SOX4 P-gp PAQR4 FGF EGCG MAPK NEAT1 FBXO11 EMT Long non-coding RNA SIRT3 ADAM19 CCAT1 MMP ZEB1 SNHG11 TDP-43 miR ROS AMPK UCA1 MALAT1 XIST GAS5 FGFRs CBLL1 HDAC ERK NPC ABC lncRNA SAMD9 Chemoresistance SDF-1 CXCR4 PARP mRNA cyt C AK4 MRP-1 CTR1 CSB CAFs TP53INP1 PCAT-1 3'-UTR TGF-β ATGs SCLC SNHG1 NORAD FZD7 STAT3 Akt MIAT CP Cisplatin LINC00707 Mcl-1 MicroRNA PLGA PTP1B |
| Language | English |
| License | Copyright © 2020 Elsevier Inc. All rights reserved. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c365t-fba809d645f3585c7cc076c1dd92c957aca0848563a3aa6160f6e37d8252f98b3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| PMID | 33279671 |
| PQID | 2467840462 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2467840462 pubmed_primary_33279671 crossref_primary_10_1016_j_cellsig_2020_109871 crossref_citationtrail_10_1016_j_cellsig_2020_109871 elsevier_sciencedirect_doi_10_1016_j_cellsig_2020_109871 |
| PublicationCentury | 2000 |
| PublicationDate | February 2021 2021-02-00 2021-Feb 20210201 |
| PublicationDateYYYYMMDD | 2021-02-01 |
| PublicationDate_xml | – month: 02 year: 2021 text: February 2021 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | Cellular signalling |
| PublicationTitleAlternate | Cell Signal |
| PublicationYear | 2021 |
| Publisher | Elsevier Inc |
| Publisher_xml | – name: Elsevier Inc |
| References | Xiang (bb0330) 2020; 10 Tan (bb0795) 2018; 428 Li (bb0010) 2020; 235 Rezaei (bb0400) 2020; 888 Reardon (bb0230) 2017; 12 Zhang (bb0730) 2017; 80 Shao (bb1530) 2019; 23 Chen (bb1675) 2017; 8 Petrera, Meroni (bb1730) 2012; 770 Sun (bb0805) 2019; 25 Skog (bb1820) 2008; 10 Li (bb0110) 2020; 10 Cheng (bb1335) 2016; 423 Tian (bb1550) 2020; 25 Conte (bb0125) 2020; 21 Dastmalchi (bb0405) 2020; 259 Xu (bb0420) 2020; 31 Cui (bb0595) 2020; 21 Peng (bb0300) 2020; 168 Lin (bb0620) 2018; 70 Lin (bb0025) 2019; 10 Li (bb1560) 2020; 13 Rao (bb1030) 2019; 114 Lamouille, Xu, Derynck (bb0870) 2014; 15 Torres (bb1810) 2020; 27 Dou (bb0490) 2019; 12 Osada, Takahashi (bb0935) 2011; 102 Fang (bb0735) 2017; 7 Li (bb0100) 2020; 471 Lu (bb0600) 2019; 38 Qi, Li (bb1605) 2020; 126 Tang (bb1615) 2019; 162 Jiang (bb1925) 2018; 107 Asou (bb0695) 2009; 383 Zhang (bb0040) 2019; 19 Huang (bb0180) 2020 Zhang (bb0845) 2019 Di Rienzo (bb1745) 2020; 27 Fabbri (bb0940) 2007; 104 Kelland (bb0160) 2007; 7 Takeyama (bb0240) 2020; 479 Li (bb0815) 2015; 47 Ba (bb0625) 2019; 166 Yu (bb1235) 2014; 35 Zhang (bb1865) 2019; 10 Xu (bb0065) 2020 Yang (bb0945) 2019; 19 Hu (bb0430) 2020; 235 Shen (bb1075) 2016; 7 Schulze (bb0680) 2020; 11 Jamaledin (bb0210) 2020; 9 Wang (bb1665) 2018; 9 Zhang (bb1365) 2019; 38 Gao (bb1570) 2019; 19 Lin (bb1505) 2019; 23 Munschauer (bb1555) 2018; 561 Chen (bb0520) 2016; 6 Pang (bb1120) 2017; 14 Li (bb0475) 2020; 21 Chen (bb0515) 2017; 13 Li (bb1800) 2020 Wang (bb0395) 2020; 20 Zeng (bb0120) 2020; 39 Pan (bb0560) 2018; 2018 Duan (bb1205) 2016; 48 Mishra (bb1855) 2019; 76 Shi (bb1175) 2017; 36 Huang (bb1040) 2018; 98 Zhang (bb0105) 2020; 254 Sun (bb0275) 2020; 21 Wang (bb1685) 2017; 10 He (bb1455) 2020; 11 Wu (bb0705) 2016; 11 Zhang (bb0960) 2018; 11 Wang (bb0645) 2018; 22 Puar (bb1755) 2018; 6 Chen (bb0095) 2019; 12 Tiemin (bb0485) 2020; 9 Yang (bb1650) 2019; 42 Qi (bb0965) 2019; 23 Wang (bb1525) 2020; 19 Hu (bb1740) 2019; 234 Contreras, Rao (bb0385) 2012; 26 Khongthong, Roseweir, Edwards (bb1760) 2019; 26 Liao (bb0070) 2020; 34 Krol, Loedige, Filipowicz (bb0350) 2010; 11 Chen (bb1495) 2020; 19 Bar (bb0755) 2015; 16 Yang (bb1785) 2015; 10 Yang (bb1920) 2019; 47 Li (bb0715) 2016; 37 Said, Mantawy, El-Demerdash (bb0200) 2019; 392 Zhao (bb1115) 2018; 9 Deng (bb1085) 2018; 106 Yang (bb0140) 2020; 34 Zhu (bb1305) 2010; 127 Tirpe (bb1790) 2019 Shahriar (bb0310) 2020; 126 Sun (bb1580) 2017; 36 Hwang (bb0855) 2020; 10 Zuo (bb0545) 2019; 19 Jiang (bb1045) 2017; 10 Pan (bb1750) 2019; 10 Liu (bb0495) 2018; 11 Shi (bb1170) 2017; 17 Kolahi (bb0325) 2018; 204 Caputo (bb0920) 2013; 12 Wang (bb0785) 2014; 111 Filipowicz (bb0335) 2005; 15 Chen (bb1645) 2019; 83 Zhao (bb0775) 2015; 22 Hung (bb1600) 2020 Li (bb0850) 2020; 12 Seidl (bb1325) 2020; 469 Huang (bb1010) 2019; 11 Kiani (bb1910) 2018; 678 Chen (bb1565) 2019; 7 Cao (bb1435) 2017 Li (bb0450) 2020; 13 Gao (bb0270) 2020; 20 Yang (bb0760) 2015; 36 Liu (bb1195) 2018; 14 Mehta, Baltimore (bb0380) 2016; 16 Huang, Lei, Liu (bb0175) 2020; 26 Huang (bb1465) 2020; 121 Chen (bb1735) 2019; 38 Wu (bb1295) 2014; 17 Xiao (bb1695) 2018; 8 Li (bb0235) 2019; 11 Zhang (bb0215) 2017; 263 Wang (bb1215) 2016; 478 Wang (bb1290) 2014; 5 Su, Jin, Chen (bb1015) 2014; 2 Chen (bb0690) 2016; 7 Rezaee (bb0890) 2017; 117 Fan (bb1460) 2020; 134 Liu (bb1090) 2018 Wang (bb1190) 2018; 9 Lu (bb0565) 2018; 16 Chen (bb0580) 2018; 9 Huang (bb1575) 2020 Hammad (bb0015) 2019; 467 Bin, Xiaofeng, Wanzi (bb1545) 2018; 44 Zang (bb0765) 2012; 19 Chian (bb0035) 2019; 30 Sun (bb1320) 2016; 5 Zhu (bb0710) 2017; 13 Liu (bb0840) 2019; 18 Shao (bb1830) 2018; 17 Zheng (bb0295) 2020; 41 Dong (bb0145) 2020; 124 Zheng (bb0510) 2020; 26 Zou, Volonte, Galbiati (bb0975) 2012; 7 Valadi (bb1825) 2007; 9 Chen, Zhang, Zheng (bb0900) 2017; 12 Bozok (bb1225) 2016; 37 Zhu (bb1240) 2012; 29 Kozak, Jonak, Maciejewski (bb0305) 2020; 125 Li (bb0770) 2013; 440 Hao (bb1180) 2017; 591 Wienholds (bb0360) 2005; 309 Jeon (bb1635) 2019; 10 Kalluri, Weinberg (bb0865) 2009; 119 Liu (bb0585) 2018; 17 Lei (bb1450) 2018; 18 Yu (bb0650) 2018; 18 Park (bb0060) 2020; 10 Wang (bb0570) 2018; 2018 Ho (bb0985) 2008; 59 Guan (bb0955) 2019; 20 Galluzzi, Green (bb1625) 2019; 177 Kang (bb1805) 2020; 10 Zeng (bb0085) 2020 Safaei (bb1845) 2005; 4 Zhang (bb0740) 2019; 9 Sun (bb1185) 2018; 51 Xu (bb1480) 2020 Li (bb0115) 2020; 59 Zhou, Wang, Feng (bb1890) 2014; 66 Chen (bb1395) 2017; 388 Pei (bb1430) 2016; 20 Radwan (bb0590) 2019; 373 Zhao (bb0660) 2019; 23 Muz (bb1795) 2015; 3 Alizadeh (bb0415) 2019; 234 Li (bb0665) 2019; 12 Yang (bb0725) 2018; 57 Sui (bb1260) 2015; 13 Frezza (bb0165) 2010; 16 Burgermeister (bb0980) 2008; 268 Zheng, Xu (bb1425) 2020; 124 Fu (bb0830) 2016; 20 Li (bb0905) 2019 Guo (bb1885) 2019; 19 Fu (bb1515) 2018; 9 Chen (bb0080) 2020; 24 Corcoran (bb1840) 2012; 7 Calcabrini (bb1900) 2020; 11 He (bb1415) 2019; 20 Li (bb0810) 2016; 37 Molist (bb0615) 2020; 477 Liu, Xing, Rong (bb1110) 2018; 39 Jin (bb0550) 2019; 47 Wang (bb0555) 2018; 14 Zeng (bb0500) 2020; 174 Xie (bb1340) 2016; 37 Kamachi, Uchikawa, Kondoh (bb1705) 2000; 16 Lei (bb0280) 2020; 125 Han (bb1025) 2019; 12 Saadi, Seillier, Carrier (bb0655) 2015; 118 Yin (bb0135) 2020; 45 Ye (bb1350) 2016; 7 Zhou (bb0170) 2020; 19 Wang (bb0435) 2020; 10 Ou (bb1360) 2020; 20 Yan (bb0875) 2018; 9 Xu (bb0880) 2020; 65 Han (bb0885) 2019; 121 Choi (bb1720) 2020; 21 Huang (bb1125) 2017; 8 Zhao (bb0535) 2019; 18 Gong (bb1895) 2020 Cheng (bb1060) 2017; 42 Li (bb1355) 2016; 16 Tung (bb1070) 2016; 7 Chang (bb1765) 2019 Chen (bb1860) 2020; 235 Yuwen (bb0635) 2019; 28 Ren, Wen, Zheng (bb0670) 2019; 18 Wu (bb1445) 2020; 20 Bartel (bb0345) 2004; 116 Su (bb0825) 2016; 6 Nascimento (bb0225) 2017; 47 Imamura (bb1020) 2014; 37 Yang (bb1130) 2017; 43 Wang (bb1610) 2020; 28 Li, Zheng (bb1585) 2020; 11 Ahmed (bb0365) 2015 Li (bb0290) 2020; 12 Barisciano (bb0470) 2020; 122 Li (bb1035) 2018; 39 Filipska (bb0720) 2018; 118 Houtkooper (bb0895) 2009; 1788 Ma (bb0700) 2014; 454 Belanger, Roussel, Couet (bb0990) 2003; 14 Qin (bb1155) 2017; 12 Mondal (bb0090) 2019; 20 Gao (bb0425) 2020 Liu (bb1485) 2020; 235 Wang (bb1680) 2017; 8 Zhao (bb0455) 2020; 39 Zhao (bb1510) 2019; 23 Hazari (bb1620) 2020; 72 Iyama (bb0925) 2015; 43 Yang (bb0630) 2015; 290 Huang (bb1470) 2019; 234 Li (bb1160) 2017; 37 Cao (bb1285) 2014; 5 Meng (bb0440) 2020; 10 Shoji (bb0150) 2020; 85 Su (bb1210) 2016; 84 Li (bb0780) 2014; 13 Ahmad (bb0195) 2019 Chen (bb0835) 2019; 11 Lavie, Fiucci, Liscovitch (bb0995) 1998; 273 Gu (bb1135) 2017; 36 Adi Harel (bb1265) 2015; 22 Giacomini (bb0130) 2020; 21 Moura, Gil, Figueiredo (bb0220) 2019; 113 Chen (bb1835) 2014; 9 Indrieri (bb0315) 2020; 21 Chen (bb1780) 2020; 235 Ozkaya, Naziroglu (bb0190) 2020; 40 Wei (bb1775) 2020; 241 Kang (bb1870) 2019; 133 Wong (bb0075) 2020; 12 Guo (bb0250) 2020 Li (bb1540) 2019; 12 Li (bb1590) 2018; 506 Zhang (bb0610) 2020; 48 Lu (bb1930) 2018; 22 Sternberg, Schmid (bb0970) 1999; 1 Koolivand (bb1905) 2018; 45 Wu (bb0505) 2020; 24 Tang (bb0020) 2020; 11 Wu, Liu, Zhang (bb1520) 2020; 19 Xu (bb0750) 2014; 207 Flamini, Jiang, Cui (bb1145) 2017; 37 Li, Liu, Qin (bb1385) 2020; 20 Bora-Singhal (bb1715) 2020; 10 Tian (bb0530) 2019; 25 ElKady, Ramadan (bb0205) 2016; 160 Datta (bb1005) 1997; 91 Cheng (bb1165) 2017; 37 Pathak (bb0910) 2018; 94 Zhang (bb0575) 2018; 36 Liang (bb1640) 2019; 38 Zhang (bb0255) 2020 Zhang (bb0790) 2014; 17 Enoiu, Jiricny, Scharer (bb0930) 2012; 40 Dong (bb1850) 2019; 12 Mathivanan, Ji, Simpson (bb1815) 2010; 73 Zhao (bb1670) 2018; 109 Aslan (bb0410) 2020; 258 Xu (bb0050) 2020; 10 Zang (bb0915) 2019; 12 Zhang (bb0465) 2020; 47 Avilion (bb1700) 2003; 17 Wei (bb1490) 2020; 20 Wang (bb1245) 2012; 139 Zhang (bb1535) 2019; 18 Ma (bb0265) 2020; 99 Qin (bb1420) 2019; 111 Olena, Patton (bb0355) 2010; 222 Huang (bb0445) 2020; 156 Zhong (bb1410) 2019; 19 Dai, Zhang, Li (bb0260) 2020; 12 Tan, Li, Chen (bb1375) 2019; 661 Zan (bb1875) 2019; 10 Hao (bb0745) 2017; 488 Oh (bb0245) 2020; 21 Xing (bb0800) 2019; 234 Hui (bb1390) 2019; 10 Chen (bb1080) 2016; 7 Jing (bb0340) 2005; 120 Jin (bb0950) 2020 Yang (bb0605) 2020; 13 Kim (bb0185) 2020; 177 Zhu (bb1405) 2019; 8 O'Brien (bb0320) 2018; 9 Wang, Shang, Feng (bb1655) 2019; 20 Song (bb1230) 2014; 115 Qiu (bb1255) 2013; 32 Datta, Brunet, Greenberg (bb1000) 1999; 13 Hua, Zhu, Wei (bb1330) 2018; 42 Xu (bb0820) 2016; 15 Zhang (bb1275) 2014; 7 Galluzzi (bb1300) 2010; 70 Jiang (bb0525) 2014; 9 Li (bb1915) 2017; 8 Jiang (bb1880) 2018; 57 Shi, Zhang (bb1595) 2019; 66 Shriwas (bb0285) 2020; 25 Guo (bb0540) 2019; 11 Yuwen (bb1150) 2017; 21 Fu (bb1095) 2017; 23 Wen, Klionsky (bb1630) 2019; 66 Li (bb1220) 2016; 37 Chiba, Marusawa, Ushijima (bb0375) 2012; 143 Yang (bb1345) 2016; 17 Li (bb0460) 2020; 13 Song (bb1200) 2017; 482 Su (bb1770) 2019; 12 Li (bb0685) 2019; 11 Pang (bb1280) 2014; 13 Wang, Gao, Liu (bb1370) 2019; 12 Wei (bb1380) 2018; 503 Bai, Wu (bb0390) 2019; 12 Rupaimoole (bb0370) 2016; 6 Cao (bb1660) 2017; 93 Cui (bb1725) 2020 Habiba (bb0155) 2020 Zhou (bb1315) 2013; 19 Verduci (bb1400) 2017; 18 Ceppi (bb1310) 2010; 8 Zhang (bb1500) 2020; 10 Wu (bb0480) 2020 Liang (bb1140) 2017; 38 Tong (bb0005) 2019; 9 Hu (bb1690) 2017; 18 Yu (bb1050) 2017; 28 Trivedi (bb1055) 2017; 7 Zhou (bb0675) 2020; 473 Lee (bb0860) 2020; 26 Li (bb0045) 2020; 25 Pan (bb1270) 2015; 6 Zheng (bb1440) 2020; 24 Liu (bb1710) 2020; 30 Guo (bb1100) 2018; 35 Li (bb1065) 2017; 13 Qiu (bb0030) 2019; 9 Sun (bb1105) 2018; 8 Zhang (bb1250) 2012; 77 Dong (bb1475) 2019; 239 Teng (bb0055) 2019; 147 Ma (bb0640) 2019; 14 Ma (10.1016/j.cellsig.2020.109871_bb0640) 2019; 14 Duan (10.1016/j.cellsig.2020.109871_bb1205) 2016; 48 Zhao (10.1016/j.cellsig.2020.109871_bb0455) 2020; 39 Chen (10.1016/j.cellsig.2020.109871_bb1080) 2016; 7 Chen (10.1016/j.cellsig.2020.109871_bb0690) 2016; 7 Li (10.1016/j.cellsig.2020.109871_bb0905) 2019 Zhang (10.1016/j.cellsig.2020.109871_bb1865) 2019; 10 Wang (10.1016/j.cellsig.2020.109871_bb0645) 2018; 22 Cheng (10.1016/j.cellsig.2020.109871_bb1165) 2017; 37 Cheng (10.1016/j.cellsig.2020.109871_bb1335) 2016; 423 Huang (10.1016/j.cellsig.2020.109871_bb0175) 2020; 26 Pan (10.1016/j.cellsig.2020.109871_bb0560) 2018; 2018 Li (10.1016/j.cellsig.2020.109871_bb0665) 2019; 12 Fang (10.1016/j.cellsig.2020.109871_bb0735) 2017; 7 Cao (10.1016/j.cellsig.2020.109871_bb1285) 2014; 5 Xu (10.1016/j.cellsig.2020.109871_bb0050) 2020; 10 Tian (10.1016/j.cellsig.2020.109871_bb0530) 2019; 25 Ahmad (10.1016/j.cellsig.2020.109871_bb0195) 2019 Zhang (10.1016/j.cellsig.2020.109871_bb0730) 2017; 80 Datta (10.1016/j.cellsig.2020.109871_bb1005) 1997; 91 Lamouille (10.1016/j.cellsig.2020.109871_bb0870) 2014; 15 Wienholds (10.1016/j.cellsig.2020.109871_bb0360) 2005; 309 Di Rienzo (10.1016/j.cellsig.2020.109871_bb1745) 2020; 27 Li (10.1016/j.cellsig.2020.109871_bb0115) 2020; 59 Sun (10.1016/j.cellsig.2020.109871_bb0275) 2020; 21 Wang (10.1016/j.cellsig.2020.109871_bb1215) 2016; 478 Cui (10.1016/j.cellsig.2020.109871_bb1725) 2020 Puar (10.1016/j.cellsig.2020.109871_bb1755) 2018; 6 He (10.1016/j.cellsig.2020.109871_bb1415) 2019; 20 Rao (10.1016/j.cellsig.2020.109871_bb1030) 2019; 114 Lee (10.1016/j.cellsig.2020.109871_bb0860) 2020; 26 Xu (10.1016/j.cellsig.2020.109871_bb1480) 2020 Wang (10.1016/j.cellsig.2020.109871_bb0785) 2014; 111 Zhang (10.1016/j.cellsig.2020.109871_bb0845) 2019 Chen (10.1016/j.cellsig.2020.109871_bb1735) 2019; 38 Guo (10.1016/j.cellsig.2020.109871_bb1100) 2018; 35 Zhao (10.1016/j.cellsig.2020.109871_bb0660) 2019; 23 Wang (10.1016/j.cellsig.2020.109871_bb1245) 2012; 139 Wei (10.1016/j.cellsig.2020.109871_bb1380) 2018; 503 Li (10.1016/j.cellsig.2020.109871_bb1160) 2017; 37 Li (10.1016/j.cellsig.2020.109871_bb0810) 2016; 37 Yuwen (10.1016/j.cellsig.2020.109871_bb0635) 2019; 28 Chen (10.1016/j.cellsig.2020.109871_bb1395) 2017; 388 Qiu (10.1016/j.cellsig.2020.109871_bb0030) 2019; 9 Dou (10.1016/j.cellsig.2020.109871_bb0490) 2019; 12 Zang (10.1016/j.cellsig.2020.109871_bb0765) 2012; 19 Burgermeister (10.1016/j.cellsig.2020.109871_bb0980) 2008; 268 Hao (10.1016/j.cellsig.2020.109871_bb1180) 2017; 591 Radwan (10.1016/j.cellsig.2020.109871_bb0590) 2019; 373 Li (10.1016/j.cellsig.2020.109871_bb0290) 2020; 12 Yan (10.1016/j.cellsig.2020.109871_bb0875) 2018; 9 Zhao (10.1016/j.cellsig.2020.109871_bb1510) 2019; 23 Gong (10.1016/j.cellsig.2020.109871_bb1895) 2020 Shao (10.1016/j.cellsig.2020.109871_bb1830) 2018; 17 Zhang (10.1016/j.cellsig.2020.109871_bb0105) 2020; 254 Lu (10.1016/j.cellsig.2020.109871_bb1930) 2018; 22 Yang (10.1016/j.cellsig.2020.109871_bb1920) 2019; 47 Skog (10.1016/j.cellsig.2020.109871_bb1820) 2008; 10 Fabbri (10.1016/j.cellsig.2020.109871_bb0940) 2007; 104 Oh (10.1016/j.cellsig.2020.109871_bb0245) 2020; 21 Galluzzi (10.1016/j.cellsig.2020.109871_bb1625) 2019; 177 Zhao (10.1016/j.cellsig.2020.109871_bb1670) 2018; 109 Hua (10.1016/j.cellsig.2020.109871_bb1330) 2018; 42 Pan (10.1016/j.cellsig.2020.109871_bb1750) 2019; 10 Zhang (10.1016/j.cellsig.2020.109871_bb0960) 2018; 11 Liu (10.1016/j.cellsig.2020.109871_bb1485) 2020; 235 Pei (10.1016/j.cellsig.2020.109871_bb1430) 2016; 20 Zhu (10.1016/j.cellsig.2020.109871_bb1240) 2012; 29 Bartel (10.1016/j.cellsig.2020.109871_bb0345) 2004; 116 Huang (10.1016/j.cellsig.2020.109871_bb1575) 2020 Saadi (10.1016/j.cellsig.2020.109871_bb0655) 2015; 118 Kiani (10.1016/j.cellsig.2020.109871_bb1910) 2018; 678 Liang (10.1016/j.cellsig.2020.109871_bb1640) 2019; 38 Song (10.1016/j.cellsig.2020.109871_bb1200) 2017; 482 Kozak (10.1016/j.cellsig.2020.109871_bb0305) 2020; 125 Huang (10.1016/j.cellsig.2020.109871_bb1010) 2019; 11 Zhang (10.1016/j.cellsig.2020.109871_bb1275) 2014; 7 Frezza (10.1016/j.cellsig.2020.109871_bb0165) 2010; 16 Kang (10.1016/j.cellsig.2020.109871_bb1870) 2019; 133 Zhou (10.1016/j.cellsig.2020.109871_bb0675) 2020; 473 Gu (10.1016/j.cellsig.2020.109871_bb1135) 2017; 36 Chen (10.1016/j.cellsig.2020.109871_bb1835) 2014; 9 Corcoran (10.1016/j.cellsig.2020.109871_bb1840) 2012; 7 Lei (10.1016/j.cellsig.2020.109871_bb1450) 2018; 18 Yang (10.1016/j.cellsig.2020.109871_bb0140) 2020; 34 Zhu (10.1016/j.cellsig.2020.109871_bb1305) 2010; 127 Li (10.1016/j.cellsig.2020.109871_bb0010) 2020; 235 Song (10.1016/j.cellsig.2020.109871_bb1230) 2014; 115 Chen (10.1016/j.cellsig.2020.109871_bb1860) 2020; 235 Wong (10.1016/j.cellsig.2020.109871_bb0075) 2020; 12 Chen (10.1016/j.cellsig.2020.109871_bb1675) 2017; 8 Pan (10.1016/j.cellsig.2020.109871_bb1270) 2015; 6 Li (10.1016/j.cellsig.2020.109871_bb1915) 2017; 8 Zhu (10.1016/j.cellsig.2020.109871_bb0710) 2017; 13 Zhang (10.1016/j.cellsig.2020.109871_bb0040) 2019; 19 Kamachi (10.1016/j.cellsig.2020.109871_bb1705) 2000; 16 Yang (10.1016/j.cellsig.2020.109871_bb0945) 2019; 19 Olena (10.1016/j.cellsig.2020.109871_bb0355) 2010; 222 Pang (10.1016/j.cellsig.2020.109871_bb1120) 2017; 14 Torres (10.1016/j.cellsig.2020.109871_bb1810) 2020; 27 Verduci (10.1016/j.cellsig.2020.109871_bb1400) 2017; 18 Mishra (10.1016/j.cellsig.2020.109871_bb1855) 2019; 76 Zhang (10.1016/j.cellsig.2020.109871_bb0740) 2019; 9 Qin (10.1016/j.cellsig.2020.109871_bb1420) 2019; 111 Yang (10.1016/j.cellsig.2020.109871_bb0630) 2015; 290 Hazari (10.1016/j.cellsig.2020.109871_bb1620) 2020; 72 Li (10.1016/j.cellsig.2020.109871_bb0100) 2020; 471 Yang (10.1016/j.cellsig.2020.109871_bb1785) 2015; 10 Tang (10.1016/j.cellsig.2020.109871_bb0020) 2020; 11 Wu (10.1016/j.cellsig.2020.109871_bb1445) 2020; 20 O'Brien (10.1016/j.cellsig.2020.109871_bb0320) 2018; 9 Li (10.1016/j.cellsig.2020.109871_bb1540) 2019; 12 Cao (10.1016/j.cellsig.2020.109871_bb1660) 2017; 93 Trivedi (10.1016/j.cellsig.2020.109871_bb1055) 2017; 7 Zhang (10.1016/j.cellsig.2020.109871_bb1535) 2019; 18 Hao (10.1016/j.cellsig.2020.109871_bb0745) 2017; 488 Seidl (10.1016/j.cellsig.2020.109871_bb1325) 2020; 469 Wang (10.1016/j.cellsig.2020.109871_bb1680) 2017; 8 Liu (10.1016/j.cellsig.2020.109871_bb1710) 2020; 30 Yang (10.1016/j.cellsig.2020.109871_bb0760) 2015; 36 Jeon (10.1016/j.cellsig.2020.109871_bb1635) 2019; 10 Ma (10.1016/j.cellsig.2020.109871_bb0700) 2014; 454 Indrieri (10.1016/j.cellsig.2020.109871_bb0315) 2020; 21 Zhang (10.1016/j.cellsig.2020.109871_bb0255) 2020 Xie (10.1016/j.cellsig.2020.109871_bb1340) 2016; 37 Li (10.1016/j.cellsig.2020.109871_bb1585) 2020; 11 Pathak (10.1016/j.cellsig.2020.109871_bb0910) 2018; 94 Habiba (10.1016/j.cellsig.2020.109871_bb0155) 2020 Xu (10.1016/j.cellsig.2020.109871_bb0420) 2020; 31 Deng (10.1016/j.cellsig.2020.109871_bb1085) 2018; 106 Ahmed (10.1016/j.cellsig.2020.109871_bb0365) 2015 Yu (10.1016/j.cellsig.2020.109871_bb1235) 2014; 35 Mathivanan (10.1016/j.cellsig.2020.109871_bb1815) 2010; 73 Zeng (10.1016/j.cellsig.2020.109871_bb0120) 2020; 39 Choi (10.1016/j.cellsig.2020.109871_bb1720) 2020; 21 Li (10.1016/j.cellsig.2020.109871_bb0685) 2019; 11 Kelland (10.1016/j.cellsig.2020.109871_bb0160) 2007; 7 Bai (10.1016/j.cellsig.2020.109871_bb0390) 2019; 12 Li (10.1016/j.cellsig.2020.109871_bb0780) 2014; 13 Xing (10.1016/j.cellsig.2020.109871_bb0800) 2019; 234 Tan (10.1016/j.cellsig.2020.109871_bb1375) 2019; 661 Wei (10.1016/j.cellsig.2020.109871_bb1775) 2020; 241 Li (10.1016/j.cellsig.2020.109871_bb1065) 2017; 13 Zuo (10.1016/j.cellsig.2020.109871_bb0545) 2019; 19 Su (10.1016/j.cellsig.2020.109871_bb1210) 2016; 84 Yang (10.1016/j.cellsig.2020.109871_bb1650) 2019; 42 Tong (10.1016/j.cellsig.2020.109871_bb0005) 2019; 9 Li (10.1016/j.cellsig.2020.109871_bb0045) 2020; 25 Huang (10.1016/j.cellsig.2020.109871_bb1465) 2020; 121 Zhang (10.1016/j.cellsig.2020.109871_bb0610) 2020; 48 Shi (10.1016/j.cellsig.2020.109871_bb1175) 2017; 36 Tian (10.1016/j.cellsig.2020.109871_bb1550) 2020; 25 Dong (10.1016/j.cellsig.2020.109871_bb0145) 2020; 124 Zhou (10.1016/j.cellsig.2020.109871_bb1315) 2013; 19 Gao (10.1016/j.cellsig.2020.109871_bb1570) 2019; 19 Wang (10.1016/j.cellsig.2020.109871_bb0570) 2018; 2018 Tung (10.1016/j.cellsig.2020.109871_bb1070) 2016; 7 Cao (10.1016/j.cellsig.2020.109871_bb1435) 2017 Zhao (10.1016/j.cellsig.2020.109871_bb0535) 2019; 18 Zheng (10.1016/j.cellsig.2020.109871_bb0510) 2020; 26 Chen (10.1016/j.cellsig.2020.109871_bb1495) 2020; 19 Chen (10.1016/j.cellsig.2020.109871_bb0515) 2017; 13 Wu (10.1016/j.cellsig.2020.109871_bb0505) 2020; 24 Zhao (10.1016/j.cellsig.2020.109871_bb0775) 2015; 22 Chen (10.1016/j.cellsig.2020.109871_bb0900) 2017; 12 Flamini (10.1016/j.cellsig.2020.109871_bb1145) 2017; 37 Calcabrini (10.1016/j.cellsig.2020.109871_bb1900) 2020; 11 Yu (10.1016/j.cellsig.2020.109871_bb1050) 2017; 28 Ceppi (10.1016/j.cellsig.2020.109871_bb1310) 2010; 8 Qiu (10.1016/j.cellsig.2020.109871_bb1255) 2013; 32 Dong (10.1016/j.cellsig.2020.109871_bb1850) 2019; 12 Pang (10.1016/j.cellsig.2020.109871_bb1280) 2014; 13 Sun (10.1016/j.cellsig.2020.109871_bb0805) 2019; 25 Li (10.1016/j.cellsig.2020.109871_bb1220) 2016; 37 Sun (10.1016/j.cellsig.2020.109871_bb1320) 2016; 5 Ou (10.1016/j.cellsig.2020.109871_bb1360) 2020; 20 Shao (10.1016/j.cellsig.2020.109871_bb1530) 2019; 23 Chang (10.1016/j.cellsig.2020.109871_bb1765) 2019 Peng (10.1016/j.cellsig.2020.109871_bb0300) 2020; 168 Wang (10.1016/j.cellsig.2020.109871_bb1525) 2020; 19 Schulze (10.1016/j.cellsig.2020.109871_bb0680) 2020; 11 Jiang (10.1016/j.cellsig.2020.109871_bb1925) 2018; 107 Liu (10.1016/j.cellsig.2020.109871_bb1090) 2018 Zheng (10.1016/j.cellsig.2020.109871_bb0295) 2020; 41 Zou (10.1016/j.cellsig.2020.109871_bb0975) 2012; 7 Li (10.1016/j.cellsig.2020.109871_bb1035) 2018; 39 Zan (10.1016/j.cellsig.2020.109871_bb1875) 2019; 10 Wu (10.1016/j.cellsig.2020.109871_bb0480) 2020 Huang (10.1016/j.cellsig.2020.109871_bb1470) 2019; 234 Li (10.1016/j.cellsig.2020.109871_bb1590) 2018; 506 Chen (10.1016/j.cellsig.2020.109871_bb0835) 2019; 11 Krol (10.1016/j.cellsig.2020.109871_bb0350) 2010; 11 Jiang (10.1016/j.cellsig.2020.1098 |
| References_xml | – volume: 770 start-page: 131 year: 2012 end-page: 141 ident: bb1730 article-title: TRIM proteins in development publication-title: Adv. Exp. Med. Biol. – volume: 21 start-page: 2650 year: 2017 end-page: 2658 ident: bb1150 article-title: MiR-146a-5p level in serum exosomes predicts therapeutic effect of cisplatin in non-small cell lung cancer publication-title: Eur. Rev. Med. Pharmacol. Sci. – start-page: 40(2) year: 2020 ident: bb1800 article-title: Genome-wide analysis of the hypoxia-related DNA methylation-driven genes in lung adenocarcinoma progression publication-title: Biosci. Rep. – volume: 503 start-page: 56 year: 2018 end-page: 61 ident: bb1380 article-title: Circular RNA circZFR contributes to papillary thyroid cancer cell proliferation and invasion by sponging miR-1261 and facilitating C8orf4 expression publication-title: Biochem. Biophys. Res. Commun. – volume: 18 start-page: 974 year: 2017 end-page: 983 ident: bb1690 article-title: LncRNA CCAT1/miR-130a-3p axis increases cisplatin resistance in non-small-cell lung cancer cell line by targeting SOX4 publication-title: Cancer Biol. Ther. – start-page: 112061 year: 2020 ident: bb1895 article-title: Sulforaphane enhances the cisplatin sensitivity through regulating DNA repair and accumulation of intracellular cisplatin in ovarian cancer cells publication-title: Exp. Cell Res. – volume: 18 start-page: 237 year: 2017 ident: bb1400 article-title: The oncogenic role of circPVT1 in head and neck squamous cell carcinoma is mediated through the mutant p53/YAP/TEAD transcription-competent complex publication-title: Genome Biol. – start-page: 109622 year: 2020 ident: bb0425 article-title: circ_ARF3 regulates the pathogenesis of osteosarcoma by sponging miR-1299 to maintain CDK6 expression publication-title: Cell. Signal. – volume: 25 start-page: 89 year: 2019 end-page: 99 ident: bb0805 article-title: MicroRNA-146-5p promotes proliferation, migration and invasion in lung cancer cells by targeting claudin-12 publication-title: Cancer Biomarkers – volume: 22 start-page: 1328 year: 2015 end-page: 1340 ident: bb1265 article-title: Reactivation of epigenetically silenced miR-512 and miR-373 sensitizes lung cancer cells to cisplatin and restricts tumor growth publication-title: Cell Death Differ. – volume: 102 start-page: 9 year: 2011 end-page: 17 ident: bb0935 article-title: let-7 and miR-17-92: small-sized major players in lung cancer development publication-title: Cancer Sci. – volume: 5 year: 2014 ident: bb1285 article-title: MiR-630 inhibits proliferation by targeting CDC7 kinase, but maintains the apoptotic balance by targeting multiple modulators in human lung cancer A549 cells publication-title: Cell Death Dis. – volume: 11 start-page: 295 year: 2020 end-page: 304 ident: bb1585 article-title: LncRNA SNHG1 influences cell proliferation, migration, invasion, and apoptosis of non-small cell lung cancer cells via the miR-361-3p/FRAT1 axis publication-title: Thorac Cancer – volume: 19 start-page: 2733 year: 2020 end-page: 2740 ident: bb0170 article-title: Cisplatin resistance-associated circRNA_101237 serves as a prognostic biomarker in hepatocellular carcinoma publication-title: Exp. Ther. Med. – volume: 20 start-page: 78 year: 2020 ident: bb1490 article-title: LncRNA MIR17HG inhibits non-small cell lung cancer by upregulating miR-142-3p to downregulate Bach-1 publication-title: BMC Pulm Med. – volume: 44 start-page: 280 year: 2018 end-page: 287 ident: bb1545 article-title: The effect of microRNA-129 on the migration and invasion in NSCLC cells and its mechanism publication-title: Exp. Lung Res. – volume: 2018 start-page: 7908950 year: 2018 ident: bb0570 article-title: Negative regulation of PTEN by MicroRNA-221 and its association with drug resistance and cellular senescence in lung cancer cells publication-title: Biomed. Res. Int. – volume: 440 start-page: 604 year: 2013 end-page: 610 ident: bb0770 article-title: MiR-92b regulates the cell growth, cisplatin chemosensitivity of A549 non small cell lung cancer cell line and target PTEN publication-title: Biochem. Biophys. Res. Commun. – volume: 40 start-page: 97 year: 2020 end-page: 108 ident: bb0190 article-title: Curcumin diminishes cisplatin-induced apoptosis and mitochondrial oxidative stress through inhibition of TRPM2 channel signaling pathway in mouse optic nerve publication-title: J. Recept. Signal Transduct. Res. – volume: 125 start-page: 110037 year: 2020 ident: bb0305 article-title: The function of miR-200 family in oxidative stress response evoked in cancer chemotherapy and radiotherapy publication-title: Biomed. Pharmacother. – volume: 7 start-page: 20728 year: 2016 end-page: 20742 ident: bb1075 article-title: MicroRNA-137 inhibits tumor growth and sensitizes chemosensitivity to paclitaxel and cisplatin in lung cancer publication-title: Oncotarget – volume: 23 start-page: 3383 year: 2019 end-page: 3389 ident: bb1510 article-title: Long noncoding RNA MIAT promotes the growth and metastasis of non-small cell lung cancer by upregulating TDP43 publication-title: Eur. Rev. Med. Pharmacol. Sci. – volume: 20 start-page: 421 year: 2020 end-page: 437 ident: bb0395 article-title: Tumor-derived EV-encapsulated miR-181b-5p induces angiogenesis to foster tumorigenesis and metastasis of ESCC publication-title: Mol. Ther. Nucleic Acids – volume: 10 start-page: 1406 year: 2020 ident: bb0855 article-title: Corilagin represses epithelial to mesenchymal transition process through modulating Wnt/β-catenin signaling cascade publication-title: Biomolecules – start-page: 12(4) year: 2020 ident: bb1600 article-title: The inhibition of Wnt restrain KRAS(G12V)-driven metastasis in non-small-cell lung cancer publication-title: Cancers (Basel) – volume: 234 start-page: 19280 year: 2019 end-page: 19297 ident: bb0415 article-title: The potential role of miR-29 in health and cancer diagnosis, prognosis, and therapy publication-title: J. Cell. Physiol. – volume: 234 start-page: 22657 year: 2019 end-page: 22665 ident: bb0800 article-title: Deregulation of lncRNA-AC078883. 3 and microRNA-19a is involved in the development of chemoresistance to cisplatin via modulating signaling pathway of PTEN/AKT publication-title: J. Cell. Physiol. – volume: 177 start-page: 1682 year: 2019 end-page: 1699 ident: bb1625 article-title: Autophagy-independent functions of the autophagy machinery publication-title: Cell – volume: 42 start-page: 660 year: 2017 end-page: 672 ident: bb1060 article-title: Prognostic significance of microRNA-7 and its roles in the regulation of cisplatin resistance in lung adenocarcinoma publication-title: Cell. Physiol. Biochem. – volume: 6 start-page: 317 year: 2015 end-page: 331 ident: bb1270 article-title: Mir-24-3p downregulation contributes to VP16-DDP resistance in small-cell lung cancer by targeting ATG4A publication-title: Oncotarget – volume: 204 start-page: 55 year: 2018 end-page: 59 ident: bb0325 article-title: Determination of mir-155 and mir-146a expression rates and its association with expression level of TNF-α and CTLA4 genes in patients with Behcet’s disease publication-title: Immunol. Lett. – volume: 17 start-page: 126 year: 2003 end-page: 140 ident: bb1700 article-title: Multipotent cell lineages in early mouse development depend on SOX2 function publication-title: Genes Dev. – volume: 235 start-page: 7970 year: 2020 end-page: 7981 ident: bb1860 article-title: EGCG regulates CTR1 expression through its pro-oxidative property in non-small-cell lung cancer cells publication-title: J. Cell. Physiol. – volume: 134 start-page: 807 year: 2020 end-page: 825 ident: bb1460 article-title: miR-210 transferred by lung cancer cell derived exosomes may act as proangiogenic factor in cancer-associated fibroblasts by modulating JAK2/STAT3 pathway publication-title: Clin. Sci. (Lond.) – start-page: 10(10) year: 2015 ident: bb0365 article-title: A database of microRNA expression patterns in Xenopus laevis publication-title: PLoS One – volume: 506 start-page: 632 year: 2018 end-page: 640 ident: bb1590 article-title: Lnc-SNHG1 may promote the progression of non-small cell lung cancer by acting as a sponge of miR-497 publication-title: Biochem. Biophys. Res. Commun. – volume: 83 start-page: 921 year: 2019 end-page: 931 ident: bb1645 article-title: The PVT1/miR-216b/Beclin-1 regulates cisplatin sensitivity of NSCLC cells via modulating autophagy and apoptosis publication-title: Cancer Chemother. Pharmacol. – volume: 20 start-page: 90 year: 2020 ident: bb0270 article-title: Inhibition of ZEB1-AS1 confers cisplatin sensitivity in breast cancer by promoting microRNA-129-5p-dependent ZEB1 downregulation publication-title: Cancer Cell Int. – volume: 24 start-page: 2098 year: 2020 end-page: 2108 ident: bb0505 article-title: MiR-129-5p promotes docetaxel resistance in prostate cancer by down-regulating CAMK2N1 expression publication-title: J. Cell. Mol. Med. – volume: 99 start-page: 103768 year: 2020 ident: bb0265 article-title: Bromocoumarinplatin, targeting simultaneously mitochondria and nuclei with p53 apoptosis pathway to overcome cisplatin resistance publication-title: Bioorg. Chem. – volume: 28 start-page: 852 year: 2017 end-page: 860 ident: bb1050 article-title: MicroRNA-106b-5p regulates cisplatin chemosensitivity by targeting polycystic kidney disease-2 in non-small-cell lung cancer publication-title: Anti-Cancer Drugs – volume: 19 start-page: 533 year: 2020 end-page: 541 ident: bb1520 article-title: Knockdown of lncRNA MIAT inhibits proliferation and cisplatin resistance in non-small cell lung cancer cells by increasing miR-184 expression publication-title: Oncol. Lett. – volume: 10 start-page: 6543 year: 2019 end-page: 6556 ident: bb1865 article-title: Synergistic inhibition of lung cancer cells by EGCG and NF-kappaB inhibitor BAY11-7082 publication-title: J. Cancer – volume: 9 start-page: 19 year: 2020 ident: bb0485 article-title: Dysregulation of the miR-148a-GLUT1 axis promotes the progression and chemoresistance of human intrahepatic cholangiocarcinoma publication-title: Oncogenesis – volume: 19 start-page: 677 year: 2013 end-page: 683 ident: bb1315 article-title: miR-135a/b modulate cisplatin resistance of human lung cancer cell line by targeting MCL1 publication-title: Pathol. Oncol. Res. – volume: 26 start-page: 499 year: 2020 end-page: 513 ident: bb0510 article-title: Upregulation of miR-34c after silencing E2F transcription factor 1 inhibits paclitaxel combined with cisplatin resistance in gastric cancer cells publication-title: World J. Gastroenterol. – volume: 48 start-page: 315 year: 2020 end-page: 324 ident: bb0610 article-title: miR-324-5p inhibits gallbladder carcinoma cell metastatic behaviours by downregulation of transforming growth factor beta 2 expression publication-title: Artif. Cells Nanomed. Biotechnol. – volume: 32 start-page: 593 year: 2013 end-page: 598 ident: bb1255 article-title: miR-503 regulates the resistance of non-small cell lung cancer cells to cisplatin by targeting Bcl-2 publication-title: Int. J. Mol. Med. – volume: 94 start-page: 79 year: 2018 end-page: 87 ident: bb0910 article-title: Significant expression of tafazzin (TAZ) protein in colon cancer cells and its downregulation by radiation publication-title: Int. J. Radiat. Biol. – volume: 41 start-page: 1223 year: 2020 end-page: 1233 ident: bb0295 article-title: RIP1 promotes proliferation through G2/M checkpoint progression and mediates cisplatin-induced apoptosis and necroptosis in human ovarian cancer cells publication-title: Acta Pharmacol. Sin. – volume: 11 start-page: 5622 year: 2018 end-page: 5634 ident: bb0495 article-title: MiR-106a-5p promotes 5-FU resistance and the metastasis of colorectal cancer by targeting TGFbetaR2 publication-title: Int. J. Clin. Exp. Pathol. – volume: 36 start-page: 194 year: 2018 end-page: 202 ident: bb0575 article-title: MicroRNA-130b targets PTEN to induce resistance to cisplatin in lung cancer cells by activating Wnt/beta-catenin pathway publication-title: Cell Biochem. Funct. – volume: 428 start-page: 55 year: 2018 end-page: 68 ident: bb0795 article-title: miRNA 146a promotes chemotherapy resistance in lung cancer cells by targeting DNA damage inducible transcript 3 (CHOP) publication-title: Cancer Lett. – volume: 21 start-page: 937 year: 2020 ident: bb0130 article-title: The pentose phosphate pathway and its involvement in cisplatin resistance publication-title: Int. J. Mol. Sci. – volume: 38 start-page: 1218 year: 2019 end-page: 1226 ident: bb1640 article-title: W941, a new PI3K inhibitor, exhibits preferable anti-proliferative activities against nonsmall cell lung cancer with autophagy inhibitors publication-title: Investig. New Drugs – volume: 20 start-page: 10 year: 2020 ident: bb1445 article-title: Knockdown of circ-ABCB10 promotes sensitivity of lung cancer cells to cisplatin via miR-556-3p/AK4 axis publication-title: BMC Pulm Med. – start-page: 20(24) year: 2019 ident: bb1790 article-title: Hypoxia: overview on hypoxia-mediated mechanisms with a focus on the role of HIF genes publication-title: Int. J. Mol. Sci. – volume: 13 start-page: 240 year: 2014 ident: bb1280 article-title: Pim-1 kinase is a target of miR-486-5p and eukaryotic translation initiation factor 4E, and plays a critical role in lung cancer publication-title: Mol. Cancer – volume: 11 start-page: 4077 year: 2019 end-page: 4088 ident: bb0685 article-title: Interleukin-22 secreted by cancer-associated fibroblasts regulates the proliferation and metastasis of lung cancer cells via the PI3K-Akt-mTOR signaling pathway publication-title: Am. J. Transl. Res. – volume: 156 start-page: 104774 year: 2020 ident: bb0445 article-title: MiR-377-3p suppresses colorectal cancer through negative regulation on Wnt/beta-catenin signaling by targeting XIAP and ZEB2 publication-title: Pharmacol. Res. – volume: 17 start-page: 138 year: 2017 ident: bb1170 article-title: Up-regulation of miR-146a increases the sensitivity of non-small cell lung cancer to DDP by downregulating cyclin J publication-title: BMC Cancer – volume: 477 start-page: 49 year: 2020 end-page: 59 ident: bb0615 article-title: miRNA-7 and miRNA-324-5p regulate alpha9-Integrin expression and exert anti-oncogenic effects in rhabdomyosarcoma publication-title: Cancer Lett. – volume: 65 start-page: 457 year: 2020 end-page: 463 ident: bb0880 article-title: miR-146b regulates cell proliferation and apoptosis in gastric cancer by targeting PTP1B publication-title: Dig. Dis. Sci. – volume: 35 start-page: 204 year: 2018 end-page: 221 ident: bb1100 article-title: The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cells publication-title: EBioMedicine – volume: 17 year: 2018 ident: bb0585 article-title: MicroRNA-29a functions as a tumor suppressor and increases cisplatin sensitivity by targeting NRAS in lung cancer publication-title: Technol. Cancer Res. Treat. – volume: 10 start-page: 215 year: 2020 ident: bb1500 article-title: A novel long non-coding RNA, MSTRG.51053.2 regulates cisplatin resistance by sponging the miR-432-5p in non-small cell lung cancer cells publication-title: Front. Oncol. – volume: 125 start-page: 109896 year: 2020 ident: bb0280 article-title: Inhibition of MGMT-mediated autophagy suppression decreases cisplatin chemosensitivity in gastric cancer publication-title: Biomed. Pharmacother. – volume: 10 start-page: 3767 year: 2020 end-page: 3778 ident: bb0050 article-title: PAQR4 promotes chemoresistance in non-small cell lung cancer through inhibiting Nrf2 protein degradation publication-title: Theranostics – volume: 6 start-page: 82 year: 2018 ident: bb1755 article-title: Evidence for the involvement of the master transcription factor NF-κB in cancer initiation and progression publication-title: Biomedicines – start-page: 117238 year: 2019 ident: bb0845 article-title: MiR-27b suppresses epithelial–mesenchymal transition and chemoresistance in lung cancer by targeting Snail1 publication-title: Life Sci. – volume: 16 start-page: 1813 year: 2010 end-page: 1825 ident: bb0165 article-title: Novel metals and metal complexes as platforms for cancer therapy publication-title: Curr. Pharm. Des. – start-page: 17(7) year: 2020 ident: bb0180 article-title: Comparing paclitaxel-carboplatin with paclitaxel-cisplatin as the front-line chemotherapy for patients with FIGO IIIC serous-type tubo-ovarian cancer publication-title: Int. J. Environ. Res. Public Health – volume: 20 start-page: 261 year: 2019 end-page: 271 ident: bb1655 article-title: LncRNA TATDN1 contributes to the cisplatin resistance of non-small cell lung cancer through TATDN1/miR-451/TRIM66 axis publication-title: Cancer Biol. Ther. – volume: 7 year: 2012 ident: bb0975 article-title: Interaction of caveolin-1 with Ku70 inhibits Bax-mediated apoptosis publication-title: PLoS One – volume: 17 start-page: 515 year: 2016 end-page: 525 ident: bb1345 article-title: Decreased MicroRNA-26a expression causes cisplatin resistance in human non-small cell lung cancer publication-title: Cancer Biol. Ther. – volume: 37 start-page: 3475 year: 2017 end-page: 3483 ident: bb1160 article-title: Effect of miR-1244 on cisplatin-treated non-small cell lung cancer via MEF2D expression publication-title: Oncol. Rep. – volume: 37 start-page: 1197 year: 2016 end-page: 1204 ident: bb1340 article-title: MicroRNA-218 regulates cisplatin (DPP) chemosensitivity in non-small cell lung cancer by targeting RUNX2 publication-title: Tumor Biol. – volume: 16 start-page: 1876 year: 2018 end-page: 1884 ident: bb0565 article-title: MicroRNA-137-regulated AKT serine/threonine kinase 2 inhibits tumor growth and sensitizes cisplatin in patients with non-small cell lung cancer publication-title: Oncol. Lett. – volume: 18 start-page: 667 year: 2019 end-page: 673 ident: bb0840 article-title: Effect of microRNA-27b on cisplatin chemotherapy sensitivity of oral squamous cell carcinoma via FZD7 signaling pathway publication-title: Oncol. Lett. – volume: 37 start-page: 4319 year: 2017 end-page: 4327 ident: bb1145 article-title: Therapeutic role of MiR-140-5p for the treatment of non-small cell lung cancer publication-title: Anticancer Res. – volume: 234 start-page: 22009 year: 2019 end-page: 22016 ident: bb1740 article-title: LncRNA LINC01857 promotes growth, migration, and invasion of glioma by modulating miR-1281/TRIM65 axis publication-title: J. Cell. Physiol. – volume: 121 start-page: 3197 year: 2020 end-page: 3207 ident: bb1465 article-title: miR-125a regulates HAS1 and inhibits the proliferation, invasion and metastasis by targeting STAT3 in non-small cell lung cancer cells publication-title: J. Cell Biochem. – volume: 234 start-page: 6116 year: 2019 end-page: 6124 ident: bb1470 article-title: LINC01433 promotes hepatocellular carcinoma progression via modulating the miR-1301/STAT3 axis publication-title: J. Cell. Physiol. – volume: 36 start-page: 114 year: 2017 ident: bb1135 article-title: Epigenetic silencing of miR-493 increases the resistance to cisplatin in lung cancer by targeting tongue cancer resistance-related protein 1(TCRP1) publication-title: J. Exp. Clin. Cancer Res. – volume: 373 start-page: 447 year: 2019 end-page: 458 ident: bb0590 article-title: Metal organic framework-graphene nano-composites for high adsorption removal of DBT as hazard material in liquid fuel publication-title: J. Hazard. Mater. – volume: 11 start-page: 2679 year: 2020 end-page: 2687 ident: bb1455 article-title: IL22 drives cutaneous melanoma cell proliferation, migration and invasion through activation of miR-181/STAT3/AKT axis publication-title: J. Cancer – volume: 39 start-page: 724 year: 2020 end-page: 732 ident: bb0455 article-title: Overexpression of growth-arrest-specific transcript 5 improved cisplatin sensitivity in hepatocellular carcinoma through sponging miR-222 publication-title: DNA Cell Biol. – volume: 9 start-page: 13758 year: 2018 end-page: 13767 ident: bb0580 article-title: MicroRNA-630 may confer favorable cisplatin-based chemotherapy and clinical outcomes in non-small cell lung cancer by targeting Bcl-2 publication-title: Oncotarget – volume: 43 start-page: 1126 year: 2017 end-page: 1139 ident: bb1130 article-title: Intensified Beclin-1 mediated by low expression of Mir-30a-5p promotes chemoresistance in human small cell lung cancer publication-title: Cell. Physiol. Biochem. – volume: 6 start-page: 19455 year: 2016 ident: bb0520 article-title: miRNA-378 reverses chemoresistance to cisplatin in lung adenocarcinoma cells by targeting secreted clusterin publication-title: Sci. Rep. – volume: 72 start-page: 183 year: 2020 end-page: 196 ident: bb1620 article-title: Autophagy in hepatic adaptation to stress publication-title: J. Hepatol. – volume: 388 start-page: 208 year: 2017 end-page: 219 ident: bb1395 article-title: Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer publication-title: Cancer Lett. – volume: 10 start-page: 5137 year: 2017 end-page: 5149 ident: bb1685 article-title: LncRNA MEG3 enhances cisplatin sensitivity in non-small cell lung cancer by regulating miR-21-5p/SOX7 axis publication-title: Onco Targets Ther. – year: 2020 ident: bb1725 article-title: SOX2 mediates cisplatin resistance in small-cell lung cancer with downregulated expression of hsa-miR-340-5p publication-title: Mol. Genet. Genomic. Med. – volume: 12 start-page: 9627 year: 2019 end-page: 9637 ident: bb0490 article-title: EZH2 contributes to cisplatin resistance in breast cancer by epigenetically suppressing miR-381 expression publication-title: Onco Targets Ther. – volume: 9 start-page: 327 year: 2018 ident: bb1190 article-title: miR-181b/Notch2 overcome chemoresistance by regulating cancer stem cell-like properties in NSCLC publication-title: Stem Cell Res. Ther. – volume: 12 start-page: 3721 year: 2017 end-page: 3733 ident: bb1155 article-title: Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner publication-title: Int. J. Nanomedicine – volume: 23 start-page: 3749 year: 2019 end-page: 3759 ident: bb1530 article-title: LINC00707 promotes cell proliferation and invasion of colorectal cancer via miR-206/FMNL2 axis publication-title: Eur. Rev. Med. Pharmacol. Sci. – volume: 9 start-page: 4717 year: 2019 end-page: 4729 ident: bb0030 article-title: CDYL promotes the chemoresistance of small cell lung cancer by regulating H3K27 trimethylation at the CDKN1C promoter publication-title: Theranostics – volume: 10 year: 2015 ident: bb1785 article-title: Modulation of NF-kappaB/miR-21/PTEN pathway sensitizes non-small cell lung cancer to cisplatin publication-title: PLoS One – volume: 47 start-page: 3745 year: 2019 end-page: 3756 ident: bb0550 article-title: MicroRNA-486-5p improves nonsmall-cell lung cancer chemotherapy sensitivity and inhibits epithelial-mesenchymal transition by targeting twinfilin actin binding protein 1 publication-title: J. Int. Med. Res. – volume: 91 start-page: 231 year: 1997 end-page: 241 ident: bb1005 article-title: Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery publication-title: Cell – volume: 25 start-page: 948 year: 2020 end-page: 960 ident: bb1550 article-title: PCAT1/miR-129/ABCB1 axis confers chemoresistance in non-small cell lung cancer publication-title: Front. Biosci. (Landmark Ed.) – volume: 9 start-page: 82 year: 2018 ident: bb1515 article-title: Silencing of long non-coding RNA MIAT sensitizes lung cancer cells to gefitinib by epigenetically regulating miR-34a publication-title: Front. Pharmacol. – volume: 10 year: 2020 ident: bb0330 article-title: The dual role of miR-186 in cancers: oncomir battling with tumor suppressor miRNA publication-title: Front. Oncol. – volume: 29 start-page: 384 year: 2012 end-page: 391 ident: bb1240 article-title: miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2 publication-title: Med. Oncol. – volume: 21 start-page: 2092 year: 2020 ident: bb0315 article-title: The pervasive role of the miR-181 family in development, neurodegeneration, and cancer publication-title: Int. J. Mol. Sci. – volume: 383 start-page: 245 year: 2009 end-page: 251 ident: bb0695 article-title: Identification of a common microdeletion cluster in 7q21.3 subband among patients with myeloid leukemia and myelodysplastic syndrome publication-title: Biochem. Biophys. Res. Commun. – volume: 9 start-page: 542 year: 2020 ident: bb0210 article-title: progress in microneedle-mediated protein delivery publication-title: J. Clin. Med. – volume: 16 start-page: 182 year: 2000 end-page: 187 ident: bb1705 article-title: Pairing SOX off: with partners in the regulation of embryonic development publication-title: Trends Genet. – volume: 39 start-page: 1227 year: 2018 end-page: 1234 ident: bb1035 article-title: Over-regulation of microRNA-133b inhibits cell proliferation of cisplatin-induced non-small cell lung cancer cells through PI3K/Akt and JAK2/STAT3 signaling pathway by targeting EGFR publication-title: Oncol. Rep. – volume: 66 start-page: 756 year: 2019 end-page: 765 ident: bb1595 article-title: Long non-coding RNA SNHG1 contributes to cisplatin resistance in non-small cell lung cancer by regulating miR-140-5p/Wnt/β-catenin pathway publication-title: Neoplasma – volume: 117 start-page: 218 year: 2017 end-page: 227 ident: bb0890 article-title: Curcumin: A potentially powerful tool to reverse cisplatin-induced toxicity publication-title: Pharmacol. Res. – volume: 36 start-page: 6774 year: 2017 end-page: 6783 ident: bb1580 article-title: The long noncoding RNA SNHG1 promotes tumor growth through regulating transcription of both local and distal genes publication-title: Oncogene – volume: 9 year: 2014 ident: bb0525 article-title: MiRNA 17 family regulates cisplatin-resistant and metastasis by targeting TGFbetaR2 in NSCLC publication-title: PLoS One – volume: 42 start-page: 270 year: 2019 end-page: 283 ident: bb1650 article-title: LncRNA MALAT1 depressed chemo-sensitivity of NSCLC cells through directly functioning on miR-197-3p/p120 catenin axis publication-title: Mol. Cell – volume: 21 start-page: 1471 year: 2020 end-page: 1480 ident: bb0275 article-title: Propofol inhibits proliferation and cisplatin resistance in ovarian cancer cells through regulating the microRNA374a/forkhead box O1 signaling axis publication-title: Mol. Med. Rep. – volume: 10 start-page: 937 year: 2020 end-page: 950 ident: bb0060 article-title: PBK attenuates paclitaxel-induced autophagic cell death by suppressing p53 in H460 non-small cell lung cancer cells publication-title: FEBS Open Biol. – volume: 13 start-page: 2905 year: 1999 end-page: 2927 ident: bb1000 article-title: Cellular survival: a play in three Akts publication-title: Genes Dev. – volume: 7 start-page: 7236 year: 2014 end-page: 7241 ident: bb1275 article-title: miR-107 regulates cisplatin chemosensitivity of A549 non small cell lung cancer cell line by targeting cyclin dependent kinase 8 publication-title: Int. J. Clin. Exp. Pathol. – volume: 14 start-page: 7745 year: 2017 end-page: 7752 ident: bb1120 article-title: Upregulation of miR-146a increases cisplatin sensitivity of the non-small cell lung cancer A549 cell line by targeting JNK-2 publication-title: Oncol. Lett. – volume: 37 start-page: 13287 year: 2016 end-page: 13294 ident: bb1220 article-title: miR-326 reverses chemoresistance in human lung adenocarcinoma cells by targeting specificity protein 1 publication-title: Tumor Biol. – volume: 115 start-page: 1234 year: 2014 end-page: 1242 ident: bb1230 article-title: miR-495 enhances the sensitivity of non-small cell lung cancer cells to platinum by modulation of copper-transporting p-type adenosine triphosphatase A (ATP7A) publication-title: J. Cell. Biochem. – volume: 10 start-page: 4722 year: 2020 ident: bb1715 article-title: Novel HDAC11 inhibitors suppress lung adenocarcinoma stem cell self-renewal and overcome drug resistance by suppressing Sox2 publication-title: Sci. Rep. – volume: 34 start-page: 6055 year: 2020 end-page: 6069 ident: bb0140 article-title: Long non-coding RNA LINC00337 induces autophagy and chemoresistance to cisplatin in esophageal squamous cell carcinoma cells via upregulation of TPX2 by recruiting E2F4 publication-title: Faseb J. – volume: 143 start-page: 550 year: 2012 end-page: 563 ident: bb0375 article-title: Inflammation-associated cancer development in digestive organs: mechanisms and roles for genetic and epigenetic modulation publication-title: Gastroenterology – volume: 36 start-page: 1903 year: 2015 end-page: 1911 ident: bb0760 article-title: Downregulation of miR-25 modulates non-small cell lung cancer cells by targeting CDC42 publication-title: Tumor Biol. – volume: 11 start-page: 120 year: 2020 end-page: 129 ident: bb0680 article-title: Prognostic impact of CD34 and SMA in cancer-associated fibroblasts in stage I-III NSCLC publication-title: Thorac Cancer – volume: 8 start-page: 23 year: 2018 ident: bb1695 article-title: TP53TG1 enhances cisplatin sensitivity of non-small cell lung cancer cells through regulating miR-18a/PTEN axis publication-title: Cell Biosci. – volume: 70 start-page: 1513 year: 2018 end-page: 1520 ident: bb0620 article-title: MiR-324-5p reduces viability and induces apoptosis in gastric cancer cells through modulating TSPAN8 publication-title: J. Pharm. Pharmacol. – volume: 77 start-page: 488 year: 2012 end-page: 494 ident: bb1250 article-title: miR-513a-3p sensitizes human lung adenocarcinoma cells to chemotherapy by targeting GSTP1 publication-title: Lung Cancer – volume: 8 start-page: 104206 year: 2017 end-page: 104215 ident: bb1125 article-title: Overexpression of miR-216b sensitizes NSCLC cells to cisplatin-induced apoptosis by targeting c-Jun publication-title: Oncotarget – volume: 12 start-page: 9165 year: 2019 end-page: 9175 ident: bb1540 article-title: Targeting ZEB2 By microRNA-129 In non-small cell lung cancer suppresses cell proliferation, invasion and migration via regulating Wnt/beta-catenin signaling pathway and epithelial-mesenchymal transition publication-title: Onco Targets Ther. – volume: 11 start-page: 1443 year: 2020 end-page: 1452 ident: bb0020 article-title: Validated LC-MS/MS method of Sphingosine 1-phosphate quantification in human serum for evaluation of response to radiotherapy in lung cancer publication-title: Thorac. Cancer – volume: 26 year: 2020 ident: bb0175 article-title: Propofol improves sensitivity of lung cancer cells to cisplatin and its mechanism publication-title: Med. Sci. Monit. – volume: 14 start-page: 745 year: 2018 end-page: 751 ident: bb1195 article-title: miR-181b inhibits chemoresistance in cisplatin-resistant H446 small cell lung cancer cells by targeting Bcl-2 publication-title: Arch. Med. Sci. – volume: 11 start-page: 142 year: 2018 end-page: 158 ident: bb0960 article-title: miR-1266 contributes to pancreatic cancer progression and chemoresistance by the stat3 and nf-kappab signaling pathways publication-title: Mol. Ther. Nucleic Acids – volume: 235 start-page: 8319 year: 2020 end-page: 8333 ident: bb0430 article-title: RFC2, a direct target of miR-744, modulates the cell cycle and promotes the proliferation of CRC cells publication-title: J. Cell. Physiol. – volume: 12 start-page: 7551 year: 2019 end-page: 7560 ident: bb0915 article-title: Restoration of miR-26b expression partially reverses the cisplatin resistance of NSCLC by targeting tafazzin publication-title: Onco Targets Ther. – volume: 12 start-page: 3197 year: 2019 end-page: 3207 ident: bb1770 article-title: Cyr61 overexpression induced by interleukin 8 via NF-kB signaling pathway and its role in tumorigenesis of gastric carcinoma in vitro publication-title: Int. J. Clin. Exp. Pathol. – volume: 678 start-page: 115 year: 2018 end-page: 123 ident: bb1910 article-title: Purified sulforaphane from broccoli (Brassica oleracea var. italica) leads to alterations of CDX1 and CDX2 expression and changes in miR-9 and miR-326 levels in human gastric cancer cells publication-title: Gene – volume: 7 year: 2012 ident: bb1840 article-title: Docetaxel-resistance in prostate cancer: evaluating associated phenotypic changes and potential for resistance transfer via exosomes publication-title: PLoS One – volume: 119 start-page: 1420 year: 2009 end-page: 1428 ident: bb0865 article-title: The basics of epithelial-mesenchymal transition publication-title: J. Clin. Invest. – volume: 11 start-page: 20649 year: 2019 end-page: 20659 ident: bb0235 article-title: Dual stable nanomedicines prepared by cisplatin-crosslinked camptothecin prodrug micelles for effective drug delivery publication-title: ACS Appl. Mater. Interfaces – volume: 8 start-page: 12067 year: 2017 end-page: 12080 ident: bb1915 article-title: Sulforaphane inhibits cancer stem-like cell properties and cisplatin resistance through miR-214-mediated downregulation of c-MYC in non-small cell lung cancer publication-title: Oncotarget – volume: 8 year: 2019 ident: bb1405 article-title: The circular RNA PVT1/miR-203/HOXD3 pathway promotes the progression of human hepatocellular carcinoma publication-title: Biol. Open – volume: 37 start-page: 1067 year: 2016 end-page: 1074 ident: bb0715 article-title: Downregulation of microRNA-196a enhances the sensitivity of non-small cell lung cancer cells to cisplatin treatment publication-title: Int. J. Mol. Med. – volume: 7 start-page: 3636 year: 2017 ident: bb1055 article-title: MicroRNA-34a encapsulated in hyaluronic acid nanoparticles induces epigenetic changes with altered mitochondrial bioenergetics and apoptosis in non-small-cell lung cancer cells publication-title: Sci. Rep. – volume: 10 start-page: 959 year: 2019 ident: bb1635 article-title: TIPRL potentiates survival of lung cancer by inducing autophagy through the eIF2alpha-ATF4 pathway publication-title: Cell Death Dis. – volume: 10 start-page: 12705 year: 2020 ident: bb0110 article-title: Circulating miR-92b and miR-375 for monitoring the chemoresistance and prognosis of small cell lung cancer publication-title: Sci. Rep. – volume: 309 start-page: 310 year: 2005 end-page: 311 ident: bb0360 article-title: MicroRNA expression in zebrafish embryonic development publication-title: Science – start-page: 12 year: 2020 ident: bb0065 article-title: Silencing of lncRNA XIST inhibits non-small cell lung cancer growth and promotes chemosensitivity to cisplatin publication-title: Aging (Albany NY) – volume: 16 start-page: e121 year: 2015 end-page: e129 ident: bb0755 article-title: miR profiling identifies cyclin-dependent kinase 6 downregulation as a potential mechanism of acquired cisplatin resistance in non–small-cell lung carcinoma publication-title: Clin. Lung Cancer – volume: 13 start-page: 212 year: 2020 end-page: 219 ident: bb0460 article-title: Scutellarin circumvents chemoresistance, promotes apoptosis, and represses tumor growth by HDAC/miR-34a-mediated down-modulation of Akt/mTOR and NF-kappaB-orchestrated signaling pathways in multiple myeloma publication-title: Int. J. Clin. Exp. Pathol. – volume: 104 start-page: 15805 year: 2007 end-page: 15810 ident: bb0940 article-title: MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B publication-title: Proc. Natl. Acad. Sci. U. S. A. – volume: 2 start-page: 14003 year: 2014 ident: bb1015 article-title: Role of FGF/FGFR signaling in skeletal development and homeostasis: learning from mouse models publication-title: Bone Res. – volume: 8 start-page: 1207 year: 2010 end-page: 1216 ident: bb1310 article-title: Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer publication-title: Mol. Cancer Res. – volume: 47 start-page: 3202 year: 2019 end-page: 3211 ident: bb1920 article-title: Baicalein inhibits proliferation and collagen synthesis of mice fibroblast cell line NIH/3T3 by regulation of miR-9/insulin-like growth factor-1 axis publication-title: Artif. Cells Nanomed. Biotechnol. – volume: 20 start-page: 308 year: 2020 end-page: 322 ident: bb1360 article-title: circRNA-AKT1 sequesters miR-942-5p to upregulate AKT1 and promote cervical cancer progression publication-title: Mol. Ther. Nucleic Acids – volume: 469 start-page: 266 year: 2020 end-page: 276 ident: bb1325 article-title: MicroRNA-182-5p regulates hedgehog signaling pathway and chemosensitivity of cisplatin-resistant lung adenocarcinoma cells via targeting GLI2 publication-title: Cancer Lett. – volume: 38 start-page: 6429 year: 2019 end-page: 6444 ident: bb1735 article-title: Ubiquitin ligase TRIM65 promotes colorectal cancer metastasis by targeting ARHGAP35 for protein degradation publication-title: Oncogene – volume: 6 start-page: 235 year: 2016 end-page: 246 ident: bb0370 article-title: miRNA deregulation in cancer cells and the tumor microenvironment publication-title: Cancer Discov. – volume: 473 start-page: 62 year: 2020 end-page: 73 ident: bb0675 article-title: VCAM-1 secreted from cancer-associated fibroblasts enhances the growth and invasion of lung cancer cells through AKT and MAPK signaling publication-title: Cancer Lett. – volume: 5 year: 2016 ident: bb1320 article-title: The novel miR-9600 suppresses tumor progression and promotes paclitaxel sensitivity in non-small-cell lung cancer through altering STAT3 expression publication-title: Mol. Ther. Nucleic Acids – volume: 85 start-page: 843 year: 2020 end-page: 853 ident: bb0150 article-title: Evaluating the immunoproteasome as a potential therapeutic target in cisplatin-resistant small cell and non-small cell lung cancer publication-title: Cancer Chemother. Pharmacol. – volume: 20 start-page: 3509 year: 2019 end-page: 3518 ident: bb1415 article-title: Overexpressed circPVT1 in oral squamous cell carcinoma promotes proliferation by serving as a miRNA sponge publication-title: Mol. Med. Rep. – volume: 19 start-page: 948 year: 2019 ident: bb0945 article-title: CSB affected on the sensitivity of lung cancer cells to platinum-based drugs through the global decrease of let-7 and miR-29 publication-title: BMC Cancer – volume: 259 start-page: 118239 year: 2020 ident: bb0405 article-title: Tumor suppressive activity of miR-424-5p in breast cancer cells through targeting PD-L1 and modulating PTEN/PI3K/AKT/mTOR signaling pathway publication-title: Life Sci. – volume: 16 start-page: 30 year: 2016 ident: bb1355 article-title: MiR-1244 sensitizes the resistance of non-small cell lung cancer A549 cell to cisplatin publication-title: Cancer Cell Int. – start-page: 40(1) year: 2020 ident: bb1575 article-title: NORAD accelerates chemo-resistance of non-small-cell lung cancer via targeting at miR-129-1-3p/SOX4 axis publication-title: Biosci. Rep. – volume: 37 start-page: 2129 year: 2017 end-page: 2136 ident: bb1165 article-title: Overexpression of miR-203 increases the sensitivity of NSCLC A549/H460 cell lines to cisplatin by targeting Dickkopf-1 publication-title: Oncol. Rep. – volume: 9 start-page: 1123 year: 2018 ident: bb0875 article-title: miR-146b promotes cell proliferation and increases chemosensitivity, but attenuates cell migration and invasion via FBXL10 in ovarian cancer publication-title: Cell Death Dis. – volume: 11 start-page: 597 year: 2010 end-page: 610 ident: bb0350 article-title: The widespread regulation of microRNA biogenesis, function and decay publication-title: Nat. Rev. Genet. – volume: 19 start-page: 240 year: 2019 ident: bb0545 article-title: Long non-coding RNA LINC00485 acts as a microRNA-195 sponge to regulate the chemotherapy sensitivity of lung adenocarcinoma cells to cisplatin by regulating CHEK1 publication-title: Cancer Cell Int. – volume: 22 start-page: 3475 year: 2018 end-page: 3488 ident: bb0645 article-title: TP53INP1 inhibits hypoxia-induced vasculogenic mimicry formation via the ROS/snail signalling axis in breast cancer publication-title: J. Cell. Mol. Med. – volume: 13 start-page: 3555 year: 2017 end-page: 3562 ident: bb0710 article-title: microRNA-664 enhances proliferation, migration and invasion of lung cancer cells publication-title: Exp. Ther. Med. – year: 2018 ident: bb1090 article-title: miR-451 selectively increases sensitivity to cisplatin in ERCC1-high non-small cell lung cancer cells publication-title: J. Cell. Biochem. – volume: 12 start-page: 3913 year: 2017 ident: bb0230 article-title: Electrohydrodynamic fabrication of core–shell PLGA nanoparticles with controlled release of cisplatin for enhanced cancer treatment publication-title: Int. J. Nanomedicine – volume: 12 start-page: 447 year: 2020 end-page: 462 ident: bb0850 article-title: Downregulation of SETBP1 promoted non-small cell lung cancer progression by inducing cellular EMT and disordered immune status publication-title: Am. J. Transl. Res. – volume: 5 start-page: 1304 year: 2014 end-page: 1314 ident: bb1290 article-title: Retaining MKP1 expression and attenuating JNK-mediated apoptosis by RIP1 for cisplatin resistance through miR-940 inhibition publication-title: Oncotarget – volume: 13 start-page: 109 year: 2020 end-page: 118 ident: bb0605 article-title: miR-1269b drives cisplatin resistance of human non-small cell lung cancer via modulating the PTEN/PI3K/AKT signaling pathway publication-title: Onco Targets Ther. – volume: 8 start-page: 8007 year: 2018 ident: bb1105 article-title: MiR-29c reduces the cisplatin resistance of non-small cell lung cancer cells by negatively regulating the PI3K/Akt pathway publication-title: Sci. Rep. – volume: 13 start-page: 1 year: 2020 end-page: 13 ident: bb1560 article-title: Long noncoding RNA NORAD regulates lung cancer cell proliferation, apoptosis, migration, and invasion by the miR-30a-5p/ADAM19 axis publication-title: Int. J. Clin. Exp. Pathol. – volume: 30 start-page: 771 year: 2020 end-page: 782 ident: bb1710 article-title: Chromosome 3q26 gain is an early event driving coordinated overexpression of the PRKCI, SOX2, and ECT2 oncogenes in lung squamous cell carcinoma publication-title: Cell Rep. – volume: 7 start-page: 573 year: 2007 end-page: 584 ident: bb0160 article-title: The resurgence of platinum-based cancer chemotherapy publication-title: Nat. Rev. Cancer – volume: 11 start-page: 2138 year: 2019 end-page: 2150 ident: bb1010 article-title: MiR-204 reduces cisplatin resistance in non-small cell lung cancer through suppression of the caveolin-1/AKT/Bad pathway publication-title: Aging (Albany NY) – volume: 111 start-page: 339 year: 2014 end-page: 354 ident: bb0785 article-title: MiR-224 promotes the chemoresistance of human lung adenocarcinoma cells to cisplatin via regulating G(1)/S transition and apoptosis by targeting p21(WAF1/CIP1) publication-title: Br. J. Cancer – volume: 106 start-page: 1072 year: 2018 end-page: 1081 ident: bb1085 article-title: miR-539 enhances chemosensitivity to cisplatin in non-small cell lung cancer by targeting DCLK1 publication-title: Biomed. Pharmacother. – volume: 70 start-page: 1793 year: 2010 end-page: 1803 ident: bb1300 article-title: miR-181a and miR-630 regulate cisplatin-induced cancer cell death publication-title: Cancer Res. – volume: 26 start-page: 83 year: 2020 end-page: 94 ident: bb0860 article-title: Brusatol suppresses STAT3-driven metastasis by downregulating epithelial-mesenchymal transition in hepatocellular carcinoma publication-title: J. Adv. Res. – volume: 241 start-page: 117142 year: 2020 ident: bb1775 article-title: MiR-345-3p attenuates apoptosis and inflammation caused by oxidized low-density lipoprotein by targeting TRAF6 via TAK1/p38/NF-kB signaling in endothelial cells publication-title: Life Sci. – volume: 10 start-page: 836 year: 2019 end-page: 843 ident: bb0025 article-title: The role of prostaglandin-endoperoxide synthase-2 in chemoresistance of non-small cell lung cancer publication-title: Front. Pharmacol. – start-page: 144629 year: 2020 ident: bb0250 article-title: SIRT3 increases cisplatin sensitivity of small-cell lung cancer through apoptosis publication-title: Gene – volume: 28 start-page: 163 year: 2019 end-page: 173 ident: bb0635 article-title: Prognostic role of circulating exosomal miR-425-3p for the response of NSCLC to platinum-based chemotherapy publication-title: Cancer Epidemiol. Biomark. Prev. – volume: 109 start-page: 3068 year: 2018 end-page: 3079 ident: bb1670 article-title: LncRNA HOXA11-AS drives cisplatin resistance of human LUAD cells via modulating miR-454-3p/Stat3 publication-title: Cancer Sci. – volume: 98 start-page: 538 year: 2018 end-page: 544 ident: bb1040 article-title: microRNA-381 suppresses the growth and increases cisplatin sensitivity in non-small cell lung cancer cells through inhibition of nuclear factor-kappaB signaling publication-title: Biomed. Pharmacother. – volume: 482 start-page: 22 year: 2017 end-page: 27 ident: bb1200 article-title: miR-34a sensitizes lung cancer cells to cisplatin via p53/miR-34a/MYCN axis publication-title: Biochem. Biophys. Res. Commun. – volume: 133 start-page: 110807 year: 2019 ident: bb1870 article-title: EGCG enhances cancer cells sensitivity under (60)Cogamma radiation based on miR-34a/Sirt1/p53 publication-title: Food Chem. Toxicol. – volume: 15 start-page: 331 year: 2005 end-page: 341 ident: bb0335 article-title: Post-transcriptional gene silencing by siRNAs and miRNAs publication-title: Curr. Opin. Struct. Biol. – volume: 35 start-page: 10341 year: 2014 end-page: 10349 ident: bb1235 article-title: Downregulation of PEBP4, a target of miR-34a, sensitizes drug-resistant lung cancer cells publication-title: Tumor Biol. – volume: 12 start-page: 293 year: 2013 end-page: 299 ident: bb0920 article-title: The CSB repair factor is overexpressed in cancer cells, increases apoptotic resistance, and promotes tumor growth publication-title: DNA Repair (Amst.) – volume: 38 start-page: 2844 year: 2019 end-page: 2859 ident: bb1365 article-title: Exosome circRNA secreted from adipocytes promotes the growth of hepatocellular carcinoma by targeting deubiquitination-related USP7 publication-title: Oncogene – volume: 126 start-page: 110100 year: 2020 ident: bb1605 article-title: Long non-coding RNA PVT1 contributes to cell growth and metastasis in non-small-cell lung cancer by regulating miR-361-3p/SOX9 axis and activating Wnt/beta-catenin signaling pathway publication-title: Biomed. Pharmacother. – volume: 23 start-page: 6336 year: 2017 end-page: 6350 ident: bb1095 article-title: miRomics and proteomics reveal a miR-296-3p/PRKCA/FAK/Ras/c-Myc feedback loop modulated by HDGF/DDX5/β-catenin complex in lung adenocarcinoma publication-title: Clin. Cancer Res. – volume: 25 start-page: 8095 year: 2019 end-page: 8104 ident: bb0530 article-title: Upregulation of long noncoding RNA (lncRNA) X-inactive specific transcript (XIST) is associated with cisplatin resistance in non-small cell lung cancer (NSCLC) by downregulating MicroRNA-144-3p publication-title: Med. Sci. Monit. – volume: 12 start-page: 1087 year: 2019 end-page: 1094 ident: bb1025 article-title: miR-5582-5p inhibits cell proliferation of non-small cell lung cancer through targeting FGF-10 publication-title: Int. J. Clin. Exp. Pathol. – volume: 661 start-page: 196 year: 2019 end-page: 202 ident: bb1375 article-title: CircZFR promotes hepatocellular carcinoma progression through regulating miR-3619-5p/CTNNB1 axis and activating Wnt/beta-catenin pathway publication-title: Arch. Biochem. Biophys. – volume: 12 start-page: 1947 year: 2019 end-page: 1956 ident: bb1850 article-title: Hypoxic non-small-cell lung cancer cell-derived exosomal miR-21 promotes resistance of normoxic cell to cisplatin publication-title: Onco Targets Ther. – volume: 263 start-page: 112 year: 2017 end-page: 119 ident: bb0215 article-title: Convection enhanced delivery of cisplatin-loaded brain penetrating nanoparticles cures malignant glioma in rats publication-title: J. Control. Release – volume: 14 start-page: 41 year: 2018 end-page: 51 ident: bb0555 article-title: microRNA-1236-3p regulates DDP resistance in lung cancer cells publication-title: Open Med. (Wars) – volume: 174 start-page: 113795 year: 2020 ident: bb0500 article-title: Curcumol enhances the sensitivity of doxorubicin in triple-negative breast cancer via regulating the miR-181b-2-3p-ABCC3 axis publication-title: Biochem. Pharmacol. – volume: 34 start-page: 1142 year: 2020 end-page: 1153 ident: bb0070 article-title: Rosmarinic acid reverses non-small cell lung cancer cisplatin resistance by activating the MAPK signaling pathway publication-title: Phytother. Res. – volume: 20 start-page: 1023 year: 2019 end-page: 1032 ident: bb0090 article-title: Non-coding RNAs in lung cancer chemoresistance publication-title: Curr. Drug Metab. – volume: 10 start-page: 11545 year: 2017 end-page: 11553 ident: bb1045 article-title: MicroRNA-146a regulates cisplatin-resistance of non-small cell lung cancer cells by targeting NF-kappaB pathway publication-title: Int. J. Clin. Exp. Pathol. – volume: 18 start-page: 74 year: 2018 ident: bb0650 article-title: MicroRNA-200a confers chemoresistance by antagonizing TP53INP1 and YAP1 in human breast cancer publication-title: BMC Cancer – volume: 19 start-page: 773 year: 2012 end-page: 778 ident: bb0765 article-title: MiR-155 inhibits the sensitivity of lung cancer cells to cisplatin via negative regulation of Apaf-1 expression publication-title: Cancer Gene Ther. – volume: 18 start-page: 4613 year: 2019 end-page: 4620 ident: bb0535 article-title: MicroRNA-152 suppresses cisplatin resistance in A549 cells publication-title: Oncol. Lett. – volume: 18 start-page: 1653 year: 2019 end-page: 1660 ident: bb0670 article-title: Downregulation of miR-3934-5p enhances A549 cell sensitivity to cisplatin by targeting TP53INP1 publication-title: Exp. Ther. Med. – volume: 7 start-page: 32362 year: 2016 end-page: 32374 ident: bb1070 article-title: Reduction of microRNA-184 by E6 oncoprotein confers cisplatin resistance in lung cancer via increasing Bcl-2 publication-title: Oncotarget – volume: 66 start-page: 3 year: 2019 end-page: 11 ident: bb1630 article-title: At a glance: a history of autophagy and cancer publication-title: Semin. Cancer Biol. – volume: 36 start-page: 2577 year: 2017 end-page: 2588 ident: bb1175 article-title: Downregulation of miR-218 contributes to epithelial-mesenchymal transition and tumor metastasis in lung cancer by targeting Slug/ZEB2 signaling publication-title: Oncogene – volume: 37 start-page: 1081 year: 2014 end-page: 1089 ident: bb1020 article-title: Physiological functions and underlying mechanisms of fibroblast growth factor (FGF) family members: recent findings and implications for their pharmacological application publication-title: Biol. Pharm. Bull. – volume: 114 start-page: 108662 year: 2019 ident: bb1030 article-title: MiR-219a-5p enhances cisplatin sensitivity of human non-small cell lung cancer by targeting FGF9 publication-title: Biomed. Pharmacother. – volume: 14 start-page: 8121 year: 2019 end-page: 8132 ident: bb0640 article-title: Exosomal transfer of cisplatin-induced miR-425-3p confers cisplatin resistance In NSCLC through activating autophagy publication-title: Int. J. Nanomedicine – volume: 127 start-page: 2520 year: 2010 end-page: 2529 ident: bb1305 article-title: miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines publication-title: Int. J. Cancer – volume: 93 start-page: 570 year: 2017 end-page: 579 ident: bb1660 article-title: GAS5 knockdown reduces the chemo-sensitivity of non-small cell lung cancer (NSCLC) cell to cisplatin (DDP) through regulating miR-21/PTEN axis publication-title: Biomed. Pharmacother. – volume: 31 start-page: 498 year: 2020 end-page: 506 ident: bb0420 article-title: miR-149 rs2292832 C allele enhances the cytotoxic effect of temozolomide against glioma cells publication-title: Neuroreport – volume: 19 start-page: 188 year: 2019 ident: bb0040 article-title: p53 sensitizes chemoresistant non-small cell lung cancer via elevation of reactive oxygen species and suppression of EGFR/PI3K/AKT signaling publication-title: Cancer Cell Int. – volume: 20 start-page: 2565 year: 2016 end-page: 2572 ident: bb0830 article-title: Inhibition of miR-141 reverses cisplatin resistance in non-small cell lung cancer cells via upregulation of programmed cell death protein 4 publication-title: Eur. Rev. Med. Pharmacol. Sci. – volume: 21 year: 2020 ident: bb1720 article-title: The FDA-approved anti-asthma medicine ciclesonide inhibits lung cancer stem cells through hedgehog signaling-mediated SOX2 regulation publication-title: Int. J. Mol. Sci. – volume: 84 start-page: 123 year: 2016 end-page: 129 ident: bb1210 article-title: miR-135b reverses chemoresistance of non-small cell lung cancer cells by downregulation of FZD1 publication-title: Biomed. Pharmacother. – volume: 19 start-page: 5397 year: 2019 end-page: 5405 ident: bb1570 article-title: Long noncoding RNA NORAD promotes cell proliferation and glycolysis in nonsmall cell lung cancer by acting as a sponge for miR1365p publication-title: Mol. Med. Rep. – volume: 454 start-page: 157 year: 2014 end-page: 161 ident: bb0700 article-title: Overexpression of SAMD9 suppresses tumorigenesis and progression during non small cell lung cancer publication-title: Biochem. Biophys. Res. Commun. – volume: 22 start-page: 108 year: 2015 end-page: 114 ident: bb0775 article-title: miR-15b regulates cisplatin resistance and metastasis by targeting PEBP4 in human lung adenocarcinoma cells publication-title: Cancer Gene Ther. – volume: 10 start-page: 429 year: 2019 ident: bb1750 article-title: Knockdown of TRIM65 inhibits autophagy and cisplatin resistance in A549/DDP cells by regulating miR-138-5p/ATG7 publication-title: Cell Death Dis. – start-page: 12(4) year: 2020 ident: bb0155 article-title: Cisplatin relocalizes RNA binding protein HuR and enhances the oncolytic activity of E4orf6 deleted adenovirus publication-title: Cancers (Basel) – volume: 12 start-page: 1929 year: 2020 end-page: 1939 ident: bb0260 article-title: LncRNA MALAT1 regulates the cell proliferation and cisplatin resistance in gastric cancer via PI3K/AKT pathway publication-title: Cancer Manag. Res. – start-page: 11(10) year: 2019 ident: bb1765 article-title: Migration and invasion enhancer 1 Is an NF-kB-inducing gene enhancing the cell proliferation and invasion ability of human prostate carcinoma cells in vitro and in vivo publication-title: Cancers (Basel) – volume: 124 start-page: 3315 year: 2020 end-page: 3325 ident: bb0145 article-title: Role of transient anions in chemoradiation therapy: base modifications, crosslinks and cluster damages induced to cisplatin-dna complexes by 1-20 eV electrons publication-title: J. Phys. Chem. B – volume: 120 start-page: 623 year: 2005 end-page: 634 ident: bb0340 article-title: Involvement of microRNA in AU-rich element-mediated mRNA instability publication-title: Cell – volume: 107 start-page: 1583 year: 2018 end-page: 1590 ident: bb1925 article-title: Baicalein inhibits proliferation and migration of bladder cancer cell line T24 by down-regulation of microRNA-106 publication-title: Biomed. Pharmacother. – volume: 17 start-page: 1 year: 2014 end-page: 7 ident: bb1295 article-title: The reversing and molecular mechanisms of miR-503 on the drug-resistance to cisplatin in A549/DDP cells publication-title: Zhongguo Fei Ai Za Zhi – volume: 11 start-page: 7553 year: 2019 end-page: 7569 ident: bb0540 article-title: Long non-coding RNA TUG1 enhances chemosensitivity in non-small cell lung cancer by impairing microRNA-221-dependent PTEN inhibition publication-title: Aging (Albany NY) – volume: 59 start-page: 105 year: 2008 end-page: 110 ident: bb0985 article-title: Caveolin-1 expression is significantly associated with drug resistance and poor prognosis in advanced non-small cell lung cancer patients treated with gemcitabine-based chemotherapy publication-title: Lung Cancer – volume: 12 start-page: 2997 year: 2019 end-page: 3004 ident: bb0095 article-title: HOTAIR contributes to chemoresistance by activating NF-kappaB signaling in small-cell lung cancer publication-title: Int. J. Clin. Exp. Pathol. – volume: 21 start-page: 452 year: 2020 end-page: 462 ident: bb0475 article-title: Knockdown of lncRNA CCAT1 enhances sensitivity of paclitaxel in prostate cancer via regulating miR-24-3p and FSCN1 publication-title: Cancer Biol. Ther. – start-page: 117325 year: 2020 ident: bb0085 article-title: Nuclear factor erythroid 2 (NF-E2)-related factor 2 (Nrf2) in non-small cell lung cancer publication-title: Life Sci. – volume: 290 start-page: 6037 year: 2015 end-page: 6046 ident: bb0630 article-title: The oncogenic microRNA-21 inhibits the tumor suppressive activity of FBXO11 to promote tumorigenesis publication-title: J. Biol. Chem. – volume: 12 start-page: 1913 year: 2020 end-page: 1927 ident: bb0075 article-title: Anticancer effects of antihypertensive L-type calcium channel blockers on chemoresistant lung cancer cells via autophagy and apoptosis publication-title: Cancer Manag. Res. – volume: 19 start-page: 643 year: 2020 end-page: 653 ident: bb1495 article-title: lncRNA UCA1 promotes gefitinib resistance as a ceRNA to target FOSL2 by sponging miR-143 in non-small cell lung cancer publication-title: Mol. Ther. Nucleic Acids – volume: 254 start-page: 117238 year: 2020 ident: bb0105 article-title: MiR-27b suppresses epithelial-mesenchymal transition and chemoresistance in lung cancer by targeting Snail1 publication-title: Life Sci. – start-page: 50(5) year: 2017 ident: bb1435 article-title: Visfatin mediates doxorubicin resistance in human non-small-cell lung cancer via Akt-mediated up-regulation of ABCC1 publication-title: Cell Prolif. – volume: 26 start-page: R369 year: 2019 end-page: r380 ident: bb1760 article-title: The NF-KB pathway and endocrine therapy resistance in breast cancer publication-title: Endocr. Relat. Cancer – volume: 6 start-page: 1317 year: 2016 end-page: 1330 ident: bb0825 article-title: Oncogenic miR-137 contributes to cisplatin resistance via repressing CASP3 in lung adenocarcinoma publication-title: Am. J. Cancer Res. – volume: 10 start-page: 308 year: 2020 ident: bb0435 article-title: Regulation of integrin subunit alpha 2 by miR-135b-5p modulates chemoresistance in gastric cancer publication-title: Front. Oncol. – volume: 268 start-page: 187 year: 2008 end-page: 201 ident: bb0980 article-title: Caveats of caveolin-1 in cancer progression publication-title: Cancer Lett. – volume: 7 start-page: 37524 year: 2016 end-page: 37535 ident: bb1350 article-title: Downregulation of miR-101 contributes to epithelial-mesenchymal transition in cisplatin resistance of NSCLC cells by targeting ROCK2 publication-title: Oncotarget – volume: 9 start-page: 78 year: 2018 ident: bb1115 article-title: Dual roles of miR-374a by modulated c-Jun respectively targets CCND1-inducing PI3K/AKT signal and PTEN-suppressing Wnt/beta-catenin signaling in non-small-cell lung cancer publication-title: Cell Death Dis. – volume: 47 start-page: 1464 year: 2020 end-page: 1472 ident: bb0465 article-title: LncRNA XIST promotes chemoresistance of breast cancer cells to doxorubicin by sponging miR-200c-3p to upregulate ANLN publication-title: Clin. Exp. Pharmacol. Physiol. – volume: 9 start-page: 1938 year: 2019 end-page: 1956 ident: bb0005 article-title: MYCN-mediated regulation of the HES1 promoter enhances the chemoresistance of small-cell lung cancer by modulating apoptosis publication-title: Am. J. Cancer Res. – volume: 235 start-page: 3721 year: 2020 end-page: 3730 ident: bb0010 article-title: Deregulation of UCA1 expression may be involved in the development of chemoresistance to cisplatin in the treatment of non-small-cell lung cancer via regulating the signaling pathway of microRNA-495/NRF2 publication-title: J. Cell. Physiol. – volume: 39 start-page: 1631 year: 2018 end-page: 1639 ident: bb1110 article-title: miR-181 regulates cisplatin-resistant non-small cell lung cancer via downregulation of autophagy through the PTEN/PI3K/AKT pathway publication-title: Oncol. Rep. – volume: 467 start-page: 40 year: 2019 end-page: 49 ident: bb0015 article-title: "NRF2 addiction" in lung cancer cells and its impact on cancer therapy publication-title: Cancer Lett. – volume: 3 start-page: 83 year: 2015 end-page: 92 ident: bb1795 article-title: The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy publication-title: Hypoxia (Auckl.) – volume: 24 start-page: 2123 year: 2020 end-page: 2134 ident: bb0080 article-title: FGFRL1 affects chemoresistance of small-cell lung cancer by modulating the PI3K/Akt pathway via ENO1 publication-title: J. Cell. Mol. Med. – volume: 126 start-page: 110099 year: 2020 ident: bb0310 article-title: The dual role of mir-146a in metastasis and disease progression publication-title: Biomed. Pharmacother. – volume: 48 start-page: 1042 year: 2016 end-page: 1049 ident: bb1205 article-title: Direct interaction between miR-203 and ZEB2 suppresses epithelial–mesenchymal transition signaling and reduces lung adenocarcinoma chemoresistance publication-title: Acta Biochim. Biophys. Sin. – volume: 51 start-page: 2160 year: 2018 end-page: 2171 ident: bb1185 article-title: miR-202 enhances the anti-tumor effect of cisplatin on non-small cell lung cancer by targeting the Ras/MAPK pathway publication-title: Cell. Physiol. Biochem. – volume: 37 start-page: 1739 year: 2016 end-page: 1751 ident: bb1225 article-title: miR-15a enhances the anticancer effects of cisplatin in the resistant non-small cell lung cancer cells publication-title: Tumour Biol. – volume: 168 start-page: 73 year: 2020 end-page: 82 ident: bb0300 article-title: JUND-dependent upregulation of HMOX1 is associated with cisplatin resistance in muscle-invasive bladder cancer publication-title: J. Biochem. – volume: 13 start-page: 4077 year: 2017 end-page: 4084 ident: bb0515 article-title: Genomic analysis of drug resistant small cell lung cancer cell lines by combining mRNA and miRNA expression profiling publication-title: Oncol. Lett. – volume: 16 start-page: 279 year: 2016 ident: bb0380 article-title: MicroRNAs as regulatory elements in immune system logic publication-title: Nat. Rev. Immunol. – volume: 27 start-page: 887 year: 2020 end-page: 902 ident: bb1745 article-title: TRIM proteins in autophagy: selective sensors in cell damage and innate immune responses publication-title: Cell Death Differ. – volume: 18 start-page: 6261 year: 2019 end-page: 6268 ident: bb1535 article-title: Silencing long intergenic non-coding RNA 00707 enhances cisplatin sensitivity in cisplatin-resistant non-small-cell lung cancer cells by sponging miR-145 publication-title: Oncol. Lett. – volume: 76 start-page: 1947 year: 2019 end-page: 1966 ident: bb1855 article-title: Long non-coding RNAs are emerging targets of phytochemicals for cancer and other chronic diseases publication-title: Cell. Mol. Life Sci. – volume: 207 start-page: 214 year: 2014 end-page: 220 ident: bb0750 article-title: Downregulation of miR-21 increases cisplatin sensitivity of non–small-cell lung cancer publication-title: Cancer Gene Ther. – volume: 8 start-page: 94317 year: 2017 end-page: 94329 ident: bb1675 article-title: MALAT1-miR-101-SOX9 feedback loop modulates the chemo-resistance of lung cancer cell to DDP via Wnt signaling pathway publication-title: Oncotarget – volume: 116 start-page: 281 year: 2004 end-page: 297 ident: bb0345 article-title: MicroRNAs: genomics, biogenesis, mechanism, and function publication-title: Cell – volume: 273 start-page: 32380 year: 1998 end-page: 32383 ident: bb0995 article-title: Up-regulation of caveolae and caveolar constituents in multidrug-resistant cancer cells publication-title: J. Biol. Chem. – volume: 26 start-page: 404 year: 2012 end-page: 413 ident: bb0385 article-title: MicroRNAs in inflammation and immune responses publication-title: Leukemia – volume: 4 start-page: 1595 year: 2005 end-page: 1604 ident: bb1845 article-title: Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells publication-title: Mol. Cancer Ther. – volume: 12 start-page: 7537 year: 2019 end-page: 7550 ident: bb1370 article-title: Silencing circZFR inhibits the proliferation, migration and invasion of human renal carcinoma cells by regulating miR-206 publication-title: Onco Targets Ther. – volume: 73 start-page: 1907 year: 2010 end-page: 1920 ident: bb1815 article-title: Exosomes: extracellular organelles important in intercellular communication publication-title: J. Proteome – volume: 888 start-page: 173483 year: 2020 ident: bb0400 article-title: microRNA-181a mediates the chemo-sensitivity of glioblastoma to carmustine and regulates cell proliferation, migration, and apoptosis publication-title: Eur. J. Pharmacol. – volume: 13 start-page: 193 year: 2014 ident: bb0780 article-title: miR-27a regulates cisplatin resistance and metastasis by targeting RKIP in human lung adenocarcinoma cells publication-title: Mol. Cancer – volume: 57 start-page: 419 year: 2018 end-page: 428 ident: bb0725 article-title: MiR-5100 increases the cisplatin resistance of the lung cancer stem cells by inhibiting the Rab6 publication-title: Mol. Carcinog. – volume: 11 start-page: 5988 year: 2019 end-page: 5997 ident: bb0835 article-title: MiR-27b targets PI3K p110alpha to inhibit proliferation and migration in colorectal cancer stem cell publication-title: Am. J. Transl. Res. – volume: 7 start-page: 24510 year: 2016 end-page: 24526 ident: bb0690 article-title: miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET publication-title: Oncotarget – start-page: 8(6) year: 2019 ident: bb0195 article-title: Quantification of berberine in publication-title: Antioxidants (Basel) – volume: 9 start-page: 654 year: 2007 end-page: 659 ident: bb1825 article-title: Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells publication-title: Nat. Cell Biol. – volume: 423 start-page: 85 year: 2016 end-page: 91 ident: bb1335 article-title: MicroRNA-451 sensitizes lung cancer cells to cisplatin through regulation of Mcl-1 publication-title: Mol. Cell. Biochem. – volume: 20 start-page: 78 year: 2020 ident: bb1385 article-title: Circ_0072083 interference enhances growth-inhibiting effects of cisplatin in non-small-cell lung cancer cells via miR-545-3p/CBLL1 axis publication-title: Cancer Cell Int. – volume: 23 start-page: 5242 year: 2019 end-page: 5250 ident: bb0965 article-title: MiR-124 changes the sensitivity of lung cancer cells to cisplatin through targeting STAT3 publication-title: Eur. Rev. Med. Pharmacol. Sci. – volume: 21 start-page: 1242 year: 2020 ident: bb0125 article-title: Cisplatin-induced skeletal muscle dysfunction: mechanisms and counteracting therapeutic strategies publication-title: Int. J. Mol. Sci. – volume: 9 start-page: 402 year: 2018 ident: bb0320 article-title: Overview of microRNA biogenesis, mechanisms of actions, and circulation publication-title: Front. Endocrinol. – year: 2019 ident: bb0905 article-title: Suppression of Tafazzin promotes thyroid cancer apoptosis via activating the JNK signaling pathway and enhancing INF2-mediated mitochondrial fission publication-title: J. Cell. Physiol. – volume: 479 start-page: 89 year: 2020 end-page: 99 ident: bb0240 article-title: Myeloid-derived suppressor cells are essential partners for immune checkpoint inhibitors in the treatment of cisplatin-resistant bladder cancer publication-title: Cancer Lett. – volume: 471 start-page: 103 year: 2020 end-page: 115 ident: bb0100 article-title: WDR74 induces nuclear beta-catenin accumulation and activates Wnt-responsive genes to promote lung cancer growth and metastasis publication-title: Cancer Lett. – volume: 166 start-page: 517 year: 2019 end-page: 527 ident: bb0625 article-title: miR-324-5p upregulation potentiates resistance to cisplatin by targeting FBXO11 signalling in non-small cell lung cancer cells publication-title: J. Biochem. – volume: 113 start-page: 357 year: 2019 end-page: 364 ident: bb0220 article-title: Cisplatin delivery systems based on different drug encapsulation techniques publication-title: Eur. Polym. J. – volume: 28 start-page: 121 year: 2020 end-page: 128 ident: bb1610 article-title: MiR-519a functions as a tumor suppressor and is negatively associated with poor prognosis of non-small cell lung cancer publication-title: Cancer Biomark – volume: 8 start-page: 84086 year: 2017 end-page: 84101 ident: bb1680 article-title: LncRNA SNHG12 contributes to multidrug resistance through activating the MAPK/Slug pathway by sponging miR-181a in non-small cell lung cancer publication-title: Oncotarget – volume: 30 start-page: 838 year: 2019 end-page: 845 ident: bb0035 article-title: Ginsenoside Rd reverses cisplatin resistance in non-small-cell lung cancer A549 cells by downregulating the nuclear factor erythroid 2-related factor 2 pathway publication-title: Anti-Cancer Drugs – volume: 57 start-page: 1835 year: 2018 end-page: 1844 ident: bb1880 article-title: EGCG inhibits CSC-like properties through targeting miR-485/CD44 axis in A549-cisplatin resistant cells publication-title: Mol. Carcinog. – volume: 40 start-page: 8953 year: 2012 end-page: 8964 ident: bb0930 article-title: Repair of cisplatin-induced DNA interstrand crosslinks by a replication-independent pathway involving transcription-coupled repair and translesion synthesis publication-title: Nucleic Acids Res. – volume: 392 start-page: 1225 year: 2019 end-page: 1238 ident: bb0200 article-title: Mechanistic perspective of protective effects of resveratrol against cisplatin-induced ovarian injury in rats: emphasis on anti-inflammatory and anti-apoptotic effects publication-title: Naunyn Schmiedeberg's Arch. Pharmacol. – volume: 177 start-page: 113939 year: 2020 ident: bb0185 article-title: Ribociclib mitigates cisplatin-associated kidney injury through retinoblastoma-1 dependent mechanisms publication-title: Biochem. Pharmacol. – volume: 24 start-page: 2518 year: 2020 end-page: 2524 ident: bb1440 article-title: Circular RNA circ-ABCB10 promotes non-small cell lung cancer proliferation and inhibits cell apoptosis through repressing KISS1 publication-title: Eur. Rev. Med. Pharmacol. Sci. – volume: 19 start-page: 347 year: 2019 ident: bb1885 article-title: Cancer-associated fibroblast-derived exosomal microRNA-98-5p promotes cisplatin resistance in ovarian cancer by targeting CDKN1A publication-title: Cancer Cell Int. – volume: 124 start-page: 109828 year: 2020 ident: bb1425 article-title: CircPVT1 contributes to chemotherapy resistance of lung adenocarcinoma through miR-145-5p/ABCC1 axis publication-title: Biomed. Pharmacother. – start-page: 40(3) year: 2020 ident: bb0480 article-title: miR-492 promotes chemoresistance to CDDP and metastasis by targeting inhibiting DNMT3B and induces stemness in gastric cancer publication-title: Biosci. Rep. – volume: 7 start-page: 20041 year: 2016 end-page: 20053 ident: bb1080 article-title: MicroRNA-432 functions as a tumor suppressor gene through targeting E2F3 and AXL in lung adenocarcinoma publication-title: Oncotarget – volume: 25 start-page: 233 year: 2020 end-page: 246 ident: bb0285 article-title: DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m(6)A-demethylation of FOXM1 and NANOG publication-title: Apoptosis – volume: 239 start-page: 116984 year: 2019 ident: bb1475 article-title: Circ_0076305 regulates cisplatin resistance of non-small cell lung cancer via positively modulating STAT3 by sponging miR-296–5p publication-title: Life Sci. – volume: 121 start-page: 3901 year: 2019 end-page: 3912 ident: bb0885 article-title: miR-146b Reverses epithelial-mesenchymal transition via targeting PTP1B in cisplatin-resistance human lung adenocarcinoma cells publication-title: J. Cell. Biochem. – volume: 222 start-page: 540 year: 2010 end-page: 545 ident: bb0355 article-title: Genomic organization of microRNAs publication-title: J. Cell. Physiol. – volume: 12 year: 2017 ident: bb0900 article-title: Tafazzin (TAZ) promotes the tumorigenicity of cervical cancer cells and inhibits apoptosis publication-title: PLoS One – volume: 19 start-page: 1439 year: 2020 end-page: 1447 ident: bb1525 article-title: Long non-coding RNA LINC00707 acts as a competing endogenous RNA to enhance cell proliferation in colorectal cancer publication-title: Exp. Ther. Med. – start-page: 1 year: 2020 end-page: 13 ident: bb1480 article-title: CircAKT3 inhibits glycolysis balance in lung cancer cells by regulating miR-516b-5p/STAT3 to inhibit cisplatin sensitivity publication-title: Biotechnol. Lett. – volume: 80 start-page: 973 year: 2017 end-page: 984 ident: bb0730 article-title: miR-181c contributes to cisplatin resistance in non-small cell lung cancer cells by targeting Wnt inhibition factor 1 publication-title: Cancer Chemother. Pharmacol. – volume: 38 start-page: 2096 year: 2017 end-page: 2104 ident: bb1140 article-title: miR-198-induced upregulation of Livin may be associated with the prognosis and contribute to the oncogenesis of lung adenocarcinoma publication-title: Oncol. Rep. – volume: 122 start-page: 1354 year: 2020 end-page: 1366 ident: bb0470 article-title: miR-27a is a master regulator of metabolic reprogramming and chemoresistance in colorectal cancer publication-title: Br. J. Cancer – volume: 11 start-page: 945 year: 2016 end-page: 952 ident: bb0705 article-title: miR-96 induces cisplatin chemoresistance in non-small cell lung cancer cells by downregulating SAMD9 publication-title: Oncol. Lett. – volume: 9 year: 2014 ident: bb1835 article-title: Exosomes from drug-resistant breast cancer cells transmit chemoresistance by a horizontal transfer of microRNAs publication-title: PLoS One – volume: 258 start-page: 118094 year: 2020 ident: bb0410 article-title: Docosahexaenoic acid (DHA) inhibits pro-angiogenic effects of breast cancer cells via down-regulating cellular and exosomal expression of angiogenic genes and microRNAs publication-title: Life Sci. – volume: 111 start-page: 244 year: 2019 end-page: 250 ident: bb1420 article-title: Circular RNA PVT1 acts as a competing endogenous RNA for miR-497 in promoting non-small cell lung cancer progression publication-title: Biomed. Pharmacother. – volume: 19 start-page: 267 year: 2019 ident: bb1410 article-title: Potential Role of circPVT1 as a proliferative factor and treatment target in esophageal carcinoma publication-title: Cancer Cell Int. – volume: 66 start-page: 636 year: 2014 end-page: 644 ident: bb1890 article-title: EGCG enhances the efficacy of cisplatin by downregulating hsa-miR-98-5p in NSCLC A549 cells publication-title: Nutr. Cancer – volume: 488 start-page: 501 year: 2017 end-page: 508 ident: bb0745 article-title: Attenuation of deregulated miR-369-3p expression sensitizes non-small cell lung cancer cells to cisplatin via modulation of the nucleotide sugar transporter SLC35F5 publication-title: Biochem. Biophys. Res. Commun. – volume: 147 start-page: 104396 year: 2019 ident: bb0055 article-title: Polyphyllin VI, a saponin from Trillium tschonoskii maxim. induces apoptotic and autophagic cell death via the ROS triggered mTOR signaling pathway in non-small cell lung cancer publication-title: Pharmacol. Res. – volume: 13 start-page: 2037 year: 2020 end-page: 2045 ident: bb0450 article-title: Long non-coding RNA DLEU1 up-regulates BIRC6 expression by competitively sponging miR-381-3p to promote cisplatin resistance in nasopharyngeal carcinoma publication-title: Onco Targets Ther. – volume: 118 start-page: 111 year: 2018 end-page: 118 ident: bb0720 article-title: MiR-192 and miR-662 enhance chemoresistance and invasiveness of squamous cell lung carcinoma publication-title: Lung Cancer – volume: 1 start-page: E35 year: 1999 end-page: E37 ident: bb0970 article-title: Caveolin, cholesterol and Ras signalling publication-title: Nat. Cell Biol. – volume: 45 start-page: 1783 year: 2020 end-page: 1792 ident: bb0135 article-title: CD44 inhibition attenuates EGFR signaling and enhances cisplatin sensitivity in human EGFR wildtype nonsmallcell lung cancer cells publication-title: Int. J. Mol. Med. – volume: 25 start-page: 1386 year: 2020 ident: bb0045 article-title: Protective effect of astaxanthin on ochratoxin a-induced kidney injury to mice by regulating oxidative stress-related NRF2/KEAP1 pathway publication-title: Molecules – volume: 10 start-page: 1854 year: 2020 ident: bb1805 article-title: Intermittent hypoxia exacerbates tumor progression in a mouse model of lung cancer publication-title: Sci. Rep. – volume: 21 year: 2020 ident: bb0245 article-title: Cordycepin resensitizes T24R2 cisplatin-resistant human bladder cancer cells to cisplatin by inactivating Ets-1 dependent MDR1 transcription publication-title: Int. J. Mol. Sci. – volume: 15 start-page: 178 year: 2014 ident: bb0870 article-title: Molecular mechanisms of epithelial–mesenchymal transition publication-title: Nat. Rev. Mol. Cell Biol. – volume: 10 start-page: 3967 year: 2020 end-page: 3979 ident: bb0440 article-title: A miR-146a-5p/TRAF6/NF-kB p65 axis regulates pancreatic cancer chemoresistance: functional validation and clinical significance publication-title: Theranostics – volume: 14 start-page: 281 year: 2003 end-page: 287 ident: bb0990 article-title: Up-regulation of caveolin expression by cytotoxic agents in drug-sensitive cancer cells publication-title: Anti-Cancer Drugs – volume: 139 start-page: 189 year: 2012 end-page: 193 ident: bb1245 article-title: Antitussive, expectorant and anti-inflammatory activities of four alkaloids isolated from Bulbus of Fritillaria wabuensis publication-title: J. Ethnopharmacol. – volume: 9 start-page: 3008 year: 2019 ident: bb0740 article-title: MiR-494 acts as a tumor promoter by targeting CASP2 in non-small cell lung cancer publication-title: Sci. Rep. – volume: 17 start-page: 120 year: 2018 ident: bb1830 article-title: Role of hypoxia-induced exosomes in tumor biology publication-title: Mol. Cancer – volume: 160 start-page: 363 year: 2016 end-page: 371 ident: bb0205 article-title: The aqueous extract of cinnamon bark ameliorated cisplatin-induced cytotoxicity in vero cells without compromising the anticancer efficiency of cisplatin publication-title: Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. – volume: 7 year: 2019 ident: bb1565 article-title: Long non-coding RNA NORAD promotes the occurrence and development of non-small cell lung cancer by adsorbing MiR-656-3p publication-title: Mol. Genet. Genomic. Med. – volume: 17 start-page: 384 year: 2014 end-page: 390 ident: bb0790 article-title: MiR-192 confers cisplatin resistance by targeting Bim in lung cancer publication-title: Zhongguo Fei Ai Za Zhi – volume: 2018 start-page: 1769040 year: 2018 ident: bb0560 article-title: MicroRNA-9 enhanced cisplatin sensitivity in nonsmall cell lung cancer cells by regulating eukaryotic translation initiation factor 5A2 publication-title: Biomed. Res. Int. – volume: 10 start-page: 1479 year: 2019 end-page: 1488 ident: bb1390 article-title: CBLL1 is highly expressed in non-small cell lung cancer and promotes cell proliferation and invasion publication-title: Thorac Cancer – volume: 23 start-page: 8219 year: 2019 end-page: 8229 ident: bb0660 article-title: MicroRNA-15a-5p down-regulation inhibits cervical cancer by targeting TP53INP1 in vitro publication-title: Eur. Rev. Med. Pharmacol. Sci. – volume: 27 start-page: 706 year: 2020 end-page: 713 ident: bb1810 article-title: Lung cancer aggressiveness in an intermittent hypoxia murine model of postmenopausal sleep apnea publication-title: Menopause – volume: 11 start-page: 567 year: 2020 ident: bb1900 article-title: Sulforaphane potentiates anticancer effects of doxorubicin and cisplatin and mitigates their toxic effects publication-title: Front. Pharmacol. – volume: 12 start-page: 3181 year: 2019 end-page: 3196 ident: bb0665 article-title: MiR-155-5p accelerates the metastasis of cervical cancer cell via targeting TP53INP1 publication-title: Onco Targets Ther. – volume: 13 start-page: 1451 year: 2017 end-page: 1455 ident: bb1065 article-title: MicroRNA-134 reverses multidrug resistance in human lung adenocarcinoma cells by targeting FOXM1 publication-title: Oncol. Lett. – volume: 12 start-page: 1285 year: 2020 end-page: 1303 ident: bb0290 article-title: DNAH10 mutation correlates with cisplatin sensitivity and tumor mutation burden in small-cell lung cancer publication-title: Aging (Albany NY) – volume: 23 start-page: 5795 year: 2019 end-page: 5801 ident: bb1505 article-title: Long non-coding RNA MIAT promotes non-small cell lung cancer progression by sponging miR-1246 publication-title: Eur. Rev. Med. Pharmacol. Sci. – volume: 38 start-page: 525 year: 2019 end-page: 533 ident: bb0600 article-title: Down-regulation of microRNA-10a mediates the anti-tumor effect of icaritin in A549 cells via the PTEN/AKT and ERK pathway publication-title: Gen. Physiol. Biophys. – volume: 235 start-page: 7541 year: 2020 end-page: 7553 ident: bb1485 article-title: lncRNA SNHG11 promotes lung cancer cell proliferation and migration via activation of Wnt/beta-catenin signaling pathway publication-title: J. Cell Physiol. – volume: 118 start-page: 44 year: 2015 end-page: 50 ident: bb0655 article-title: The stress protein TP53INP1 plays a tumor suppressive role by regulating metabolic homeostasis publication-title: Biochimie – volume: 13 start-page: 132 year: 2015 ident: bb1260 article-title: miR-148b reverses cisplatin-resistance in non-small cell cancer cells via negatively regulating DNA (cytosine-5)-methyltransferase 1(DNMT1) expression publication-title: J. Transl. Med. – volume: 7 start-page: 40384 year: 2017 ident: bb0735 article-title: MiR-488 inhibits proliferation and cisplatin sensibility in non-small-cell lung cancer (NSCLC) cells by activating the eIF3a-mediated NER signaling pathway publication-title: Sci. Rep. – volume: 47 start-page: 1379 year: 2015 end-page: 1392 ident: bb0815 article-title: MicroRNA-181a regulates epithelial-mesenchymal transition by targeting PTEN in drug-resistant lung adenocarcinoma cells publication-title: Int. J. Oncol. – volume: 47 start-page: 71 year: 2017 end-page: 80 ident: bb0225 article-title: Overcoming cisplatin resistance in non-small cell lung cancer with Mad2 silencing siRNA delivered systemically using EGFR-targeted chitosan nanoparticles publication-title: Acta Biomater. – volume: 22 start-page: 2478 year: 2018 end-page: 2487 ident: bb1930 article-title: Baicalein inhibits cell growth and increases cisplatin sensitivity of A549 and H460 cells via miR-424-3p and targeting PTEN/PI3K/Akt pathway publication-title: J. Cell. Mol. Med. – volume: 10 start-page: 1470 year: 2008 end-page: 1476 ident: bb1820 article-title: Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers publication-title: Nat. Cell Biol. – volume: 21 start-page: 2589 year: 2020 end-page: 2596 ident: bb0595 article-title: MicroRNA28 promotes the proliferation of nonsmallcell lung cancer cells by targeting PTEN publication-title: Mol. Med. Rep. – volume: 43 start-page: 247 year: 2015 end-page: 258 ident: bb0925 article-title: CSB interacts with SNM1A and promotes DNA interstrand crosslink processing publication-title: Nucleic Acids Res. – volume: 235 start-page: 4001 year: 2020 end-page: 4010 ident: bb1780 article-title: Circular RNA circC3P1 restrains kidney cancer cell activity by regulating miR-21/PTEN axis and inactivating PI3K/AKT and NF- kB pathways publication-title: J. Cell. Physiol. – volume: 162 start-page: 134 year: 2019 end-page: 143 ident: bb1615 article-title: Linc00221 modulates cisplatin resistance in non-small-cell lung cancer via sponging miR-519a publication-title: Biochimie – volume: 561 start-page: 132 year: 2018 end-page: 136 ident: bb1555 article-title: The NORAD lncRNA assembles a topoisomerase complex critical for genome stability publication-title: Nature – volume: 37 start-page: 2387 year: 2016 end-page: 2394 ident: bb0810 article-title: Inhibition of microRNA-196a might reverse cisplatin resistance of A549/DDP non-small-cell lung cancer cell line publication-title: Tumor Biol. – volume: 478 start-page: 676 year: 2016 end-page: 682 ident: bb1215 article-title: MiR-509-3-5p causes aberrant mitosis and anti-proliferative effect by suppression of PLK1 in human lung cancer A549 cells publication-title: Biochem. Biophys. Res. Commun. – volume: 10 start-page: 374 year: 2019 end-page: 382 ident: bb1875 article-title: Epigallocatechin gallate (EGCG) suppresses growth and tumorigenicity in breast cancer cells by downregulation of miR-25 publication-title: Bioengineered – volume: 59 start-page: 141 year: 2020 end-page: 153 ident: bb0115 article-title: circMTDH.4/miR-630/AEG-1 axis participates in the regulation of proliferation, migration, invasion, chemoresistance, and radioresistance of NSCLC publication-title: Mol. Carcinog. – volume: 42 start-page: 1240 year: 2018 end-page: 1249 ident: bb1330 article-title: MicroRNA-1 overexpression increases chemosensitivity of non-small cell lung cancer cells by inhibiting autophagy related 3-mediated autophagy publication-title: Cell Biol. Int. – volume: 18 start-page: 631 year: 2018 ident: bb1450 article-title: MiR-199a-3p affects the multi-chemoresistance of osteosarcoma through targeting AK4 publication-title: BMC Cancer – volume: 591 start-page: 636 year: 2017 end-page: 645 ident: bb1180 article-title: Suppression of EIF4G2 by miR-379 potentiates the cisplatin chemosensitivity in nonsmall cell lung cancer cells publication-title: FEBS Lett. – start-page: 144623 year: 2020 ident: bb0255 article-title: Metformin enhances the sensitivity of colorectal cancer cells to cisplatin through ROS-mediated PI3K/Akt signaling pathway publication-title: Gene – volume: 15 start-page: 2920 year: 2016 end-page: 2930 ident: bb0820 article-title: DNA damage responsive miR-33b-3p promoted lung cancer cells survival and cisplatin resistance by targeting p21(WAF1/CIP1) publication-title: Cell Cycle – volume: 45 start-page: 2491 year: 2018 end-page: 2499 ident: bb1905 article-title: Alleviating the progression of acute myeloid leukemia (AML) by sulforaphane through controlling miR-155 levels publication-title: Mol. Biol. Rep. – volume: 39 start-page: 293 year: 2020 end-page: 307 ident: bb0120 article-title: Linc00173 promotes chemoresistance and progression of small cell lung cancer by sponging miR-218 to regulate Etk expression publication-title: Oncogene – volume: 20 start-page: 4697 year: 2016 end-page: 4704 ident: bb1430 article-title: MicroRNA-185-5p modulates chemosensitivity of human non-small cell lung cancer to cisplatin via targeting ABCC1 publication-title: Eur. Rev. Med. Pharmacol. Sci. – start-page: 9(1) year: 2020 ident: bb0950 article-title: Role of JAK/STAT3 signaling in the regulation of metastasis, the transition of cancer stem cells, and chemoresistance of cancer by epithelial-mesenchymal transition publication-title: Cells – volume: 20 start-page: 3917 year: 2019 end-page: 3923 ident: bb0955 article-title: Increased lncRNA HOTAIR expression promotes the chemoresistance of multiple myeloma to dexamethasone by regulating cell viability and apoptosis by mediating the JAK2/STAT3 signaling pathway publication-title: Mol. Med. Rep. – volume: 9 start-page: 7501 year: 2018 end-page: 7512 ident: bb1665 article-title: MALAT1/miR-101-3p/MCL1 axis mediates cisplatin resistance in lung cancer publication-title: Oncotarget – volume: 12 start-page: 11069 year: 2019 ident: bb0390 article-title: miR-451: a novel biomarker and potential therapeutic target for cancer publication-title: OncoTargets Ther. – volume: 1788 start-page: 2003 year: 2009 end-page: 2014 ident: bb0895 article-title: The enigmatic role of tafazzin in cardiolipin metabolism publication-title: Biochim. Biophys. Acta – volume: 8 start-page: 104206 issue: 61 year: 2017 ident: 10.1016/j.cellsig.2020.109871_bb1125 article-title: Overexpression of miR-216b sensitizes NSCLC cells to cisplatin-induced apoptosis by targeting c-Jun publication-title: Oncotarget doi: 10.18632/oncotarget.22171 – volume: 10 start-page: 3767 issue: 8 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0050 article-title: PAQR4 promotes chemoresistance in non-small cell lung cancer through inhibiting Nrf2 protein degradation publication-title: Theranostics doi: 10.7150/thno.43142 – volume: 9 start-page: 3008 issue: 1 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb0740 article-title: MiR-494 acts as a tumor promoter by targeting CASP2 in non-small cell lung cancer publication-title: Sci. Rep. doi: 10.1038/s41598-019-39453-2 – volume: 12 start-page: 3721 year: 2017 ident: 10.1016/j.cellsig.2020.109871_bb1155 article-title: Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner publication-title: Int. J. Nanomedicine doi: 10.2147/IJN.S131516 – volume: 113 start-page: 357 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb0220 article-title: Cisplatin delivery systems based on different drug encapsulation techniques publication-title: Eur. Polym. J. doi: 10.1016/j.eurpolymj.2019.02.007 – volume: 73 start-page: 1907 issue: 10 year: 2010 ident: 10.1016/j.cellsig.2020.109871_bb1815 article-title: Exosomes: extracellular organelles important in intercellular communication publication-title: J. Proteome doi: 10.1016/j.jprot.2010.06.006 – volume: 454 start-page: 157 issue: 1 year: 2014 ident: 10.1016/j.cellsig.2020.109871_bb0700 article-title: Overexpression of SAMD9 suppresses tumorigenesis and progression during non small cell lung cancer publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2014.10.054 – volume: 20 start-page: 1023 issue: 13 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb0090 article-title: Non-coding RNAs in lung cancer chemoresistance publication-title: Curr. Drug Metab. doi: 10.2174/1389200221666200106105201 – volume: 177 start-page: 1682 issue: 7 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb1625 article-title: Autophagy-independent functions of the autophagy machinery publication-title: Cell doi: 10.1016/j.cell.2019.05.026 – volume: 234 start-page: 22657 issue: 12 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb0800 article-title: Deregulation of lncRNA-AC078883. 3 and microRNA-19a is involved in the development of chemoresistance to cisplatin via modulating signaling pathway of PTEN/AKT publication-title: J. Cell. Physiol. doi: 10.1002/jcp.28832 – volume: 43 start-page: 1126 issue: 3 year: 2017 ident: 10.1016/j.cellsig.2020.109871_bb1130 article-title: Intensified Beclin-1 mediated by low expression of Mir-30a-5p promotes chemoresistance in human small cell lung cancer publication-title: Cell. Physiol. Biochem. doi: 10.1159/000481754 – volume: 17 start-page: 120 issue: 1 year: 2018 ident: 10.1016/j.cellsig.2020.109871_bb1830 article-title: Role of hypoxia-induced exosomes in tumor biology publication-title: Mol. Cancer doi: 10.1186/s12943-018-0869-y – volume: 21 start-page: 2092 issue: 6 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0315 article-title: The pervasive role of the miR-181 family in development, neurodegeneration, and cancer publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms21062092 – volume: 11 start-page: 945 issue: 2 year: 2016 ident: 10.1016/j.cellsig.2020.109871_bb0705 article-title: miR-96 induces cisplatin chemoresistance in non-small cell lung cancer cells by downregulating SAMD9 publication-title: Oncol. Lett. doi: 10.3892/ol.2015.4000 – volume: 5 year: 2014 ident: 10.1016/j.cellsig.2020.109871_bb1285 article-title: MiR-630 inhibits proliferation by targeting CDC7 kinase, but maintains the apoptotic balance by targeting multiple modulators in human lung cancer A549 cells publication-title: Cell Death Dis. doi: 10.1038/cddis.2014.386 – start-page: 10(10) year: 2015 ident: 10.1016/j.cellsig.2020.109871_bb0365 article-title: A database of microRNA expression patterns in Xenopus laevis publication-title: PLoS One – volume: 166 start-page: 517 issue: 6 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb0625 article-title: miR-324-5p upregulation potentiates resistance to cisplatin by targeting FBXO11 signalling in non-small cell lung cancer cells publication-title: J. Biochem. doi: 10.1093/jb/mvz066 – volume: 76 start-page: 1947 issue: 10 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb1855 article-title: Long non-coding RNAs are emerging targets of phytochemicals for cancer and other chronic diseases publication-title: Cell. Mol. Life Sci. doi: 10.1007/s00018-019-03053-0 – volume: 19 start-page: 267 issue: 1 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb1410 article-title: Potential Role of circPVT1 as a proliferative factor and treatment target in esophageal carcinoma publication-title: Cancer Cell Int. doi: 10.1186/s12935-019-0985-9 – volume: 42 start-page: 270 issue: 3 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb1650 article-title: LncRNA MALAT1 depressed chemo-sensitivity of NSCLC cells through directly functioning on miR-197-3p/p120 catenin axis publication-title: Mol. Cell – start-page: 11(10) year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb1765 article-title: Migration and invasion enhancer 1 Is an NF-kB-inducing gene enhancing the cell proliferation and invasion ability of human prostate carcinoma cells in vitro and in vivo publication-title: Cancers (Basel) – volume: 6 start-page: 1317 issue: 6 year: 2016 ident: 10.1016/j.cellsig.2020.109871_bb0825 article-title: Oncogenic miR-137 contributes to cisplatin resistance via repressing CASP3 in lung adenocarcinoma publication-title: Am. J. Cancer Res. – volume: 423 start-page: 85 issue: 1-2 year: 2016 ident: 10.1016/j.cellsig.2020.109871_bb1335 article-title: MicroRNA-451 sensitizes lung cancer cells to cisplatin through regulation of Mcl-1 publication-title: Mol. Cell. Biochem. doi: 10.1007/s11010-016-2827-6 – volume: 7 start-page: 37524 issue: 25 year: 2016 ident: 10.1016/j.cellsig.2020.109871_bb1350 article-title: Downregulation of miR-101 contributes to epithelial-mesenchymal transition in cisplatin resistance of NSCLC cells by targeting ROCK2 publication-title: Oncotarget doi: 10.18632/oncotarget.6852 – volume: 20 start-page: 261 issue: 3 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb1655 article-title: LncRNA TATDN1 contributes to the cisplatin resistance of non-small cell lung cancer through TATDN1/miR-451/TRIM66 axis publication-title: Cancer Biol. Ther. doi: 10.1080/15384047.2018.1529091 – volume: 38 start-page: 1218 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb1640 article-title: W941, a new PI3K inhibitor, exhibits preferable anti-proliferative activities against nonsmall cell lung cancer with autophagy inhibitors publication-title: Investig. New Drugs doi: 10.1007/s10637-019-00886-1 – volume: 9 start-page: 13758 issue: 17 year: 2018 ident: 10.1016/j.cellsig.2020.109871_bb0580 article-title: MicroRNA-630 may confer favorable cisplatin-based chemotherapy and clinical outcomes in non-small cell lung cancer by targeting Bcl-2 publication-title: Oncotarget doi: 10.18632/oncotarget.24474 – volume: 18 start-page: 4613 issue: 5 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb0535 article-title: MicroRNA-152 suppresses cisplatin resistance in A549 cells publication-title: Oncol. Lett. – volume: 12 start-page: 3181 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb0665 article-title: MiR-155-5p accelerates the metastasis of cervical cancer cell via targeting TP53INP1 publication-title: Onco Targets Ther. doi: 10.2147/OTT.S193097 – volume: 27 start-page: 706 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb1810 article-title: Lung cancer aggressiveness in an intermittent hypoxia murine model of postmenopausal sleep apnea publication-title: Menopause doi: 10.1097/GME.0000000000001526 – volume: 40 start-page: 97 issue: 2 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0190 article-title: Curcumin diminishes cisplatin-induced apoptosis and mitochondrial oxidative stress through inhibition of TRPM2 channel signaling pathway in mouse optic nerve publication-title: J. Recept. Signal Transduct. Res. doi: 10.1080/10799893.2020.1720240 – volume: 473 start-page: 62 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0675 article-title: VCAM-1 secreted from cancer-associated fibroblasts enhances the growth and invasion of lung cancer cells through AKT and MAPK signaling publication-title: Cancer Lett. doi: 10.1016/j.canlet.2019.12.039 – volume: 26 start-page: 404 issue: 3 year: 2012 ident: 10.1016/j.cellsig.2020.109871_bb0385 article-title: MicroRNAs in inflammation and immune responses publication-title: Leukemia doi: 10.1038/leu.2011.356 – volume: 15 start-page: 178 issue: 3 year: 2014 ident: 10.1016/j.cellsig.2020.109871_bb0870 article-title: Molecular mechanisms of epithelial–mesenchymal transition publication-title: Nat. Rev. Mol. Cell Biol. doi: 10.1038/nrm3758 – volume: 17 start-page: 126 issue: 1 year: 2003 ident: 10.1016/j.cellsig.2020.109871_bb1700 article-title: Multipotent cell lineages in early mouse development depend on SOX2 function publication-title: Genes Dev. doi: 10.1101/gad.224503 – volume: 47 start-page: 1379 issue: 4 year: 2015 ident: 10.1016/j.cellsig.2020.109871_bb0815 article-title: MicroRNA-181a regulates epithelial-mesenchymal transition by targeting PTEN in drug-resistant lung adenocarcinoma cells publication-title: Int. J. Oncol. doi: 10.3892/ijo.2015.3144 – volume: 19 start-page: 643 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb1495 article-title: lncRNA UCA1 promotes gefitinib resistance as a ceRNA to target FOSL2 by sponging miR-143 in non-small cell lung cancer publication-title: Mol. Ther. Nucleic Acids doi: 10.1016/j.omtn.2019.10.047 – volume: 6 start-page: 19455 year: 2016 ident: 10.1016/j.cellsig.2020.109871_bb0520 article-title: miRNA-378 reverses chemoresistance to cisplatin in lung adenocarcinoma cells by targeting secreted clusterin publication-title: Sci. Rep. doi: 10.1038/srep19455 – volume: 121 start-page: 3197 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb1465 article-title: miR-125a regulates HAS1 and inhibits the proliferation, invasion and metastasis by targeting STAT3 in non-small cell lung cancer cells publication-title: J. Cell Biochem. doi: 10.1002/jcb.29586 – volume: 10 start-page: 836 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb0025 article-title: The role of prostaglandin-endoperoxide synthase-2 in chemoresistance of non-small cell lung cancer publication-title: Front. Pharmacol. doi: 10.3389/fphar.2019.00836 – volume: 37 start-page: 2387 issue: 2 year: 2016 ident: 10.1016/j.cellsig.2020.109871_bb0810 article-title: Inhibition of microRNA-196a might reverse cisplatin resistance of A549/DDP non-small-cell lung cancer cell line publication-title: Tumor Biol. doi: 10.1007/s13277-015-4017-7 – volume: 77 start-page: 488 issue: 3 year: 2012 ident: 10.1016/j.cellsig.2020.109871_bb1250 article-title: miR-513a-3p sensitizes human lung adenocarcinoma cells to chemotherapy by targeting GSTP1 publication-title: Lung Cancer doi: 10.1016/j.lungcan.2012.05.107 – volume: 28 start-page: 852 issue: 8 year: 2017 ident: 10.1016/j.cellsig.2020.109871_bb1050 article-title: MicroRNA-106b-5p regulates cisplatin chemosensitivity by targeting polycystic kidney disease-2 in non-small-cell lung cancer publication-title: Anti-Cancer Drugs doi: 10.1097/CAD.0000000000000524 – volume: 36 start-page: 2577 issue: 18 year: 2017 ident: 10.1016/j.cellsig.2020.109871_bb1175 article-title: Downregulation of miR-218 contributes to epithelial-mesenchymal transition and tumor metastasis in lung cancer by targeting Slug/ZEB2 signaling publication-title: Oncogene doi: 10.1038/onc.2016.414 – volume: 37 start-page: 1067 issue: 4 year: 2016 ident: 10.1016/j.cellsig.2020.109871_bb0715 article-title: Downregulation of microRNA-196a enhances the sensitivity of non-small cell lung cancer cells to cisplatin treatment publication-title: Int. J. Mol. Med. doi: 10.3892/ijmm.2016.2513 – volume: 126 start-page: 110100 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb1605 article-title: Long non-coding RNA PVT1 contributes to cell growth and metastasis in non-small-cell lung cancer by regulating miR-361-3p/SOX9 axis and activating Wnt/beta-catenin signaling pathway publication-title: Biomed. Pharmacother. doi: 10.1016/j.biopha.2020.110100 – volume: 8 start-page: 8007 issue: 1 year: 2018 ident: 10.1016/j.cellsig.2020.109871_bb1105 article-title: MiR-29c reduces the cisplatin resistance of non-small cell lung cancer cells by negatively regulating the PI3K/Akt pathway publication-title: Sci. Rep. doi: 10.1038/s41598-018-26381-w – volume: 19 start-page: 948 issue: 1 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb0945 article-title: CSB affected on the sensitivity of lung cancer cells to platinum-based drugs through the global decrease of let-7 and miR-29 publication-title: BMC Cancer doi: 10.1186/s12885-019-6194-z – volume: 20 start-page: 78 issue: 1 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb1490 article-title: LncRNA MIR17HG inhibits non-small cell lung cancer by upregulating miR-142-3p to downregulate Bach-1 publication-title: BMC Pulm Med. doi: 10.1186/s12890-020-1112-3 – volume: 28 start-page: 163 issue: 1 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb0635 article-title: Prognostic role of circulating exosomal miR-425-3p for the response of NSCLC to platinum-based chemotherapy publication-title: Cancer Epidemiol. Biomark. Prev. doi: 10.1158/1055-9965.EPI-18-0569 – volume: 121 start-page: 3901 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb0885 article-title: miR-146b Reverses epithelial-mesenchymal transition via targeting PTP1B in cisplatin-resistance human lung adenocarcinoma cells publication-title: J. Cell. Biochem. doi: 10.1002/jcb.29554 – volume: 13 start-page: 193 year: 2014 ident: 10.1016/j.cellsig.2020.109871_bb0780 article-title: miR-27a regulates cisplatin resistance and metastasis by targeting RKIP in human lung adenocarcinoma cells publication-title: Mol. Cancer doi: 10.1186/1476-4598-13-193 – volume: 235 start-page: 3721 issue: 4 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0010 article-title: Deregulation of UCA1 expression may be involved in the development of chemoresistance to cisplatin in the treatment of non-small-cell lung cancer via regulating the signaling pathway of microRNA-495/NRF2 publication-title: J. Cell. Physiol. doi: 10.1002/jcp.29266 – volume: 85 start-page: 843 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0150 article-title: Evaluating the immunoproteasome as a potential therapeutic target in cisplatin-resistant small cell and non-small cell lung cancer publication-title: Cancer Chemother. Pharmacol. doi: 10.1007/s00280-020-04061-9 – volume: 40 start-page: 8953 issue: 18 year: 2012 ident: 10.1016/j.cellsig.2020.109871_bb0930 article-title: Repair of cisplatin-induced DNA interstrand crosslinks by a replication-independent pathway involving transcription-coupled repair and translesion synthesis publication-title: Nucleic Acids Res. doi: 10.1093/nar/gks670 – volume: 10 start-page: 374 issue: 1 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb1875 article-title: Epigallocatechin gallate (EGCG) suppresses growth and tumorigenicity in breast cancer cells by downregulation of miR-25 publication-title: Bioengineered doi: 10.1080/21655979.2019.1657327 – volume: 124 start-page: 3315 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0145 article-title: Role of transient anions in chemoradiation therapy: base modifications, crosslinks and cluster damages induced to cisplatin-dna complexes by 1-20 eV electrons publication-title: J. Phys. Chem. B doi: 10.1021/acs.jpcb.0c00946 – volume: 48 start-page: 315 issue: 1 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0610 article-title: miR-324-5p inhibits gallbladder carcinoma cell metastatic behaviours by downregulation of transforming growth factor beta 2 expression publication-title: Artif. Cells Nanomed. Biotechnol. doi: 10.1080/21691401.2019.1703724 – volume: 43 start-page: 247 issue: 1 year: 2015 ident: 10.1016/j.cellsig.2020.109871_bb0925 article-title: CSB interacts with SNM1A and promotes DNA interstrand crosslink processing publication-title: Nucleic Acids Res. doi: 10.1093/nar/gku1279 – volume: 34 start-page: 6055 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0140 article-title: Long non-coding RNA LINC00337 induces autophagy and chemoresistance to cisplatin in esophageal squamous cell carcinoma cells via upregulation of TPX2 by recruiting E2F4 publication-title: Faseb J. doi: 10.1096/fj.201900731RR – start-page: 117325 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0085 article-title: Nuclear factor erythroid 2 (NF-E2)-related factor 2 (Nrf2) in non-small cell lung cancer publication-title: Life Sci. doi: 10.1016/j.lfs.2020.117325 – volume: 561 start-page: 132 issue: 7721 year: 2018 ident: 10.1016/j.cellsig.2020.109871_bb1555 article-title: The NORAD lncRNA assembles a topoisomerase complex critical for genome stability publication-title: Nature doi: 10.1038/s41586-018-0453-z – volume: 45 start-page: 2491 issue: 6 year: 2018 ident: 10.1016/j.cellsig.2020.109871_bb1905 article-title: Alleviating the progression of acute myeloid leukemia (AML) by sulforaphane through controlling miR-155 levels publication-title: Mol. Biol. Rep. doi: 10.1007/s11033-018-4416-0 – volume: 207 start-page: 214 issue: 5 year: 2014 ident: 10.1016/j.cellsig.2020.109871_bb0750 article-title: Downregulation of miR-21 increases cisplatin sensitivity of non–small-cell lung cancer publication-title: Cancer Gene Ther. doi: 10.1016/j.cancergen.2014.04.003 – volume: 7 start-page: 32362 issue: 22 year: 2016 ident: 10.1016/j.cellsig.2020.109871_bb1070 article-title: Reduction of microRNA-184 by E6 oncoprotein confers cisplatin resistance in lung cancer via increasing Bcl-2 publication-title: Oncotarget doi: 10.18632/oncotarget.8708 – start-page: 12(4) year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb1600 article-title: The inhibition of Wnt restrain KRAS(G12V)-driven metastasis in non-small-cell lung cancer publication-title: Cancers (Basel) – volume: 428 start-page: 55 year: 2018 ident: 10.1016/j.cellsig.2020.109871_bb0795 article-title: miRNA 146a promotes chemotherapy resistance in lung cancer cells by targeting DNA damage inducible transcript 3 (CHOP) publication-title: Cancer Lett. doi: 10.1016/j.canlet.2018.04.028 – volume: 21 start-page: 2589 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0595 article-title: MicroRNA28 promotes the proliferation of nonsmallcell lung cancer cells by targeting PTEN publication-title: Mol. Med. Rep. – volume: 478 start-page: 676 issue: 2 year: 2016 ident: 10.1016/j.cellsig.2020.109871_bb1215 article-title: MiR-509-3-5p causes aberrant mitosis and anti-proliferative effect by suppression of PLK1 in human lung cancer A549 cells publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2016.08.006 – volume: 10 start-page: 308 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0435 article-title: Regulation of integrin subunit alpha 2 by miR-135b-5p modulates chemoresistance in gastric cancer publication-title: Front. Oncol. doi: 10.3389/fonc.2020.00308 – volume: 177 start-page: 113939 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0185 article-title: Ribociclib mitigates cisplatin-associated kidney injury through retinoblastoma-1 dependent mechanisms publication-title: Biochem. Pharmacol. doi: 10.1016/j.bcp.2020.113939 – volume: 10 start-page: 215 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb1500 article-title: A novel long non-coding RNA, MSTRG.51053.2 regulates cisplatin resistance by sponging the miR-432-5p in non-small cell lung cancer cells publication-title: Front. Oncol. doi: 10.3389/fonc.2020.00215 – volume: 116 start-page: 281 issue: 2 year: 2004 ident: 10.1016/j.cellsig.2020.109871_bb0345 article-title: MicroRNAs: genomics, biogenesis, mechanism, and function publication-title: Cell doi: 10.1016/S0092-8674(04)00045-5 – volume: 11 start-page: 5622 issue: 12 year: 2018 ident: 10.1016/j.cellsig.2020.109871_bb0495 article-title: MiR-106a-5p promotes 5-FU resistance and the metastasis of colorectal cancer by targeting TGFbetaR2 publication-title: Int. J. Clin. Exp. Pathol. – volume: 26 start-page: 83 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0860 article-title: Brusatol suppresses STAT3-driven metastasis by downregulating epithelial-mesenchymal transition in hepatocellular carcinoma publication-title: J. Adv. Res. doi: 10.1016/j.jare.2020.07.004 – volume: 488 start-page: 501 issue: 3 year: 2017 ident: 10.1016/j.cellsig.2020.109871_bb0745 article-title: Attenuation of deregulated miR-369-3p expression sensitizes non-small cell lung cancer cells to cisplatin via modulation of the nucleotide sugar transporter SLC35F5 publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2017.05.075 – volume: 83 start-page: 921 issue: 5 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb1645 article-title: The PVT1/miR-216b/Beclin-1 regulates cisplatin sensitivity of NSCLC cells via modulating autophagy and apoptosis publication-title: Cancer Chemother. Pharmacol. doi: 10.1007/s00280-019-03808-3 – volume: 7 start-page: 20728 issue: 15 year: 2016 ident: 10.1016/j.cellsig.2020.109871_bb1075 article-title: MicroRNA-137 inhibits tumor growth and sensitizes chemosensitivity to paclitaxel and cisplatin in lung cancer publication-title: Oncotarget doi: 10.18632/oncotarget.8011 – volume: 18 start-page: 631 issue: 1 year: 2018 ident: 10.1016/j.cellsig.2020.109871_bb1450 article-title: MiR-199a-3p affects the multi-chemoresistance of osteosarcoma through targeting AK4 publication-title: BMC Cancer doi: 10.1186/s12885-018-4460-0 – volume: 4 start-page: 1595 issue: 10 year: 2005 ident: 10.1016/j.cellsig.2020.109871_bb1845 article-title: Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells publication-title: Mol. Cancer Ther. doi: 10.1158/1535-7163.MCT-05-0102 – volume: 204 start-page: 55 year: 2018 ident: 10.1016/j.cellsig.2020.109871_bb0325 article-title: Determination of mir-155 and mir-146a expression rates and its association with expression level of TNF-α and CTLA4 genes in patients with Behcet’s disease publication-title: Immunol. Lett. doi: 10.1016/j.imlet.2018.10.012 – volume: 104 start-page: 15805 issue: 40 year: 2007 ident: 10.1016/j.cellsig.2020.109871_bb0940 article-title: MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.0707628104 – volume: 125 start-page: 109896 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0280 article-title: Inhibition of MGMT-mediated autophagy suppression decreases cisplatin chemosensitivity in gastric cancer publication-title: Biomed. Pharmacother. doi: 10.1016/j.biopha.2020.109896 – volume: 20 start-page: 78 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb1385 article-title: Circ_0072083 interference enhances growth-inhibiting effects of cisplatin in non-small-cell lung cancer cells via miR-545-3p/CBLL1 axis publication-title: Cancer Cell Int. doi: 10.1186/s12935-020-1162-x – volume: 12 start-page: 1087 issue: 3 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb1025 article-title: miR-5582-5p inhibits cell proliferation of non-small cell lung cancer through targeting FGF-10 publication-title: Int. J. Clin. Exp. Pathol. – volume: 19 start-page: 533 issue: 1 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb1520 article-title: Knockdown of lncRNA MIAT inhibits proliferation and cisplatin resistance in non-small cell lung cancer cells by increasing miR-184 expression publication-title: Oncol. Lett. – volume: 12 start-page: 1929 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0260 article-title: LncRNA MALAT1 regulates the cell proliferation and cisplatin resistance in gastric cancer via PI3K/AKT pathway publication-title: Cancer Manag. Res. doi: 10.2147/CMAR.S243796 – volume: 23 start-page: 3383 issue: 8 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb1510 article-title: Long noncoding RNA MIAT promotes the growth and metastasis of non-small cell lung cancer by upregulating TDP43 publication-title: Eur. Rev. Med. Pharmacol. Sci. – volume: 12 start-page: 3197 issue: 9 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb1770 article-title: Cyr61 overexpression induced by interleukin 8 via NF-kB signaling pathway and its role in tumorigenesis of gastric carcinoma in vitro publication-title: Int. J. Clin. Exp. Pathol. – volume: 19 start-page: 347 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb1885 article-title: Cancer-associated fibroblast-derived exosomal microRNA-98-5p promotes cisplatin resistance in ovarian cancer by targeting CDKN1A publication-title: Cancer Cell Int. doi: 10.1186/s12935-019-1051-3 – volume: 20 start-page: 421 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0395 article-title: Tumor-derived EV-encapsulated miR-181b-5p induces angiogenesis to foster tumorigenesis and metastasis of ESCC publication-title: Mol. Ther. Nucleic Acids doi: 10.1016/j.omtn.2020.03.002 – start-page: 20(24) year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb1790 article-title: Hypoxia: overview on hypoxia-mediated mechanisms with a focus on the role of HIF genes publication-title: Int. J. Mol. Sci. – volume: 13 start-page: 3555 issue: 6 year: 2017 ident: 10.1016/j.cellsig.2020.109871_bb0710 article-title: microRNA-664 enhances proliferation, migration and invasion of lung cancer cells publication-title: Exp. Ther. Med. doi: 10.3892/etm.2017.4433 – volume: 11 start-page: 1443 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0020 article-title: Validated LC-MS/MS method of Sphingosine 1-phosphate quantification in human serum for evaluation of response to radiotherapy in lung cancer publication-title: Thorac. Cancer doi: 10.1111/1759-7714.13409 – volume: 16 start-page: 1876 issue: 2 year: 2018 ident: 10.1016/j.cellsig.2020.109871_bb0565 article-title: MicroRNA-137-regulated AKT serine/threonine kinase 2 inhibits tumor growth and sensitizes cisplatin in patients with non-small cell lung cancer publication-title: Oncol. Lett. – volume: 11 start-page: 2679 issue: 9 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb1455 article-title: IL22 drives cutaneous melanoma cell proliferation, migration and invasion through activation of miR-181/STAT3/AKT axis publication-title: J. Cancer doi: 10.7150/jca.40974 – volume: 9 start-page: 327 issue: 1 year: 2018 ident: 10.1016/j.cellsig.2020.109871_bb1190 article-title: miR-181b/Notch2 overcome chemoresistance by regulating cancer stem cell-like properties in NSCLC publication-title: Stem Cell Res. Ther. doi: 10.1186/s13287-018-1072-1 – volume: 10 start-page: 429 issue: 6 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb1750 article-title: Knockdown of TRIM65 inhibits autophagy and cisplatin resistance in A549/DDP cells by regulating miR-138-5p/ATG7 publication-title: Cell Death Dis. doi: 10.1038/s41419-019-1660-8 – volume: 1788 start-page: 2003 issue: 10 year: 2009 ident: 10.1016/j.cellsig.2020.109871_bb0895 article-title: The enigmatic role of tafazzin in cardiolipin metabolism publication-title: Biochim. Biophys. Acta doi: 10.1016/j.bbamem.2009.07.009 – volume: 20 start-page: 4697 issue: 22 year: 2016 ident: 10.1016/j.cellsig.2020.109871_bb1430 article-title: MicroRNA-185-5p modulates chemosensitivity of human non-small cell lung cancer to cisplatin via targeting ABCC1 publication-title: Eur. Rev. Med. Pharmacol. Sci. – volume: 11 start-page: 20649 issue: 23 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb0235 article-title: Dual stable nanomedicines prepared by cisplatin-crosslinked camptothecin prodrug micelles for effective drug delivery publication-title: ACS Appl. Mater. Interfaces doi: 10.1021/acsami.9b03960 – volume: 10 start-page: 4722 issue: 1 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb1715 article-title: Novel HDAC11 inhibitors suppress lung adenocarcinoma stem cell self-renewal and overcome drug resistance by suppressing Sox2 publication-title: Sci. Rep. doi: 10.1038/s41598-020-61295-6 – volume: 10 start-page: 11545 issue: 12 year: 2017 ident: 10.1016/j.cellsig.2020.109871_bb1045 article-title: MicroRNA-146a regulates cisplatin-resistance of non-small cell lung cancer cells by targeting NF-kappaB pathway publication-title: Int. J. Clin. Exp. Pathol. – volume: 9 start-page: 542 issue: 2 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0210 article-title: progress in microneedle-mediated protein delivery publication-title: J. Clin. Med. doi: 10.3390/jcm9020542 – year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb0905 article-title: Suppression of Tafazzin promotes thyroid cancer apoptosis via activating the JNK signaling pathway and enhancing INF2-mediated mitochondrial fission publication-title: J. Cell. Physiol. – volume: 17 start-page: 138 issue: 1 year: 2017 ident: 10.1016/j.cellsig.2020.109871_bb1170 article-title: Up-regulation of miR-146a increases the sensitivity of non-small cell lung cancer to DDP by downregulating cyclin J publication-title: BMC Cancer doi: 10.1186/s12885-017-3132-9 – volume: 13 start-page: 1 issue: 1 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb1560 article-title: Long noncoding RNA NORAD regulates lung cancer cell proliferation, apoptosis, migration, and invasion by the miR-30a-5p/ADAM19 axis publication-title: Int. J. Clin. Exp. Pathol. – volume: 31 start-page: 498 issue: 6 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0420 article-title: miR-149 rs2292832 C allele enhances the cytotoxic effect of temozolomide against glioma cells publication-title: Neuroreport doi: 10.1097/WNR.0000000000001440 – volume: 235 start-page: 7541 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb1485 article-title: lncRNA SNHG11 promotes lung cancer cell proliferation and migration via activation of Wnt/beta-catenin signaling pathway publication-title: J. Cell Physiol. doi: 10.1002/jcp.29656 – volume: 18 start-page: 237 issue: 1 year: 2017 ident: 10.1016/j.cellsig.2020.109871_bb1400 article-title: The oncogenic role of circPVT1 in head and neck squamous cell carcinoma is mediated through the mutant p53/YAP/TEAD transcription-competent complex publication-title: Genome Biol. doi: 10.1186/s13059-017-1368-y – volume: 19 start-page: 188 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb0040 article-title: p53 sensitizes chemoresistant non-small cell lung cancer via elevation of reactive oxygen species and suppression of EGFR/PI3K/AKT signaling publication-title: Cancer Cell Int. doi: 10.1186/s12935-019-0910-2 – volume: 126 start-page: 110099 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0310 article-title: The dual role of mir-146a in metastasis and disease progression publication-title: Biomed. Pharmacother. doi: 10.1016/j.biopha.2020.110099 – volume: 2 start-page: 14003 year: 2014 ident: 10.1016/j.cellsig.2020.109871_bb1015 article-title: Role of FGF/FGFR signaling in skeletal development and homeostasis: learning from mouse models publication-title: Bone Res. doi: 10.1038/boneres.2014.3 – volume: 9 start-page: 654 issue: 6 year: 2007 ident: 10.1016/j.cellsig.2020.109871_bb1825 article-title: Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells publication-title: Nat. Cell Biol. doi: 10.1038/ncb1596 – volume: 9 start-page: 78 issue: 2 year: 2018 ident: 10.1016/j.cellsig.2020.109871_bb1115 article-title: Dual roles of miR-374a by modulated c-Jun respectively targets CCND1-inducing PI3K/AKT signal and PTEN-suppressing Wnt/beta-catenin signaling in non-small-cell lung cancer publication-title: Cell Death Dis. doi: 10.1038/s41419-017-0103-7 – year: 2018 ident: 10.1016/j.cellsig.2020.109871_bb1090 article-title: miR-451 selectively increases sensitivity to cisplatin in ERCC1-high non-small cell lung cancer cells publication-title: J. Cell. Biochem. – volume: 10 start-page: 959 issue: 12 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb1635 article-title: TIPRL potentiates survival of lung cancer by inducing autophagy through the eIF2alpha-ATF4 pathway publication-title: Cell Death Dis. doi: 10.1038/s41419-019-2190-0 – volume: 26 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0175 article-title: Propofol improves sensitivity of lung cancer cells to cisplatin and its mechanism publication-title: Med. Sci. Monit. – volume: 25 start-page: 8095 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb0530 article-title: Upregulation of long noncoding RNA (lncRNA) X-inactive specific transcript (XIST) is associated with cisplatin resistance in non-small cell lung cancer (NSCLC) by downregulating MicroRNA-144-3p publication-title: Med. Sci. Monit. doi: 10.12659/MSM.916075 – volume: 20 start-page: 2565 issue: 12 year: 2016 ident: 10.1016/j.cellsig.2020.109871_bb0830 article-title: Inhibition of miR-141 reverses cisplatin resistance in non-small cell lung cancer cells via upregulation of programmed cell death protein 4 publication-title: Eur. Rev. Med. Pharmacol. Sci. – start-page: 50(5) year: 2017 ident: 10.1016/j.cellsig.2020.109871_bb1435 article-title: Visfatin mediates doxorubicin resistance in human non-small-cell lung cancer via Akt-mediated up-regulation of ABCC1 publication-title: Cell Prolif. – volume: 6 start-page: 82 issue: 3 year: 2018 ident: 10.1016/j.cellsig.2020.109871_bb1755 article-title: Evidence for the involvement of the master transcription factor NF-κB in cancer initiation and progression publication-title: Biomedicines doi: 10.3390/biomedicines6030082 – volume: 94 start-page: 79 issue: 1 year: 2018 ident: 10.1016/j.cellsig.2020.109871_bb0910 article-title: Significant expression of tafazzin (TAZ) protein in colon cancer cells and its downregulation by radiation publication-title: Int. J. Radiat. Biol. doi: 10.1080/09553002.2018.1400191 – volume: 57 start-page: 419 issue: 3 year: 2018 ident: 10.1016/j.cellsig.2020.109871_bb0725 article-title: MiR-5100 increases the cisplatin resistance of the lung cancer stem cells by inhibiting the Rab6 publication-title: Mol. Carcinog. doi: 10.1002/mc.22765 – volume: 57 start-page: 1835 issue: 12 year: 2018 ident: 10.1016/j.cellsig.2020.109871_bb1880 article-title: EGCG inhibits CSC-like properties through targeting miR-485/CD44 axis in A549-cisplatin resistant cells publication-title: Mol. Carcinog. doi: 10.1002/mc.22901 – volume: 5 start-page: 1304 issue: 5 year: 2014 ident: 10.1016/j.cellsig.2020.109871_bb1290 article-title: Retaining MKP1 expression and attenuating JNK-mediated apoptosis by RIP1 for cisplatin resistance through miR-940 inhibition publication-title: Oncotarget doi: 10.18632/oncotarget.1798 – volume: 482 start-page: 22 issue: 1 year: 2017 ident: 10.1016/j.cellsig.2020.109871_bb1200 article-title: miR-34a sensitizes lung cancer cells to cisplatin via p53/miR-34a/MYCN axis publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2016.11.037 – volume: 29 start-page: 384 issue: 1 year: 2012 ident: 10.1016/j.cellsig.2020.109871_bb1240 article-title: miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2 publication-title: Med. Oncol. doi: 10.1007/s12032-010-9797-4 – volume: 477 start-page: 49 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0615 article-title: miRNA-7 and miRNA-324-5p regulate alpha9-Integrin expression and exert anti-oncogenic effects in rhabdomyosarcoma publication-title: Cancer Lett. doi: 10.1016/j.canlet.2020.02.035 – volume: 28 start-page: 121 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb1610 article-title: MiR-519a functions as a tumor suppressor and is negatively associated with poor prognosis of non-small cell lung cancer publication-title: Cancer Biomark doi: 10.3233/CBM-190672 – start-page: 40(1) year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb1575 article-title: NORAD accelerates chemo-resistance of non-small-cell lung cancer via targeting at miR-129-1-3p/SOX4 axis publication-title: Biosci. Rep. – volume: 12 start-page: 447 issue: 2 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0850 article-title: Downregulation of SETBP1 promoted non-small cell lung cancer progression by inducing cellular EMT and disordered immune status publication-title: Am. J. Transl. Res. – volume: 12 start-page: 9627 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb0490 article-title: EZH2 contributes to cisplatin resistance in breast cancer by epigenetically suppressing miR-381 expression publication-title: Onco Targets Ther. doi: 10.2147/OTT.S214104 – volume: 14 start-page: 7745 issue: 6 year: 2017 ident: 10.1016/j.cellsig.2020.109871_bb1120 article-title: Upregulation of miR-146a increases cisplatin sensitivity of the non-small cell lung cancer A549 cell line by targeting JNK-2 publication-title: Oncol. Lett. – volume: 503 start-page: 56 issue: 1 year: 2018 ident: 10.1016/j.cellsig.2020.109871_bb1380 article-title: Circular RNA circZFR contributes to papillary thyroid cancer cell proliferation and invasion by sponging miR-1261 and facilitating C8orf4 expression publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2018.05.174 – volume: 7 start-page: 7236 issue: 10 year: 2014 ident: 10.1016/j.cellsig.2020.109871_bb1275 article-title: miR-107 regulates cisplatin chemosensitivity of A549 non small cell lung cancer cell line by targeting cyclin dependent kinase 8 publication-title: Int. J. Clin. Exp. Pathol. – volume: 37 start-page: 1081 issue: 7 year: 2014 ident: 10.1016/j.cellsig.2020.109871_bb1020 article-title: Physiological functions and underlying mechanisms of fibroblast growth factor (FGF) family members: recent findings and implications for their pharmacological application publication-title: Biol. Pharm. Bull. doi: 10.1248/bpb.b14-00265 – volume: 8 start-page: 84086 issue: 48 year: 2017 ident: 10.1016/j.cellsig.2020.109871_bb1680 article-title: LncRNA SNHG12 contributes to multidrug resistance through activating the MAPK/Slug pathway by sponging miR-181a in non-small cell lung cancer publication-title: Oncotarget doi: 10.18632/oncotarget.20475 – volume: 18 start-page: 1653 issue: 3 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb0670 article-title: Downregulation of miR-3934-5p enhances A549 cell sensitivity to cisplatin by targeting TP53INP1 publication-title: Exp. Ther. Med. – volume: 9 start-page: 7501 issue: 7 year: 2018 ident: 10.1016/j.cellsig.2020.109871_bb1665 article-title: MALAT1/miR-101-3p/MCL1 axis mediates cisplatin resistance in lung cancer publication-title: Oncotarget doi: 10.18632/oncotarget.23483 – volume: 11 start-page: 142 year: 2018 ident: 10.1016/j.cellsig.2020.109871_bb0960 article-title: miR-1266 contributes to pancreatic cancer progression and chemoresistance by the stat3 and nf-kappab signaling pathways publication-title: Mol. Ther. Nucleic Acids doi: 10.1016/j.omtn.2018.01.004 – volume: 22 start-page: 108 issue: 3 year: 2015 ident: 10.1016/j.cellsig.2020.109871_bb0775 article-title: miR-15b regulates cisplatin resistance and metastasis by targeting PEBP4 in human lung adenocarcinoma cells publication-title: Cancer Gene Ther. doi: 10.1038/cgt.2014.73 – volume: 234 start-page: 19280 issue: 11 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb0415 article-title: The potential role of miR-29 in health and cancer diagnosis, prognosis, and therapy publication-title: J. Cell. Physiol. doi: 10.1002/jcp.28607 – volume: 23 start-page: 6336 issue: 20 year: 2017 ident: 10.1016/j.cellsig.2020.109871_bb1095 article-title: miRomics and proteomics reveal a miR-296-3p/PRKCA/FAK/Ras/c-Myc feedback loop modulated by HDGF/DDX5/β-catenin complex in lung adenocarcinoma publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-16-2813 – volume: 174 start-page: 113795 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0500 article-title: Curcumol enhances the sensitivity of doxorubicin in triple-negative breast cancer via regulating the miR-181b-2-3p-ABCC3 axis publication-title: Biochem. Pharmacol. doi: 10.1016/j.bcp.2020.113795 – volume: 162 start-page: 134 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb1615 article-title: Linc00221 modulates cisplatin resistance in non-small-cell lung cancer via sponging miR-519a publication-title: Biochimie doi: 10.1016/j.biochi.2019.04.019 – volume: 13 start-page: 1451 issue: 3 year: 2017 ident: 10.1016/j.cellsig.2020.109871_bb1065 article-title: MicroRNA-134 reverses multidrug resistance in human lung adenocarcinoma cells by targeting FOXM1 publication-title: Oncol. Lett. doi: 10.3892/ol.2017.5574 – volume: 127 start-page: 2520 issue: 11 year: 2010 ident: 10.1016/j.cellsig.2020.109871_bb1305 article-title: miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines publication-title: Int. J. Cancer doi: 10.1002/ijc.25260 – volume: 45 start-page: 1783 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0135 article-title: CD44 inhibition attenuates EGFR signaling and enhances cisplatin sensitivity in human EGFR wildtype nonsmallcell lung cancer cells publication-title: Int. J. Mol. Med. – volume: 23 start-page: 5242 issue: 12 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb0965 article-title: MiR-124 changes the sensitivity of lung cancer cells to cisplatin through targeting STAT3 publication-title: Eur. Rev. Med. Pharmacol. Sci. – volume: 125 start-page: 110037 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0305 article-title: The function of miR-200 family in oxidative stress response evoked in cancer chemotherapy and radiotherapy publication-title: Biomed. Pharmacother. doi: 10.1016/j.biopha.2020.110037 – volume: 35 start-page: 204 year: 2018 ident: 10.1016/j.cellsig.2020.109871_bb1100 article-title: The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cells publication-title: EBioMedicine doi: 10.1016/j.ebiom.2018.08.001 – volume: 16 start-page: 182 issue: 4 year: 2000 ident: 10.1016/j.cellsig.2020.109871_bb1705 article-title: Pairing SOX off: with partners in the regulation of embryonic development publication-title: Trends Genet. doi: 10.1016/S0168-9525(99)01955-1 – volume: 234 start-page: 22009 issue: 12 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb1740 article-title: LncRNA LINC01857 promotes growth, migration, and invasion of glioma by modulating miR-1281/TRIM65 axis publication-title: J. Cell. Physiol. doi: 10.1002/jcp.28763 – volume: 6 start-page: 235 issue: 3 year: 2016 ident: 10.1016/j.cellsig.2020.109871_bb0370 article-title: miRNA deregulation in cancer cells and the tumor microenvironment publication-title: Cancer Discov. doi: 10.1158/2159-8290.CD-15-0893 – volume: 10 start-page: 1406 issue: 10 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0855 article-title: Corilagin represses epithelial to mesenchymal transition process through modulating Wnt/β-catenin signaling cascade publication-title: Biomolecules doi: 10.3390/biom10101406 – volume: 59 start-page: 105 issue: 1 year: 2008 ident: 10.1016/j.cellsig.2020.109871_bb0985 article-title: Caveolin-1 expression is significantly associated with drug resistance and poor prognosis in advanced non-small cell lung cancer patients treated with gemcitabine-based chemotherapy publication-title: Lung Cancer doi: 10.1016/j.lungcan.2007.07.024 – volume: 17 start-page: 384 issue: 5 year: 2014 ident: 10.1016/j.cellsig.2020.109871_bb0790 article-title: MiR-192 confers cisplatin resistance by targeting Bim in lung cancer publication-title: Zhongguo Fei Ai Za Zhi – volume: 30 start-page: 771 issue: 3 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb1710 article-title: Chromosome 3q26 gain is an early event driving coordinated overexpression of the PRKCI, SOX2, and ECT2 oncogenes in lung squamous cell carcinoma publication-title: Cell Rep. doi: 10.1016/j.celrep.2019.12.071 – volume: 22 start-page: 1328 issue: 8 year: 2015 ident: 10.1016/j.cellsig.2020.109871_bb1265 article-title: Reactivation of epigenetically silenced miR-512 and miR-373 sensitizes lung cancer cells to cisplatin and restricts tumor growth publication-title: Cell Death Differ. doi: 10.1038/cdd.2014.221 – volume: 10 start-page: 3967 issue: 9 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0440 article-title: A miR-146a-5p/TRAF6/NF-kB p65 axis regulates pancreatic cancer chemoresistance: functional validation and clinical significance publication-title: Theranostics doi: 10.7150/thno.40566 – volume: 22 start-page: 3475 issue: 7 year: 2018 ident: 10.1016/j.cellsig.2020.109871_bb0645 article-title: TP53INP1 inhibits hypoxia-induced vasculogenic mimicry formation via the ROS/snail signalling axis in breast cancer publication-title: J. Cell. Mol. Med. doi: 10.1111/jcmm.13625 – volume: 7 start-page: 24510 issue: 17 year: 2016 ident: 10.1016/j.cellsig.2020.109871_bb0690 article-title: miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET publication-title: Oncotarget doi: 10.18632/oncotarget.8229 – volume: 13 start-page: 212 issue: 2 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0460 article-title: Scutellarin circumvents chemoresistance, promotes apoptosis, and represses tumor growth by HDAC/miR-34a-mediated down-modulation of Akt/mTOR and NF-kappaB-orchestrated signaling pathways in multiple myeloma publication-title: Int. J. Clin. Exp. Pathol. – volume: 37 start-page: 4319 issue: 8 year: 2017 ident: 10.1016/j.cellsig.2020.109871_bb1145 article-title: Therapeutic role of MiR-140-5p for the treatment of non-small cell lung cancer publication-title: Anticancer Res. – volume: 9 start-page: 82 year: 2018 ident: 10.1016/j.cellsig.2020.109871_bb1515 article-title: Silencing of long non-coding RNA MIAT sensitizes lung cancer cells to gefitinib by epigenetically regulating miR-34a publication-title: Front. Pharmacol. doi: 10.3389/fphar.2018.00082 – volume: 392 start-page: 1225 issue: 10 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb0200 article-title: Mechanistic perspective of protective effects of resveratrol against cisplatin-induced ovarian injury in rats: emphasis on anti-inflammatory and anti-apoptotic effects publication-title: Naunyn Schmiedeberg's Arch. Pharmacol. doi: 10.1007/s00210-019-01662-x – volume: 12 start-page: 7537 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb1370 article-title: Silencing circZFR inhibits the proliferation, migration and invasion of human renal carcinoma cells by regulating miR-206 publication-title: Onco Targets Ther. doi: 10.2147/OTT.S215012 – volume: 21 start-page: 1242 issue: 4 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0125 article-title: Cisplatin-induced skeletal muscle dysfunction: mechanisms and counteracting therapeutic strategies publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms21041242 – start-page: 40(2) year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb1800 article-title: Genome-wide analysis of the hypoxia-related DNA methylation-driven genes in lung adenocarcinoma progression publication-title: Biosci. Rep. – start-page: 8(6) year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb0195 article-title: Quantification of berberine in Berberis vulgaris L. root extract and its curative and prophylactic role in cisplatin-induced in vivo toxicity and in vitro cytotoxicity publication-title: Antioxidants (Basel) – volume: 235 start-page: 8319 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0430 article-title: RFC2, a direct target of miR-744, modulates the cell cycle and promotes the proliferation of CRC cells publication-title: J. Cell. Physiol. doi: 10.1002/jcp.29676 – volume: 2018 start-page: 1769040 year: 2018 ident: 10.1016/j.cellsig.2020.109871_bb0560 article-title: MicroRNA-9 enhanced cisplatin sensitivity in nonsmall cell lung cancer cells by regulating eukaryotic translation initiation factor 5A2 publication-title: Biomed. Res. Int. doi: 10.1155/2018/1769040 – volume: 268 start-page: 187 issue: 2 year: 2008 ident: 10.1016/j.cellsig.2020.109871_bb0980 article-title: Caveats of caveolin-1 in cancer progression publication-title: Cancer Lett. doi: 10.1016/j.canlet.2008.03.055 – volume: 47 start-page: 3745 issue: 8 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb0550 article-title: MicroRNA-486-5p improves nonsmall-cell lung cancer chemotherapy sensitivity and inhibits epithelial-mesenchymal transition by targeting twinfilin actin binding protein 1 publication-title: J. Int. Med. Res. doi: 10.1177/0300060519850739 – volume: 25 start-page: 948 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb1550 article-title: PCAT1/miR-129/ABCB1 axis confers chemoresistance in non-small cell lung cancer publication-title: Front. Biosci. (Landmark Ed.) doi: 10.2741/4842 – volume: 10 start-page: 12705 issue: 1 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0110 article-title: Circulating miR-92b and miR-375 for monitoring the chemoresistance and prognosis of small cell lung cancer publication-title: Sci. Rep. doi: 10.1038/s41598-020-69615-6 – volume: 39 start-page: 293 issue: 2 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0120 article-title: Linc00173 promotes chemoresistance and progression of small cell lung cancer by sponging miR-218 to regulate Etk expression publication-title: Oncogene doi: 10.1038/s41388-019-0984-2 – volume: 39 start-page: 1227 issue: 3 year: 2018 ident: 10.1016/j.cellsig.2020.109871_bb1035 article-title: Over-regulation of microRNA-133b inhibits cell proliferation of cisplatin-induced non-small cell lung cancer cells through PI3K/Akt and JAK2/STAT3 signaling pathway by targeting EGFR publication-title: Oncol. Rep. – volume: 37 start-page: 13287 issue: 10 year: 2016 ident: 10.1016/j.cellsig.2020.109871_bb1220 article-title: miR-326 reverses chemoresistance in human lung adenocarcinoma cells by targeting specificity protein 1 publication-title: Tumor Biol. doi: 10.1007/s13277-016-5244-2 – volume: 383 start-page: 245 issue: 2 year: 2009 ident: 10.1016/j.cellsig.2020.109871_bb0695 article-title: Identification of a common microdeletion cluster in 7q21.3 subband among patients with myeloid leukemia and myelodysplastic syndrome publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2009.04.004 – volume: 11 start-page: 295 issue: 2 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb1585 article-title: LncRNA SNHG1 influences cell proliferation, migration, invasion, and apoptosis of non-small cell lung cancer cells via the miR-361-3p/FRAT1 axis publication-title: Thorac Cancer doi: 10.1111/1759-7714.13256 – volume: 309 start-page: 310 issue: 5732 year: 2005 ident: 10.1016/j.cellsig.2020.109871_bb0360 article-title: MicroRNA expression in zebrafish embryonic development publication-title: Science doi: 10.1126/science.1114519 – volume: 13 start-page: 2905 issue: 22 year: 1999 ident: 10.1016/j.cellsig.2020.109871_bb1000 article-title: Cellular survival: a play in three Akts publication-title: Genes Dev. doi: 10.1101/gad.13.22.2905 – volume: 21 start-page: 1471 issue: 3 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0275 article-title: Propofol inhibits proliferation and cisplatin resistance in ovarian cancer cells through regulating the microRNA374a/forkhead box O1 signaling axis publication-title: Mol. Med. Rep. – volume: 38 start-page: 525 issue: 6 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb0600 article-title: Down-regulation of microRNA-10a mediates the anti-tumor effect of icaritin in A549 cells via the PTEN/AKT and ERK pathway publication-title: Gen. Physiol. Biophys. doi: 10.4149/gpb_2019041 – volume: 39 start-page: 1631 issue: 4 year: 2018 ident: 10.1016/j.cellsig.2020.109871_bb1110 article-title: miR-181 regulates cisplatin-resistant non-small cell lung cancer via downregulation of autophagy through the PTEN/PI3K/AKT pathway publication-title: Oncol. Rep. – volume: 8 start-page: 12067 issue: 7 year: 2017 ident: 10.1016/j.cellsig.2020.109871_bb1915 article-title: Sulforaphane inhibits cancer stem-like cell properties and cisplatin resistance through miR-214-mediated downregulation of c-MYC in non-small cell lung cancer publication-title: Oncotarget doi: 10.18632/oncotarget.14512 – volume: 168 start-page: 73 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0300 article-title: JUND-dependent upregulation of HMOX1 is associated with cisplatin resistance in muscle-invasive bladder cancer publication-title: J. Biochem. doi: 10.1093/jb/mvaa027 – volume: 20 start-page: 90 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0270 article-title: Inhibition of ZEB1-AS1 confers cisplatin sensitivity in breast cancer by promoting microRNA-129-5p-dependent ZEB1 downregulation publication-title: Cancer Cell Int. doi: 10.1186/s12935-020-1164-8 – volume: 12 start-page: 1947 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb1850 article-title: Hypoxic non-small-cell lung cancer cell-derived exosomal miR-21 promotes resistance of normoxic cell to cisplatin publication-title: Onco Targets Ther. doi: 10.2147/OTT.S186922 – volume: 11 start-page: 4077 issue: 7 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb0685 article-title: Interleukin-22 secreted by cancer-associated fibroblasts regulates the proliferation and metastasis of lung cancer cells via the PI3K-Akt-mTOR signaling pathway publication-title: Am. J. Transl. Res. – volume: 80 start-page: 973 issue: 5 year: 2017 ident: 10.1016/j.cellsig.2020.109871_bb0730 article-title: miR-181c contributes to cisplatin resistance in non-small cell lung cancer cells by targeting Wnt inhibition factor 1 publication-title: Cancer Chemother. Pharmacol. doi: 10.1007/s00280-017-3435-1 – volume: 10 start-page: 1854 issue: 1 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb1805 article-title: Intermittent hypoxia exacerbates tumor progression in a mouse model of lung cancer publication-title: Sci. Rep. doi: 10.1038/s41598-020-58906-7 – volume: 11 start-page: 5988 issue: 9 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb0835 article-title: MiR-27b targets PI3K p110alpha to inhibit proliferation and migration in colorectal cancer stem cell publication-title: Am. J. Transl. Res. – volume: 37 start-page: 3475 issue: 6 year: 2017 ident: 10.1016/j.cellsig.2020.109871_bb1160 article-title: Effect of miR-1244 on cisplatin-treated non-small cell lung cancer via MEF2D expression publication-title: Oncol. Rep. doi: 10.3892/or.2017.5624 – volume: 17 year: 2018 ident: 10.1016/j.cellsig.2020.109871_bb0585 article-title: MicroRNA-29a functions as a tumor suppressor and increases cisplatin sensitivity by targeting NRAS in lung cancer publication-title: Technol. Cancer Res. Treat. doi: 10.1177/1533033818758905 – volume: 16 start-page: 279 issue: 5 year: 2016 ident: 10.1016/j.cellsig.2020.109871_bb0380 article-title: MicroRNAs as regulatory elements in immune system logic publication-title: Nat. Rev. Immunol. doi: 10.1038/nri.2016.40 – volume: 109 start-page: 3068 issue: 10 year: 2018 ident: 10.1016/j.cellsig.2020.109871_bb1670 article-title: LncRNA HOXA11-AS drives cisplatin resistance of human LUAD cells via modulating miR-454-3p/Stat3 publication-title: Cancer Sci. doi: 10.1111/cas.13764 – volume: 102 start-page: 9 issue: 1 year: 2011 ident: 10.1016/j.cellsig.2020.109871_bb0935 article-title: let-7 and miR-17-92: small-sized major players in lung cancer development publication-title: Cancer Sci. doi: 10.1111/j.1349-7006.2010.01707.x – volume: 234 start-page: 6116 issue: 5 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb1470 article-title: LINC01433 promotes hepatocellular carcinoma progression via modulating the miR-1301/STAT3 axis publication-title: J. Cell. Physiol. doi: 10.1002/jcp.27366 – volume: 19 start-page: 1439 issue: 2 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb1525 article-title: Long non-coding RNA LINC00707 acts as a competing endogenous RNA to enhance cell proliferation in colorectal cancer publication-title: Exp. Ther. Med. – volume: 9 start-page: 19 issue: 2 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0485 article-title: Dysregulation of the miR-148a-GLUT1 axis promotes the progression and chemoresistance of human intrahepatic cholangiocarcinoma publication-title: Oncogenesis doi: 10.1038/s41389-020-0207-2 – start-page: 109622 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0425 article-title: circ_ARF3 regulates the pathogenesis of osteosarcoma by sponging miR-1299 to maintain CDK6 expression publication-title: Cell. Signal. doi: 10.1016/j.cellsig.2020.109622 – volume: 156 start-page: 104774 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0445 article-title: MiR-377-3p suppresses colorectal cancer through negative regulation on Wnt/beta-catenin signaling by targeting XIAP and ZEB2 publication-title: Pharmacol. Res. doi: 10.1016/j.phrs.2020.104774 – volume: 12 start-page: 11069 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb0390 article-title: miR-451: a novel biomarker and potential therapeutic target for cancer publication-title: OncoTargets Ther. doi: 10.2147/OTT.S230963 – volume: 37 start-page: 1739 issue: 2 year: 2016 ident: 10.1016/j.cellsig.2020.109871_bb1225 article-title: miR-15a enhances the anticancer effects of cisplatin in the resistant non-small cell lung cancer cells publication-title: Tumour Biol. doi: 10.1007/s13277-015-3950-9 – volume: 21 start-page: 452 issue: 5 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0475 article-title: Knockdown of lncRNA CCAT1 enhances sensitivity of paclitaxel in prostate cancer via regulating miR-24-3p and FSCN1 publication-title: Cancer Biol. Ther. doi: 10.1080/15384047.2020.1727700 – volume: 888 start-page: 173483 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0400 article-title: microRNA-181a mediates the chemo-sensitivity of glioblastoma to carmustine and regulates cell proliferation, migration, and apoptosis publication-title: Eur. J. Pharmacol. doi: 10.1016/j.ejphar.2020.173483 – volume: 11 start-page: 2138 issue: 7 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb1010 article-title: MiR-204 reduces cisplatin resistance in non-small cell lung cancer through suppression of the caveolin-1/AKT/Bad pathway publication-title: Aging (Albany NY) doi: 10.18632/aging.101907 – volume: 10 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0330 article-title: The dual role of miR-186 in cancers: oncomir battling with tumor suppressor miRNA publication-title: Front. Oncol. doi: 10.3389/fonc.2020.00233 – volume: 124 start-page: 109828 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb1425 article-title: CircPVT1 contributes to chemotherapy resistance of lung adenocarcinoma through miR-145-5p/ABCC1 axis publication-title: Biomed. Pharmacother. doi: 10.1016/j.biopha.2020.109828 – volume: 235 start-page: 4001 issue: 4 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb1780 article-title: Circular RNA circC3P1 restrains kidney cancer cell activity by regulating miR-21/PTEN axis and inactivating PI3K/AKT and NF- kB pathways publication-title: J. Cell. Physiol. doi: 10.1002/jcp.29296 – volume: 17 start-page: 1 issue: 1 year: 2014 ident: 10.1016/j.cellsig.2020.109871_bb1295 article-title: The reversing and molecular mechanisms of miR-503 on the drug-resistance to cisplatin in A549/DDP cells publication-title: Zhongguo Fei Ai Za Zhi – volume: 273 start-page: 32380 issue: 49 year: 1998 ident: 10.1016/j.cellsig.2020.109871_bb0995 article-title: Up-regulation of caveolae and caveolar constituents in multidrug-resistant cancer cells publication-title: J. Biol. Chem. doi: 10.1074/jbc.273.49.32380 – volume: 23 start-page: 5795 issue: 13 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb1505 article-title: Long non-coding RNA MIAT promotes non-small cell lung cancer progression by sponging miR-1246 publication-title: Eur. Rev. Med. Pharmacol. Sci. – volume: 7 start-page: 20041 issue: 15 year: 2016 ident: 10.1016/j.cellsig.2020.109871_bb1080 article-title: MicroRNA-432 functions as a tumor suppressor gene through targeting E2F3 and AXL in lung adenocarcinoma publication-title: Oncotarget doi: 10.18632/oncotarget.7884 – volume: 20 start-page: 308 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb1360 article-title: circRNA-AKT1 sequesters miR-942-5p to upregulate AKT1 and promote cervical cancer progression publication-title: Mol. Ther. Nucleic Acids doi: 10.1016/j.omtn.2020.01.003 – start-page: 12(4) year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0155 article-title: Cisplatin relocalizes RNA binding protein HuR and enhances the oncolytic activity of E4orf6 deleted adenovirus publication-title: Cancers (Basel) – volume: 14 start-page: 745 issue: 4 year: 2018 ident: 10.1016/j.cellsig.2020.109871_bb1195 article-title: miR-181b inhibits chemoresistance in cisplatin-resistant H446 small cell lung cancer cells by targeting Bcl-2 publication-title: Arch. Med. Sci. – volume: 19 start-page: 677 issue: 4 year: 2013 ident: 10.1016/j.cellsig.2020.109871_bb1315 article-title: miR-135a/b modulate cisplatin resistance of human lung cancer cell line by targeting MCL1 publication-title: Pathol. Oncol. Res. doi: 10.1007/s12253-013-9630-4 – volume: 20 start-page: 3509 issue: 4 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb1415 article-title: Overexpressed circPVT1 in oral squamous cell carcinoma promotes proliferation by serving as a miRNA sponge publication-title: Mol. Med. Rep. – volume: 47 start-page: 3202 issue: 1 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb1920 article-title: Baicalein inhibits proliferation and collagen synthesis of mice fibroblast cell line NIH/3T3 by regulation of miR-9/insulin-like growth factor-1 axis publication-title: Artif. Cells Nanomed. Biotechnol. doi: 10.1080/21691401.2019.1645150 – year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb1725 article-title: SOX2 mediates cisplatin resistance in small-cell lung cancer with downregulated expression of hsa-miR-340-5p publication-title: Mol. Genet. Genomic. Med. doi: 10.1002/mgg3.1195 – volume: 44 start-page: 280 issue: 6 year: 2018 ident: 10.1016/j.cellsig.2020.109871_bb1545 article-title: The effect of microRNA-129 on the migration and invasion in NSCLC cells and its mechanism publication-title: Exp. Lung Res. doi: 10.1080/01902148.2018.1536174 – volume: 9 issue: 4 year: 2014 ident: 10.1016/j.cellsig.2020.109871_bb0525 article-title: MiRNA 17 family regulates cisplatin-resistant and metastasis by targeting TGFbetaR2 in NSCLC publication-title: PLoS One doi: 10.1371/journal.pone.0094639 – volume: 14 start-page: 41 year: 2018 ident: 10.1016/j.cellsig.2020.109871_bb0555 article-title: microRNA-1236-3p regulates DDP resistance in lung cancer cells publication-title: Open Med. (Wars) doi: 10.1515/med-2019-0007 – volume: 10 start-page: 937 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0060 article-title: PBK attenuates paclitaxel-induced autophagic cell death by suppressing p53 in H460 non-small cell lung cancer cells publication-title: FEBS Open Biol. doi: 10.1002/2211-5463.12855 – volume: 770 start-page: 131 year: 2012 ident: 10.1016/j.cellsig.2020.109871_bb1730 article-title: TRIM proteins in development publication-title: Adv. Exp. Med. Biol. doi: 10.1007/978-1-4614-5398-7_10 – volume: 24 start-page: 2518 issue: 5 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb1440 article-title: Circular RNA circ-ABCB10 promotes non-small cell lung cancer proliferation and inhibits cell apoptosis through repressing KISS1 publication-title: Eur. Rev. Med. Pharmacol. Sci. – volume: 8 issue: 9 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb1405 article-title: The circular RNA PVT1/miR-203/HOXD3 pathway promotes the progression of human hepatocellular carcinoma publication-title: Biol. Open – start-page: 144629 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0250 article-title: SIRT3 increases cisplatin sensitivity of small-cell lung cancer through apoptosis publication-title: Gene doi: 10.1016/j.gene.2020.144629 – volume: 93 start-page: 570 year: 2017 ident: 10.1016/j.cellsig.2020.109871_bb1660 article-title: GAS5 knockdown reduces the chemo-sensitivity of non-small cell lung cancer (NSCLC) cell to cisplatin (DDP) through regulating miR-21/PTEN axis publication-title: Biomed. Pharmacother. doi: 10.1016/j.biopha.2017.06.089 – start-page: 17(7) year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0180 article-title: Comparing paclitaxel-carboplatin with paclitaxel-cisplatin as the front-line chemotherapy for patients with FIGO IIIC serous-type tubo-ovarian cancer publication-title: Int. J. Environ. Res. Public Health – volume: 91 start-page: 231 issue: 2 year: 1997 ident: 10.1016/j.cellsig.2020.109871_bb1005 article-title: Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery publication-title: Cell doi: 10.1016/S0092-8674(00)80405-5 – volume: 14 start-page: 8121 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb0640 article-title: Exosomal transfer of cisplatin-induced miR-425-3p confers cisplatin resistance In NSCLC through activating autophagy publication-title: Int. J. Nanomedicine doi: 10.2147/IJN.S221383 – volume: 290 start-page: 6037 issue: 10 year: 2015 ident: 10.1016/j.cellsig.2020.109871_bb0630 article-title: The oncogenic microRNA-21 inhibits the tumor suppressive activity of FBXO11 to promote tumorigenesis publication-title: J. Biol. Chem. doi: 10.1074/jbc.M114.632125 – volume: 139 start-page: 189 issue: 1 year: 2012 ident: 10.1016/j.cellsig.2020.109871_bb1245 article-title: Antitussive, expectorant and anti-inflammatory activities of four alkaloids isolated from Bulbus of Fritillaria wabuensis publication-title: J. Ethnopharmacol. doi: 10.1016/j.jep.2011.10.036 – volume: 11 start-page: 7553 issue: 18 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb0540 article-title: Long non-coding RNA TUG1 enhances chemosensitivity in non-small cell lung cancer by impairing microRNA-221-dependent PTEN inhibition publication-title: Aging (Albany NY) doi: 10.18632/aging.102271 – volume: 591 start-page: 636 issue: 4 year: 2017 ident: 10.1016/j.cellsig.2020.109871_bb1180 article-title: Suppression of EIF4G2 by miR-379 potentiates the cisplatin chemosensitivity in nonsmall cell lung cancer cells publication-title: FEBS Lett. doi: 10.1002/1873-3468.12566 – start-page: 112061 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb1895 article-title: Sulforaphane enhances the cisplatin sensitivity through regulating DNA repair and accumulation of intracellular cisplatin in ovarian cancer cells publication-title: Exp. Cell Res. doi: 10.1016/j.yexcr.2020.112061 – volume: 36 start-page: 6774 issue: 49 year: 2017 ident: 10.1016/j.cellsig.2020.109871_bb1580 article-title: The long noncoding RNA SNHG1 promotes tumor growth through regulating transcription of both local and distal genes publication-title: Oncogene doi: 10.1038/onc.2017.286 – volume: 9 start-page: 4717 issue: 16 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb0030 article-title: CDYL promotes the chemoresistance of small cell lung cancer by regulating H3K27 trimethylation at the CDKN1C promoter publication-title: Theranostics doi: 10.7150/thno.33680 – volume: 38 start-page: 2844 issue: 15 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb1365 article-title: Exosome circRNA secreted from adipocytes promotes the growth of hepatocellular carcinoma by targeting deubiquitination-related USP7 publication-title: Oncogene doi: 10.1038/s41388-018-0619-z – volume: 11 start-page: 120 issue: 1 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0680 article-title: Prognostic impact of CD34 and SMA in cancer-associated fibroblasts in stage I-III NSCLC publication-title: Thorac Cancer doi: 10.1111/1759-7714.13248 – volume: 13 start-page: 4077 issue: 6 year: 2017 ident: 10.1016/j.cellsig.2020.109871_bb0515 article-title: Genomic analysis of drug resistant small cell lung cancer cell lines by combining mRNA and miRNA expression profiling publication-title: Oncol. Lett. doi: 10.3892/ol.2017.5967 – volume: 17 start-page: 515 issue: 5 year: 2016 ident: 10.1016/j.cellsig.2020.109871_bb1345 article-title: Decreased MicroRNA-26a expression causes cisplatin resistance in human non-small cell lung cancer publication-title: Cancer Biol. Ther. doi: 10.1080/15384047.2015.1095405 – volume: 19 start-page: 773 issue: 11 year: 2012 ident: 10.1016/j.cellsig.2020.109871_bb0765 article-title: MiR-155 inhibits the sensitivity of lung cancer cells to cisplatin via negative regulation of Apaf-1 expression publication-title: Cancer Gene Ther. doi: 10.1038/cgt.2012.60 – volume: 18 start-page: 74 issue: 1 year: 2018 ident: 10.1016/j.cellsig.2020.109871_bb0650 article-title: MicroRNA-200a confers chemoresistance by antagonizing TP53INP1 and YAP1 in human breast cancer publication-title: BMC Cancer doi: 10.1186/s12885-017-3930-0 – volume: 12 start-page: 7551 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb0915 article-title: Restoration of miR-26b expression partially reverses the cisplatin resistance of NSCLC by targeting tafazzin publication-title: Onco Targets Ther. doi: 10.2147/OTT.S212649 – volume: 106 start-page: 1072 year: 2018 ident: 10.1016/j.cellsig.2020.109871_bb1085 article-title: miR-539 enhances chemosensitivity to cisplatin in non-small cell lung cancer by targeting DCLK1 publication-title: Biomed. Pharmacother. doi: 10.1016/j.biopha.2018.07.024 – volume: 7 start-page: 3636 issue: 1 year: 2017 ident: 10.1016/j.cellsig.2020.109871_bb1055 article-title: MicroRNA-34a encapsulated in hyaluronic acid nanoparticles induces epigenetic changes with altered mitochondrial bioenergetics and apoptosis in non-small-cell lung cancer cells publication-title: Sci. Rep. doi: 10.1038/s41598-017-02816-8 – volume: 24 start-page: 2123 issue: 3 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0080 article-title: FGFRL1 affects chemoresistance of small-cell lung cancer by modulating the PI3K/Akt pathway via ENO1 publication-title: J. Cell. Mol. Med. doi: 10.1111/jcmm.14763 – volume: 20 start-page: 3917 issue: 4 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb0955 article-title: Increased lncRNA HOTAIR expression promotes the chemoresistance of multiple myeloma to dexamethasone by regulating cell viability and apoptosis by mediating the JAK2/STAT3 signaling pathway publication-title: Mol. Med. Rep. – volume: 1 start-page: E35 issue: 2 year: 1999 ident: 10.1016/j.cellsig.2020.109871_bb0970 article-title: Caveolin, cholesterol and Ras signalling publication-title: Nat. Cell Biol. doi: 10.1038/10028 – volume: 10 start-page: 6543 issue: 26 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb1865 article-title: Synergistic inhibition of lung cancer cells by EGCG and NF-kappaB inhibitor BAY11-7082 publication-title: J. Cancer doi: 10.7150/jca.34285 – volume: 111 start-page: 339 issue: 2 year: 2014 ident: 10.1016/j.cellsig.2020.109871_bb0785 article-title: MiR-224 promotes the chemoresistance of human lung adenocarcinoma cells to cisplatin via regulating G(1)/S transition and apoptosis by targeting p21(WAF1/CIP1) publication-title: Br. J. Cancer doi: 10.1038/bjc.2014.157 – volume: 122 start-page: 1354 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0470 article-title: miR-27a is a master regulator of metabolic reprogramming and chemoresistance in colorectal cancer publication-title: Br. J. Cancer doi: 10.1038/s41416-020-0773-2 – volume: 19 start-page: 5397 issue: 6 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb1570 article-title: Long noncoding RNA NORAD promotes cell proliferation and glycolysis in nonsmall cell lung cancer by acting as a sponge for miR1365p publication-title: Mol. Med. Rep. – volume: 66 start-page: 636 issue: 4 year: 2014 ident: 10.1016/j.cellsig.2020.109871_bb1890 article-title: EGCG enhances the efficacy of cisplatin by downregulating hsa-miR-98-5p in NSCLC A549 cells publication-title: Nutr. Cancer doi: 10.1080/01635581.2014.894101 – volume: 7 start-page: 40384 year: 2017 ident: 10.1016/j.cellsig.2020.109871_bb0735 article-title: MiR-488 inhibits proliferation and cisplatin sensibility in non-small-cell lung cancer (NSCLC) cells by activating the eIF3a-mediated NER signaling pathway publication-title: Sci. Rep. doi: 10.1038/srep40384 – volume: 66 start-page: 756 issue: 5 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb1595 article-title: Long non-coding RNA SNHG1 contributes to cisplatin resistance in non-small cell lung cancer by regulating miR-140-5p/Wnt/β-catenin pathway publication-title: Neoplasma doi: 10.4149/neo_2018_181218N980 – volume: 10 start-page: 5137 year: 2017 ident: 10.1016/j.cellsig.2020.109871_bb1685 article-title: LncRNA MEG3 enhances cisplatin sensitivity in non-small cell lung cancer by regulating miR-21-5p/SOX7 axis publication-title: Onco Targets Ther. doi: 10.2147/OTT.S146423 – volume: 25 start-page: 233 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0285 article-title: DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m(6)A-demethylation of FOXM1 and NANOG publication-title: Apoptosis doi: 10.1007/s10495-020-01591-8 – volume: 16 start-page: 1813 issue: 16 year: 2010 ident: 10.1016/j.cellsig.2020.109871_bb0165 article-title: Novel metals and metal complexes as platforms for cancer therapy publication-title: Curr. Pharm. Des. doi: 10.2174/138161210791209009 – volume: 11 start-page: 597 issue: 9 year: 2010 ident: 10.1016/j.cellsig.2020.109871_bb0350 article-title: The widespread regulation of microRNA biogenesis, function and decay publication-title: Nat. Rev. Genet. doi: 10.1038/nrg2843 – volume: 22 start-page: 2478 issue: 4 year: 2018 ident: 10.1016/j.cellsig.2020.109871_bb1930 article-title: Baicalein inhibits cell growth and increases cisplatin sensitivity of A549 and H460 cells via miR-424-3p and targeting PTEN/PI3K/Akt pathway publication-title: J. Cell. Mol. Med. doi: 10.1111/jcmm.13556 – volume: 59 start-page: 141 issue: 2 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0115 article-title: circMTDH.4/miR-630/AEG-1 axis participates in the regulation of proliferation, migration, invasion, chemoresistance, and radioresistance of NSCLC publication-title: Mol. Carcinog. doi: 10.1002/mc.23135 – volume: 258 start-page: 118094 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0410 article-title: Docosahexaenoic acid (DHA) inhibits pro-angiogenic effects of breast cancer cells via down-regulating cellular and exosomal expression of angiogenic genes and microRNAs publication-title: Life Sci. doi: 10.1016/j.lfs.2020.118094 – volume: 19 start-page: 2733 issue: 4 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0170 article-title: Cisplatin resistance-associated circRNA_101237 serves as a prognostic biomarker in hepatocellular carcinoma publication-title: Exp. Ther. Med. – volume: 13 start-page: 240 year: 2014 ident: 10.1016/j.cellsig.2020.109871_bb1280 article-title: Pim-1 kinase is a target of miR-486-5p and eukaryotic translation initiation factor 4E, and plays a critical role in lung cancer publication-title: Mol. Cancer doi: 10.1186/1476-4598-13-240 – volume: 18 start-page: 667 issue: 1 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb0840 article-title: Effect of microRNA-27b on cisplatin chemotherapy sensitivity of oral squamous cell carcinoma via FZD7 signaling pathway publication-title: Oncol. Lett. – volume: 13 start-page: 109 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0605 article-title: miR-1269b drives cisplatin resistance of human non-small cell lung cancer via modulating the PTEN/PI3K/AKT signaling pathway publication-title: Onco Targets Ther. doi: 10.2147/OTT.S225010 – volume: 15 start-page: 331 issue: 3 year: 2005 ident: 10.1016/j.cellsig.2020.109871_bb0335 article-title: Post-transcriptional gene silencing by siRNAs and miRNAs publication-title: Curr. Opin. Struct. Biol. doi: 10.1016/j.sbi.2005.05.006 – volume: 70 start-page: 1793 issue: 5 year: 2010 ident: 10.1016/j.cellsig.2020.109871_bb1300 article-title: miR-181a and miR-630 regulate cisplatin-induced cancer cell death publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-09-3112 – volume: 26 start-page: R369 issue: 6 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb1760 article-title: The NF-KB pathway and endocrine therapy resistance in breast cancer publication-title: Endocr. Relat. Cancer doi: 10.1530/ERC-19-0087 – volume: 143 start-page: 550 issue: 3 year: 2012 ident: 10.1016/j.cellsig.2020.109871_bb0375 article-title: Inflammation-associated cancer development in digestive organs: mechanisms and roles for genetic and epigenetic modulation publication-title: Gastroenterology doi: 10.1053/j.gastro.2012.07.009 – volume: 222 start-page: 540 issue: 3 year: 2010 ident: 10.1016/j.cellsig.2020.109871_bb0355 article-title: Genomic organization of microRNAs publication-title: J. Cell. Physiol. doi: 10.1002/jcp.21993 – volume: 36 start-page: 114 issue: 1 year: 2017 ident: 10.1016/j.cellsig.2020.109871_bb1135 article-title: Epigenetic silencing of miR-493 increases the resistance to cisplatin in lung cancer by targeting tongue cancer resistance-related protein 1(TCRP1) publication-title: J. Exp. Clin. Cancer Res. doi: 10.1186/s13046-017-0582-5 – volume: 5 issue: 11 year: 2016 ident: 10.1016/j.cellsig.2020.109871_bb1320 article-title: The novel miR-9600 suppresses tumor progression and promotes paclitaxel sensitivity in non-small-cell lung cancer through altering STAT3 expression publication-title: Mol. Ther. Nucleic Acids – volume: 35 start-page: 10341 issue: 10 year: 2014 ident: 10.1016/j.cellsig.2020.109871_bb1235 article-title: Downregulation of PEBP4, a target of miR-34a, sensitizes drug-resistant lung cancer cells publication-title: Tumor Biol. doi: 10.1007/s13277-014-2284-3 – volume: 479 start-page: 89 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0240 article-title: Myeloid-derived suppressor cells are essential partners for immune checkpoint inhibitors in the treatment of cisplatin-resistant bladder cancer publication-title: Cancer Lett. doi: 10.1016/j.canlet.2020.03.013 – volume: 7 issue: 6 year: 2012 ident: 10.1016/j.cellsig.2020.109871_bb0975 article-title: Interaction of caveolin-1 with Ku70 inhibits Bax-mediated apoptosis publication-title: PLoS One doi: 10.1371/journal.pone.0039379 – volume: 6 start-page: 317 issue: 1 year: 2015 ident: 10.1016/j.cellsig.2020.109871_bb1270 article-title: Mir-24-3p downregulation contributes to VP16-DDP resistance in small-cell lung cancer by targeting ATG4A publication-title: Oncotarget doi: 10.18632/oncotarget.2787 – volume: 10 issue: 3 year: 2015 ident: 10.1016/j.cellsig.2020.109871_bb1785 article-title: Modulation of NF-kappaB/miR-21/PTEN pathway sensitizes non-small cell lung cancer to cisplatin publication-title: PLoS One doi: 10.1371/journal.pone.0121547 – volume: 72 start-page: 183 issue: 1 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb1620 article-title: Autophagy in hepatic adaptation to stress publication-title: J. Hepatol. doi: 10.1016/j.jhep.2019.08.026 – volume: 661 start-page: 196 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb1375 article-title: CircZFR promotes hepatocellular carcinoma progression through regulating miR-3619-5p/CTNNB1 axis and activating Wnt/beta-catenin pathway publication-title: Arch. Biochem. Biophys. doi: 10.1016/j.abb.2018.11.020 – volume: 3 start-page: 83 year: 2015 ident: 10.1016/j.cellsig.2020.109871_bb1795 article-title: The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy publication-title: Hypoxia (Auckl.) doi: 10.2147/HP.S93413 – volume: 12 start-page: 293 issue: 4 year: 2013 ident: 10.1016/j.cellsig.2020.109871_bb0920 article-title: The CSB repair factor is overexpressed in cancer cells, increases apoptotic resistance, and promotes tumor growth publication-title: DNA Repair (Amst.) doi: 10.1016/j.dnarep.2013.01.008 – volume: 37 start-page: 2129 issue: 4 year: 2017 ident: 10.1016/j.cellsig.2020.109871_bb1165 article-title: Overexpression of miR-203 increases the sensitivity of NSCLC A549/H460 cell lines to cisplatin by targeting Dickkopf-1 publication-title: Oncol. Rep. doi: 10.3892/or.2017.5505 – volume: 25 start-page: 89 issue: 1 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb0805 article-title: MicroRNA-146-5p promotes proliferation, migration and invasion in lung cancer cells by targeting claudin-12 publication-title: Cancer Biomarkers doi: 10.3233/CBM-182374 – volume: 115 start-page: 1234 issue: 7 year: 2014 ident: 10.1016/j.cellsig.2020.109871_bb1230 article-title: miR-495 enhances the sensitivity of non-small cell lung cancer cells to platinum by modulation of copper-transporting p-type adenosine triphosphatase A (ATP7A) publication-title: J. Cell. Biochem. doi: 10.1002/jcb.24665 – volume: 18 start-page: 6261 issue: 6 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb1535 article-title: Silencing long intergenic non-coding RNA 00707 enhances cisplatin sensitivity in cisplatin-resistant non-small-cell lung cancer cells by sponging miR-145 publication-title: Oncol. Lett. – volume: 39 start-page: 724 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0455 article-title: Overexpression of growth-arrest-specific transcript 5 improved cisplatin sensitivity in hepatocellular carcinoma through sponging miR-222 publication-title: DNA Cell Biol. doi: 10.1089/dna.2019.5282 – volume: 9 start-page: 402 year: 2018 ident: 10.1016/j.cellsig.2020.109871_bb0320 article-title: Overview of microRNA biogenesis, mechanisms of actions, and circulation publication-title: Front. Endocrinol. doi: 10.3389/fendo.2018.00402 – volume: 18 start-page: 974 issue: 12 year: 2017 ident: 10.1016/j.cellsig.2020.109871_bb1690 article-title: LncRNA CCAT1/miR-130a-3p axis increases cisplatin resistance in non-small-cell lung cancer cell line by targeting SOX4 publication-title: Cancer Biol. Ther. doi: 10.1080/15384047.2017.1385679 – volume: 12 start-page: 3913 year: 2017 ident: 10.1016/j.cellsig.2020.109871_bb0230 article-title: Electrohydrodynamic fabrication of core–shell PLGA nanoparticles with controlled release of cisplatin for enhanced cancer treatment publication-title: Int. J. Nanomedicine doi: 10.2147/IJN.S134833 – volume: 37 start-page: 1197 issue: 1 year: 2016 ident: 10.1016/j.cellsig.2020.109871_bb1340 article-title: MicroRNA-218 regulates cisplatin (DPP) chemosensitivity in non-small cell lung cancer by targeting RUNX2 publication-title: Tumor Biol. doi: 10.1007/s13277-015-3831-2 – volume: 34 start-page: 1142 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0070 article-title: Rosmarinic acid reverses non-small cell lung cancer cisplatin resistance by activating the MAPK signaling pathway publication-title: Phytother. Res. doi: 10.1002/ptr.6584 – volume: 134 start-page: 807 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb1460 article-title: miR-210 transferred by lung cancer cell derived exosomes may act as proangiogenic factor in cancer-associated fibroblasts by modulating JAK2/STAT3 pathway publication-title: Clin. Sci. (Lond.) doi: 10.1042/CS20200039 – volume: 70 start-page: 1513 issue: 11 year: 2018 ident: 10.1016/j.cellsig.2020.109871_bb0620 article-title: MiR-324-5p reduces viability and induces apoptosis in gastric cancer cells through modulating TSPAN8 publication-title: J. Pharm. Pharmacol. doi: 10.1111/jphp.12995 – volume: 7 start-page: 573 issue: 8 year: 2007 ident: 10.1016/j.cellsig.2020.109871_bb0160 article-title: The resurgence of platinum-based cancer chemotherapy publication-title: Nat. Rev. Cancer doi: 10.1038/nrc2167 – volume: 388 start-page: 208 year: 2017 ident: 10.1016/j.cellsig.2020.109871_bb1395 article-title: Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer publication-title: Cancer Lett. doi: 10.1016/j.canlet.2016.12.006 – volume: 36 start-page: 194 issue: 4 year: 2018 ident: 10.1016/j.cellsig.2020.109871_bb0575 article-title: MicroRNA-130b targets PTEN to induce resistance to cisplatin in lung cancer cells by activating Wnt/beta-catenin pathway publication-title: Cell Biochem. Funct. doi: 10.1002/cbf.3331 – volume: 119 start-page: 1420 issue: 6 year: 2009 ident: 10.1016/j.cellsig.2020.109871_bb0865 article-title: The basics of epithelial-mesenchymal transition publication-title: J. Clin. Invest. doi: 10.1172/JCI39104 – volume: 27 start-page: 887 issue: 3 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb1745 article-title: TRIM proteins in autophagy: selective sensors in cell damage and innate immune responses publication-title: Cell Death Differ. doi: 10.1038/s41418-020-0495-2 – volume: 2018 start-page: 7908950 year: 2018 ident: 10.1016/j.cellsig.2020.109871_bb0570 article-title: Negative regulation of PTEN by MicroRNA-221 and its association with drug resistance and cellular senescence in lung cancer cells publication-title: Biomed. Res. Int. – volume: 21 issue: 5 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0245 article-title: Cordycepin resensitizes T24R2 cisplatin-resistant human bladder cancer cells to cisplatin by inactivating Ets-1 dependent MDR1 transcription publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms21051710 – volume: 114 start-page: 108662 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb1030 article-title: MiR-219a-5p enhances cisplatin sensitivity of human non-small cell lung cancer by targeting FGF9 publication-title: Biomed. Pharmacother. doi: 10.1016/j.biopha.2019.108662 – volume: 36 start-page: 1903 issue: 3 year: 2015 ident: 10.1016/j.cellsig.2020.109871_bb0760 article-title: Downregulation of miR-25 modulates non-small cell lung cancer cells by targeting CDC42 publication-title: Tumor Biol. doi: 10.1007/s13277-014-2793-0 – volume: 241 start-page: 117142 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb1775 article-title: MiR-345-3p attenuates apoptosis and inflammation caused by oxidized low-density lipoprotein by targeting TRAF6 via TAK1/p38/NF-kB signaling in endothelial cells publication-title: Life Sci. doi: 10.1016/j.lfs.2019.117142 – volume: 467 start-page: 40 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb0015 article-title: "NRF2 addiction" in lung cancer cells and its impact on cancer therapy publication-title: Cancer Lett. doi: 10.1016/j.canlet.2019.09.016 – volume: 47 start-page: 1464 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0465 article-title: LncRNA XIST promotes chemoresistance of breast cancer cells to doxorubicin by sponging miR-200c-3p to upregulate ANLN publication-title: Clin. Exp. Pharmacol. Physiol. doi: 10.1111/1440-1681.13307 – volume: 12 start-page: 1913 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0075 article-title: Anticancer effects of antihypertensive L-type calcium channel blockers on chemoresistant lung cancer cells via autophagy and apoptosis publication-title: Cancer Manag. Res. doi: 10.2147/CMAR.S228718 – volume: 111 start-page: 244 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb1420 article-title: Circular RNA PVT1 acts as a competing endogenous RNA for miR-497 in promoting non-small cell lung cancer progression publication-title: Biomed. Pharmacother. doi: 10.1016/j.biopha.2018.12.007 – volume: 9 start-page: 1938 issue: 9 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb0005 article-title: MYCN-mediated regulation of the HES1 promoter enhances the chemoresistance of small-cell lung cancer by modulating apoptosis publication-title: Am. J. Cancer Res. – volume: 12 start-page: 2997 issue: 8 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb0095 article-title: HOTAIR contributes to chemoresistance by activating NF-kappaB signaling in small-cell lung cancer publication-title: Int. J. Clin. Exp. Pathol. – volume: 16 start-page: 30 year: 2016 ident: 10.1016/j.cellsig.2020.109871_bb1355 article-title: MiR-1244 sensitizes the resistance of non-small cell lung cancer A549 cell to cisplatin publication-title: Cancer Cell Int. doi: 10.1186/s12935-016-0305-6 – volume: 259 start-page: 118239 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0405 article-title: Tumor suppressive activity of miR-424-5p in breast cancer cells through targeting PD-L1 and modulating PTEN/PI3K/AKT/mTOR signaling pathway publication-title: Life Sci. doi: 10.1016/j.lfs.2020.118239 – volume: 66 start-page: 3 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb1630 article-title: At a glance: a history of autophagy and cancer publication-title: Semin. Cancer Biol. doi: 10.1016/j.semcancer.2019.11.005 – volume: 440 start-page: 604 issue: 4 year: 2013 ident: 10.1016/j.cellsig.2020.109871_bb0770 article-title: MiR-92b regulates the cell growth, cisplatin chemosensitivity of A549 non small cell lung cancer cell line and target PTEN publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2013.09.111 – volume: 254 start-page: 117238 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0105 article-title: MiR-27b suppresses epithelial-mesenchymal transition and chemoresistance in lung cancer by targeting Snail1 publication-title: Life Sci. doi: 10.1016/j.lfs.2019.117238 – volume: 15 start-page: 2920 issue: 21 year: 2016 ident: 10.1016/j.cellsig.2020.109871_bb0820 article-title: DNA damage responsive miR-33b-3p promoted lung cancer cells survival and cisplatin resistance by targeting p21(WAF1/CIP1) publication-title: Cell Cycle doi: 10.1080/15384101.2016.1224043 – volume: 469 start-page: 266 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb1325 article-title: MicroRNA-182-5p regulates hedgehog signaling pathway and chemosensitivity of cisplatin-resistant lung adenocarcinoma cells via targeting GLI2 publication-title: Cancer Lett. doi: 10.1016/j.canlet.2019.10.044 – volume: 8 start-page: 94317 issue: 55 year: 2017 ident: 10.1016/j.cellsig.2020.109871_bb1675 article-title: MALAT1-miR-101-SOX9 feedback loop modulates the chemo-resistance of lung cancer cell to DDP via Wnt signaling pathway publication-title: Oncotarget doi: 10.18632/oncotarget.21693 – volume: 9 start-page: 1123 issue: 11 year: 2018 ident: 10.1016/j.cellsig.2020.109871_bb0875 article-title: miR-146b promotes cell proliferation and increases chemosensitivity, but attenuates cell migration and invasion via FBXL10 in ovarian cancer publication-title: Cell Death Dis. doi: 10.1038/s41419-018-1093-9 – volume: 8 start-page: 23 year: 2018 ident: 10.1016/j.cellsig.2020.109871_bb1695 article-title: TP53TG1 enhances cisplatin sensitivity of non-small cell lung cancer cells through regulating miR-18a/PTEN axis publication-title: Cell Biosci. doi: 10.1186/s13578-018-0221-7 – volume: 38 start-page: 6429 issue: 37 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb1735 article-title: Ubiquitin ligase TRIM65 promotes colorectal cancer metastasis by targeting ARHGAP35 for protein degradation publication-title: Oncogene doi: 10.1038/s41388-019-0891-6 – start-page: 12 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0065 article-title: Silencing of lncRNA XIST inhibits non-small cell lung cancer growth and promotes chemosensitivity to cisplatin publication-title: Aging (Albany NY) – volume: 24 start-page: 2098 issue: 3 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0505 article-title: MiR-129-5p promotes docetaxel resistance in prostate cancer by down-regulating CAMK2N1 expression publication-title: J. Cell. Mol. Med. doi: 10.1111/jcmm.14050 – volume: 471 start-page: 103 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0100 article-title: WDR74 induces nuclear beta-catenin accumulation and activates Wnt-responsive genes to promote lung cancer growth and metastasis publication-title: Cancer Lett. doi: 10.1016/j.canlet.2019.12.011 – volume: 9 issue: 4 year: 2014 ident: 10.1016/j.cellsig.2020.109871_bb1835 article-title: Exosomes from drug-resistant breast cancer cells transmit chemoresistance by a horizontal transfer of microRNAs publication-title: PLoS One doi: 10.1371/journal.pone.0095240 – volume: 21 issue: 3 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb1720 article-title: The FDA-approved anti-asthma medicine ciclesonide inhibits lung cancer stem cells through hedgehog signaling-mediated SOX2 regulation publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms21031014 – volume: 11 start-page: 567 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb1900 article-title: Sulforaphane potentiates anticancer effects of doxorubicin and cisplatin and mitigates their toxic effects publication-title: Front. Pharmacol. doi: 10.3389/fphar.2020.00567 – volume: 10 start-page: 1479 issue: 6 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb1390 article-title: CBLL1 is highly expressed in non-small cell lung cancer and promotes cell proliferation and invasion publication-title: Thorac Cancer doi: 10.1111/1759-7714.13097 – start-page: 40(3) year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0480 article-title: miR-492 promotes chemoresistance to CDDP and metastasis by targeting inhibiting DNMT3B and induces stemness in gastric cancer publication-title: Biosci. Rep. – volume: 99 start-page: 103768 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0265 article-title: Bromocoumarinplatin, targeting simultaneously mitochondria and nuclei with p53 apoptosis pathway to overcome cisplatin resistance publication-title: Bioorg. Chem. doi: 10.1016/j.bioorg.2020.103768 – volume: 235 start-page: 7970 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb1860 article-title: EGCG regulates CTR1 expression through its pro-oxidative property in non-small-cell lung cancer cells publication-title: J. Cell. Physiol. doi: 10.1002/jcp.29451 – volume: 506 start-page: 632 issue: 3 year: 2018 ident: 10.1016/j.cellsig.2020.109871_bb1590 article-title: Lnc-SNHG1 may promote the progression of non-small cell lung cancer by acting as a sponge of miR-497 publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2018.10.086 – volume: 23 start-page: 8219 issue: 19 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb0660 article-title: MicroRNA-15a-5p down-regulation inhibits cervical cancer by targeting TP53INP1 in vitro publication-title: Eur. Rev. Med. Pharmacol. Sci. – volume: 117 start-page: 218 year: 2017 ident: 10.1016/j.cellsig.2020.109871_bb0890 article-title: Curcumin: A potentially powerful tool to reverse cisplatin-induced toxicity publication-title: Pharmacol. Res. doi: 10.1016/j.phrs.2016.12.037 – volume: 65 start-page: 457 issue: 2 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0880 article-title: miR-146b regulates cell proliferation and apoptosis in gastric cancer by targeting PTP1B publication-title: Dig. Dis. Sci. doi: 10.1007/s10620-019-05771-8 – volume: 42 start-page: 1240 issue: 9 year: 2018 ident: 10.1016/j.cellsig.2020.109871_bb1330 article-title: MicroRNA-1 overexpression increases chemosensitivity of non-small cell lung cancer cells by inhibiting autophagy related 3-mediated autophagy publication-title: Cell Biol. Int. doi: 10.1002/cbin.10995 – volume: 239 start-page: 116984 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb1475 article-title: Circ_0076305 regulates cisplatin resistance of non-small cell lung cancer via positively modulating STAT3 by sponging miR-296–5p publication-title: Life Sci. doi: 10.1016/j.lfs.2019.116984 – volume: 38 start-page: 2096 issue: 4 year: 2017 ident: 10.1016/j.cellsig.2020.109871_bb1140 article-title: miR-198-induced upregulation of Livin may be associated with the prognosis and contribute to the oncogenesis of lung adenocarcinoma publication-title: Oncol. Rep. doi: 10.3892/or.2017.5866 – volume: 107 start-page: 1583 year: 2018 ident: 10.1016/j.cellsig.2020.109871_bb1925 article-title: Baicalein inhibits proliferation and migration of bladder cancer cell line T24 by down-regulation of microRNA-106 publication-title: Biomed. Pharmacother. doi: 10.1016/j.biopha.2018.08.107 – volume: 25 start-page: 1386 issue: 6 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0045 article-title: Protective effect of astaxanthin on ochratoxin a-induced kidney injury to mice by regulating oxidative stress-related NRF2/KEAP1 pathway publication-title: Molecules doi: 10.3390/molecules25061386 – volume: 160 start-page: 363 issue: 3 year: 2016 ident: 10.1016/j.cellsig.2020.109871_bb0205 article-title: The aqueous extract of cinnamon bark ameliorated cisplatin-induced cytotoxicity in vero cells without compromising the anticancer efficiency of cisplatin publication-title: Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. doi: 10.5507/bp.2016.034 – volume: 47 start-page: 71 year: 2017 ident: 10.1016/j.cellsig.2020.109871_bb0225 article-title: Overcoming cisplatin resistance in non-small cell lung cancer with Mad2 silencing siRNA delivered systemically using EGFR-targeted chitosan nanoparticles publication-title: Acta Biomater. doi: 10.1016/j.actbio.2016.09.045 – volume: 13 start-page: 2037 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0450 article-title: Long non-coding RNA DLEU1 up-regulates BIRC6 expression by competitively sponging miR-381-3p to promote cisplatin resistance in nasopharyngeal carcinoma publication-title: Onco Targets Ther. doi: 10.2147/OTT.S237456 – volume: 12 issue: 5 year: 2017 ident: 10.1016/j.cellsig.2020.109871_bb0900 article-title: Tafazzin (TAZ) promotes the tumorigenicity of cervical cancer cells and inhibits apoptosis publication-title: PLoS One doi: 10.1371/journal.pone.0177171 – volume: 263 start-page: 112 year: 2017 ident: 10.1016/j.cellsig.2020.109871_bb0215 article-title: Convection enhanced delivery of cisplatin-loaded brain penetrating nanoparticles cures malignant glioma in rats publication-title: J. Control. Release doi: 10.1016/j.jconrel.2017.03.007 – volume: 16 start-page: e121 issue: 6 year: 2015 ident: 10.1016/j.cellsig.2020.109871_bb0755 article-title: miR profiling identifies cyclin-dependent kinase 6 downregulation as a potential mechanism of acquired cisplatin resistance in non–small-cell lung carcinoma publication-title: Clin. Lung Cancer doi: 10.1016/j.cllc.2015.01.008 – start-page: 117238 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb0845 article-title: MiR-27b suppresses epithelial–mesenchymal transition and chemoresistance in lung cancer by targeting Snail1 publication-title: Life Sci. – volume: 51 start-page: 2160 issue: 5 year: 2018 ident: 10.1016/j.cellsig.2020.109871_bb1185 article-title: miR-202 enhances the anti-tumor effect of cisplatin on non-small cell lung cancer by targeting the Ras/MAPK pathway publication-title: Cell. Physiol. Biochem. doi: 10.1159/000495835 – volume: 13 start-page: 132 year: 2015 ident: 10.1016/j.cellsig.2020.109871_bb1260 article-title: miR-148b reverses cisplatin-resistance in non-small cell cancer cells via negatively regulating DNA (cytosine-5)-methyltransferase 1(DNMT1) expression publication-title: J. Transl. Med. doi: 10.1186/s12967-015-0488-y – volume: 41 start-page: 1223 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0295 article-title: RIP1 promotes proliferation through G2/M checkpoint progression and mediates cisplatin-induced apoptosis and necroptosis in human ovarian cancer cells publication-title: Acta Pharmacol. Sin. doi: 10.1038/s41401-019-0340-7 – volume: 14 start-page: 281 issue: 4 year: 2003 ident: 10.1016/j.cellsig.2020.109871_bb0990 article-title: Up-regulation of caveolin expression by cytotoxic agents in drug-sensitive cancer cells publication-title: Anti-Cancer Drugs doi: 10.1097/00001813-200304000-00005 – volume: 8 start-page: 1207 issue: 9 year: 2010 ident: 10.1016/j.cellsig.2020.109871_bb1310 article-title: Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer publication-title: Mol. Cancer Res. doi: 10.1158/1541-7786.MCR-10-0052 – start-page: 1 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb1480 article-title: CircAKT3 inhibits glycolysis balance in lung cancer cells by regulating miR-516b-5p/STAT3 to inhibit cisplatin sensitivity publication-title: Biotechnol. Lett. – volume: 42 start-page: 660 issue: 2 year: 2017 ident: 10.1016/j.cellsig.2020.109871_bb1060 article-title: Prognostic significance of microRNA-7 and its roles in the regulation of cisplatin resistance in lung adenocarcinoma publication-title: Cell. Physiol. Biochem. doi: 10.1159/000477884 – volume: 10 start-page: 1470 issue: 12 year: 2008 ident: 10.1016/j.cellsig.2020.109871_bb1820 article-title: Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers publication-title: Nat. Cell Biol. doi: 10.1038/ncb1800 – volume: 30 start-page: 838 issue: 8 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb0035 article-title: Ginsenoside Rd reverses cisplatin resistance in non-small-cell lung cancer A549 cells by downregulating the nuclear factor erythroid 2-related factor 2 pathway publication-title: Anti-Cancer Drugs doi: 10.1097/CAD.0000000000000781 – volume: 19 start-page: 240 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb0545 article-title: Long non-coding RNA LINC00485 acts as a microRNA-195 sponge to regulate the chemotherapy sensitivity of lung adenocarcinoma cells to cisplatin by regulating CHEK1 publication-title: Cancer Cell Int. doi: 10.1186/s12935-019-0934-7 – volume: 12 start-page: 9165 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb1540 article-title: Targeting ZEB2 By microRNA-129 In non-small cell lung cancer suppresses cell proliferation, invasion and migration via regulating Wnt/beta-catenin signaling pathway and epithelial-mesenchymal transition publication-title: Onco Targets Ther. doi: 10.2147/OTT.S217536 – volume: 120 start-page: 623 issue: 5 year: 2005 ident: 10.1016/j.cellsig.2020.109871_bb0340 article-title: Involvement of microRNA in AU-rich element-mediated mRNA instability publication-title: Cell doi: 10.1016/j.cell.2004.12.038 – volume: 48 start-page: 1042 issue: 11 year: 2016 ident: 10.1016/j.cellsig.2020.109871_bb1205 article-title: Direct interaction between miR-203 and ZEB2 suppresses epithelial–mesenchymal transition signaling and reduces lung adenocarcinoma chemoresistance publication-title: Acta Biochim. Biophys. Sin. doi: 10.1093/abbs/gmw099 – volume: 12 start-page: 1285 issue: 2 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0290 article-title: DNAH10 mutation correlates with cisplatin sensitivity and tumor mutation burden in small-cell lung cancer publication-title: Aging (Albany NY) doi: 10.18632/aging.102683 – volume: 21 start-page: 937 issue: 3 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0130 article-title: The pentose phosphate pathway and its involvement in cisplatin resistance publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms21030937 – volume: 7 issue: 12 year: 2012 ident: 10.1016/j.cellsig.2020.109871_bb1840 article-title: Docetaxel-resistance in prostate cancer: evaluating associated phenotypic changes and potential for resistance transfer via exosomes publication-title: PLoS One doi: 10.1371/journal.pone.0050999 – volume: 98 start-page: 538 year: 2018 ident: 10.1016/j.cellsig.2020.109871_bb1040 article-title: microRNA-381 suppresses the growth and increases cisplatin sensitivity in non-small cell lung cancer cells through inhibition of nuclear factor-kappaB signaling publication-title: Biomed. Pharmacother. doi: 10.1016/j.biopha.2017.12.092 – start-page: 144623 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0255 article-title: Metformin enhances the sensitivity of colorectal cancer cells to cisplatin through ROS-mediated PI3K/Akt signaling pathway publication-title: Gene doi: 10.1016/j.gene.2020.144623 – volume: 133 start-page: 110807 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb1870 article-title: EGCG enhances cancer cells sensitivity under (60)Cogamma radiation based on miR-34a/Sirt1/p53 publication-title: Food Chem. Toxicol. doi: 10.1016/j.fct.2019.110807 – volume: 21 start-page: 2650 issue: 11 year: 2017 ident: 10.1016/j.cellsig.2020.109871_bb1150 article-title: MiR-146a-5p level in serum exosomes predicts therapeutic effect of cisplatin in non-small cell lung cancer publication-title: Eur. Rev. Med. Pharmacol. Sci. – volume: 118 start-page: 44 year: 2015 ident: 10.1016/j.cellsig.2020.109871_bb0655 article-title: The stress protein TP53INP1 plays a tumor suppressive role by regulating metabolic homeostasis publication-title: Biochimie doi: 10.1016/j.biochi.2015.07.024 – volume: 23 start-page: 3749 issue: 9 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb1530 article-title: LINC00707 promotes cell proliferation and invasion of colorectal cancer via miR-206/FMNL2 axis publication-title: Eur. Rev. Med. Pharmacol. Sci. – volume: 373 start-page: 447 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb0590 article-title: Metal organic framework-graphene nano-composites for high adsorption removal of DBT as hazard material in liquid fuel publication-title: J. Hazard. Mater. doi: 10.1016/j.jhazmat.2019.03.098 – volume: 147 start-page: 104396 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb0055 article-title: Polyphyllin VI, a saponin from Trillium tschonoskii maxim. induces apoptotic and autophagic cell death via the ROS triggered mTOR signaling pathway in non-small cell lung cancer publication-title: Pharmacol. Res. doi: 10.1016/j.phrs.2019.104396 – start-page: 9(1) year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0950 article-title: Role of JAK/STAT3 signaling in the regulation of metastasis, the transition of cancer stem cells, and chemoresistance of cancer by epithelial-mesenchymal transition publication-title: Cells – volume: 32 start-page: 593 issue: 3 year: 2013 ident: 10.1016/j.cellsig.2020.109871_bb1255 article-title: miR-503 regulates the resistance of non-small cell lung cancer cells to cisplatin by targeting Bcl-2 publication-title: Int. J. Mol. Med. doi: 10.3892/ijmm.2013.1439 – volume: 678 start-page: 115 year: 2018 ident: 10.1016/j.cellsig.2020.109871_bb1910 article-title: Purified sulforaphane from broccoli (Brassica oleracea var. italica) leads to alterations of CDX1 and CDX2 expression and changes in miR-9 and miR-326 levels in human gastric cancer cells publication-title: Gene doi: 10.1016/j.gene.2018.08.026 – volume: 118 start-page: 111 year: 2018 ident: 10.1016/j.cellsig.2020.109871_bb0720 article-title: MiR-192 and miR-662 enhance chemoresistance and invasiveness of squamous cell lung carcinoma publication-title: Lung Cancer doi: 10.1016/j.lungcan.2018.02.002 – volume: 7 issue: 8 year: 2019 ident: 10.1016/j.cellsig.2020.109871_bb1565 article-title: Long non-coding RNA NORAD promotes the occurrence and development of non-small cell lung cancer by adsorbing MiR-656-3p publication-title: Mol. Genet. Genomic. Med. doi: 10.1002/mgg3.757 – volume: 84 start-page: 123 year: 2016 ident: 10.1016/j.cellsig.2020.109871_bb1210 article-title: miR-135b reverses chemoresistance of non-small cell lung cancer cells by downregulation of FZD1 publication-title: Biomed. Pharmacother. doi: 10.1016/j.biopha.2016.09.027 – volume: 26 start-page: 499 issue: 5 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb0510 article-title: Upregulation of miR-34c after silencing E2F transcription factor 1 inhibits paclitaxel combined with cisplatin resistance in gastric cancer cells publication-title: World J. Gastroenterol. doi: 10.3748/wjg.v26.i5.499 – volume: 20 start-page: 10 issue: 1 year: 2020 ident: 10.1016/j.cellsig.2020.109871_bb1445 article-title: Knockdown of circ-ABCB10 promotes sensitivity of lung cancer cells to cisplatin via miR-556-3p/AK4 axis publication-title: BMC Pulm Med. doi: 10.1186/s12890-019-1035-z |
| SSID | ssj0015062 |
| Score | 2.6167192 |
| SecondaryResourceType | review_article |
| Snippet | Cisplatin (CP) is a well-known chemotherapeutic agent with excellent clinical effects. The anti-tumor activity of CP has been demonstrated in different cancers... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 109871 |
| SubjectTerms | Chemoresistance Cisplatin Long non-coding RNA Lung cancer MicroRNA |
| Title | Lung cancer cells and their sensitivity/resistance to cisplatin chemotherapy: Role of microRNAs and upstream mediators |
| URI | https://dx.doi.org/10.1016/j.cellsig.2020.109871 https://www.ncbi.nlm.nih.gov/pubmed/33279671 https://www.proquest.com/docview/2467840462 |
| Volume | 78 |
| WOSCitedRecordID | wos000604742800003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVESC databaseName: ScienceDirect Freedom Collection - Elsevier customDbUrl: eissn: 1873-3913 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0015062 issn: 0898-6568 databaseCode: AIEXJ dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1db9MwFLW6DSReEN-Uj8lIiJcpXRInsc1bNXUCVBU0dahvkeMkNFOblqStBn-Gv4qv7aRFbNp44CWKrNiOck5urp177kXobeCxLGVZ4siEuE6QyMDhfiocnpJEqg9aJHW2z69DOhqxyYR_6XR-NVqYzYyWJbu85Mv_CrVqU2CDdPYf4G4HVQ3qXIGujgp2dbwV8MM1yGgBzOoItuXrJkiyqI5qCFc39SLUBGqlDd4jvNrKA5VFvYTAuPJI4Ti3wiydD-rMRiDOIXjvbNQ3I66XoDMRcyM-gaI9u47uiZpZR7hCgIjQib9bbtXTSuTFT5FmUxO5PxNpu4EtqkokhdHeFFvS1dM5CHC0XSrERtTTre2sIemB9sLVwj_d3cfwvSb0uTW9jBKHcKNM7WVXtFl7bUr-WIPruZyZGi5_fQvMtsRFTz_q4ltPTaqzZ9nr_8y9Pfocn54Ph_F4MBm_W353oCwZ_L63NVr20IFPQ67M5kH_42Dyqf1RFbq6Zm17o1uR2PGVM1_n_ly3vNFuzvgBum_XJ7hvePUQdbLyEbprKpb-eIw2wC5s2IX1xFjBgjW78A67jrfcwqsFbrmFd7n1HgOz8CLHLbP0aA2zcMusJ-j8dDA--eDY0h2OJFG4cvJEMJenURDmRC1IJZXSpZH00pT7kodUSAGFHMKICCJE5EVuHmWEpswP_ZyzhDxF--WizJ4j7AlPJiyDvFMySAXn1JU5yYlkUkbS5V0UNE80ljavPZRXmcVNAONFbIGIAYjYANFFvbbb0iR2uakDa-CKrXdqvM5YEe6mrm8aeGNlveEKUWaLdR37yk9hAQjEu-iZwb29G0J8yiPqvbhF75fo3vadeoX2V9U6e43uyM2qqKtDtEcn7NBS9zew9Mrd |
| linkProvider | Elsevier |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Lung+cancer+cells+and+their+sensitivity%2Fresistance+to+cisplatin+chemotherapy%3A+Role+of+microRNAs+and+upstream+mediators&rft.jtitle=Cellular+signalling&rft.au=Ashrafizadeh%2C+Milad&rft.au=Zarrabi%2C+Ali&rft.au=Hushmandi%2C+Kiavash&rft.au=Hashemi%2C+Farid&rft.date=2021-02-01&rft.issn=1873-3913&rft.eissn=1873-3913&rft.volume=78&rft.spage=109871&rft_id=info:doi/10.1016%2Fj.cellsig.2020.109871&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0898-6568&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0898-6568&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0898-6568&client=summon |